The Neural Basis of Psychotic-Like Experiences by Papanastasiou, Evangelos
This electronic thesis or dissertation has been 











The copyright of this thesis rests with the author and no quotation from it or information derived from it 
may be published without proper acknowledgement. 
 
Take down policy 
If you believe that this document breaches copyright please contact librarypure@kcl.ac.uk providing 
details, and we will remove access to the work immediately and investigate your claim. 
END USER LICENCE AGREEMENT                                                                         
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 
International licence. https://creativecommons.org/licenses/by-nc-nd/4.0/ 
You are free to: 
 Share: to copy, distribute and transmit the work  
 
Under the following conditions: 
 Attribution: You must attribute the work in the manner specified by the author (but not in any 
way that suggests that they endorse you or your use of the work).  
 Non Commercial: You may not use this work for commercial purposes. 
 No Derivative Works - You may not alter, transform, or build upon this work. 
 
Any of these conditions can be waived if you receive permission from the author. Your fair dealings and 












Download date: 05. Apr. 2019
University of London 
King’s College London 







The Neural Basis of Psychotic-Like Experiences 







Candidate: Dr Evangelos Papanastasiou  
First Supervisor: Prof Sukhwinder Shergill 
Second Supervisor: Prof Gunter Schumann 















For my dear wife, Eleni  
and my parents, Irene and Giorgos 
ACKNOWLEDGMENTS 3 
 
EVANGELOS PAPANASTASIOU  DOCTORAL THESIS 
Acknowledgments 
First and foremost, I would like to deeply thank my primary supervisor, Prof Sukhi Shergill for 
his enduring support, guidance and input on this research project, throughout the lengthy 
period of 6 years it took to complete. Under his smooth but fixed direction, this thesis came to 
completion by making optimal use of time and resources. His naturally suave leadership 
inspired me to maintain high morale, and to absorb all anxieties, in my darkest moments.  
I would also like to thank my second and third supervisors, Prof Gunter Schumann and Prof 
Philip McGuire, for their critical involvement in various aspects related to this project. They 
both provided highly stimulating comments in preparation of the publications related to my 
thesis. Prof Schumann enabled my unrestricted access to the multitude of IMAGEN data, the 
primary material of my research; Prof McGuire guided and assisted my applications for grants 
required to cover the financial cost of the project.  
I feel particularly indebted to Dr Elias Mouchlianitis, for his priceless support during 
preparation of various technical aspects of the neuroimaging analysis. Elias’ help in drafting 
MATLAB scripts allowed me to perform numerous sets of analyses, in the most time‐efficient 
and clever way; he also offered his valuable comments, as co‐author of related publications 
and helped me to prepare for the oral examination.  
I am equally grateful to Dr Teresa D’ Oliveira for reading through my thesis, providing detailed 
and constructive comments and helping me to prepare for the oral examination.  
I am also very glad to have Dr Dan W. Joyce providing his insightful comments, as a co‐author 
of our related publications, and a reader of the thesis; I am also thankful to Dan for drawing 
my attention to the promising field of personalised psychiatry, highly pertinent to the scope of 
my thesis.  
Finally, I would like to thank all ex‐ and current members of the Cognition and Schizophrenia 
Imaging Lab at the Institute of Psychiatry, Psychology and Neuroscience, in particular Dr 
Thomas White (for introducing me to basic neuroimaging analysis techniques), Dr Rebekah 
Wigton, Dr James Gilleen, Dr Anne Fett, Dr Natasza Orlov, Dr Lucy Vanes and Mrs Tracy Collier. 
They were always keen on answering my numerous questions, and building a nurturing and 
pleasant ambience.    
In preparation of the present work, I have received support from a NIHR Mental Health BRC 
Pilot funding award of £10,000.00 in 2012 and a NIHR CLAHRC South London Fee Support 




EVANGELOS PAPANASTASIOU  DOCTORAL THESIS 
Contents  
Acknowledgments ......................................................................................................................... 3 
Contents ........................................................................................................................................ 4 
List of Tables, Figures & Graphs .................................................................................................... 5 
Background ................................................................................................................................... 6 
Overview of the Thesis .................................................................................................................. 9 
Abstract ....................................................................................................................................... 10 
Chapter I: Biomarkers as Predictors of Psychosis ....................................................................... 12 
Chapter II: Psychotic‐Like Experiences and the CAPE Questionnaire ......................................... 23 
Chapter III: Cognitive Tasks and the Neuroimaging of Schizophrenia ........................................ 48 
Chapter IV: Aim, Materials and Methods ................................................................................... 59 
Chapter V: The Faces Task Study ................................................................................................ 72 
Chapter VI: The Reward Task Study ............................................................................................ 91 
Chapter VII: Conclusions ........................................................................................................... 108 
Curriculum Vitae ....................................................................................................................... 117 
Abbreviations ............................................................................................................................ 118 
Appendices ................................................................................................................................ 122 
Bibliography .............................................................................................................................. 180 
 
  
LIST OF TABLES, FIGURES & GRAPHS 5 
 
EVANGELOS PAPANASTASIOU  DOCTORAL THESIS 
List of Tables, Figures & Graphs 
Tables 
Table 1: CAPE‐42 Clusters ........................................................................................................... 37 
Table 2: IMAGEN Exclusion Criteria ............................................................................................ 61 
Table 3: Epidemiological Characteristics, Overall Sample .......................................................... 63 
Table 4: FT Study, Factorial Analysis, Mixed Model 2‐Way ANOVA, General Stratification ....... 76 
Table 5: FT Studies, Summary of Findings, General Stratification .............................................. 78 
Table 6: FT Study, Factorial Analysis, Mixed Model 2‐Way ANOVA, Specific Stratification ....... 80 
Table 7: FT Study, Summary of Findings, Specific Stratification ................................................. 81 
Table 8: CANTAB Measures Factorial Analysis, Mixed Model 2‐Way ANOVA, General & Specific 
Stratification ................................................................................................................................ 82 
Table 9: CANTAB Measures, Summary of Findings, General & Specific Stratification ............... 84 
Table 10: MID Study, Factorial Analysis, Mixed Model 2‐Way ANOVA, General Stratification .. 95 
Table 11: MID Study, Summary of Findings, General Stratification ........................................... 97 
Table 12: MID Study, Factorial Analysis, Mixed Model 2‐Way ANOVA, Specific Stratification .. 99 
Table 13: MID Study, Summary of Findings, Specific Stratification .......................................... 100 
Table 14: FT Studies, Summary of Findings, High PLE Group ................................................... 110 
Table 15: MID Studies, Summary of Findings, High PLE Group ................................................ 112 
Table 16: CANTAB Studies, Summary of Findings, High PLE Group .......................................... 113 
Figures 
Figure 1: From Genotypes to Endophenotypes and Single Phenotypes. ................................... 49 
Figure 2: FT Study, ROIs selected for Analysis, General Stratification ........................................ 75 
Figure 3: FT Study, ROIs selected for Analysis, Specific Stratification ........................................ 79 
Figure 4: MID Study, ROIs selected for Analysis, General Stratification ..................................... 94 
Figure 5: MID Study, ROIs selected for Analysis, Specific Stratification ..................................... 98 
Graphs 
Graph 1: CAPE Grand Total Scores Frequencies Histogram........................................................ 66 
Graph 2: CAPE 3‐Items Score Frequencies Histogram ................................................................ 67 
Graph 3: FT Study, Longitudinal Analysis Graphs, General Stratification ................................... 77 
Graph 4: FT Study, Longitudinal Analysis Graphs, Specific Stratification ................................... 81 
Graph 5: CANTAB Measures, Longitudinal Analysis Graphs, General & Specific Stratification .. 83 
Graph 6: MID Study, Longitudinal Analysis Graphs, General Stratification ................................ 96 




EVANGELOS PAPANASTASIOU  DOCTORAL THESIS 
Background 
Despite ongoing research in the field of psychosis, its aetiology remains an enigma. Psychosis 
proved to be a convoluted brain disorder and lack of a biological understanding has had a 
negative impact on the development of efficient treatments, which further undermined the 
health and well‐being of sufferers.  
Contemporary models of psychosis have enriched the long‐standing dopamine hypothesis 
(subcortical pre-synaptic hyperdopaminergia with prefrontal hypodopaminergia) with the 
addition of the aberrant salience hypothesis: context‐independent firing of dopamine 
neurons, produces an aberrant sense of novelty and salience to irrelevant stimuli. This can give 
rise to development of hallucinations, and delusions, as cognitive explanations to account for 
abnormal experiences. The aberrant salience model has thus placed “top-down” cognitive 
control mechanisms at the core of the aetiology of psychosis and has reinforced the use of 
various cognitive tasks, alone or in combination with functional neuroimaging, as paradigms 
for the study of psychotic phenomenology. Among the several tasks employed, reward-based 
tasks were often selected to explore aberrant salience and more socially‐relevant processes of 
psychosis, while face perception tasks were chosen to assess cognitive control and 
emotionally‐relevant processes of psychosis. 
Another persistent idea in psychosis studies has been the developmental model, which 
postulates that psychosis emerges as the lengthy outcome of multiple insults to normal brain 
development, dating from in utero life, through childhood to adolescence; this morbid process 
is further perplexed by the interplay of genetics and the environment. Due to the complex 
nature of these pathogenic interactions, various degrees of symptomatology can be observed, 
ranging from subtle prodromal manifestations, to fully blown clinical presentations. This was 
conceptualised in the prevalent notion of the psychosis continuum or the extended psychosis 
phenotype: psychotic symptoms are not “all‐or‐nothing” phenomena but form a spectrum 
with normal experiences. The natural history of these symptoms was typically described as 
starting with a transitory state (psychosis proneness) which later becomes abnormally 
persistent and finally clinically significant. This is how the concept of ultra-high-risk for 
psychosis or the at-risk-mental-state emerged: individuals with sub‐clinical psychotic 
manifestations, called psychotic-like-experiences or attenuated psychotic symptoms, carry an 
increased risk for future transition to psychosis. The model was supported by a wealth of 
epidemiological and neuroimaging data, such the presence of dysconnectivity between various 
brain areas across the whole psychosis spectrum; further use of functional neuroimaging was 
consequently seen as the royal road to discover brain biomarkers as predictors of psychosis. A 
notable consequence of the psychosis continuum model, is that the study of psychosis should 
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no longer be restricted to clinical populations; healthy people at high risk for psychosis could 
also offer a useful test of this new paradigm in more accessible and more widely available 
samples.  
I was fortunate in gaining access to a large cohort of adolescents from the IMAGEN project, 
part of an existing longitudinal study, combining neuroimaging data during a face perception 
and a reward-based task, selected measures from CANTAB neurocognitive battery with 
measures of psychotic-like experiences, and observing my subjects during early and late 
adolescence. My aim was to investigate the neural correlates of this prodromal * psychotic 
presentations beyond the bounds of the illness phenotype, the use of antipsychotic 
medication, and test the continuum models of psychosis.  
I spent 6 years in total, working on this project part‐time, between July 2012 and July 2018. 
The momentum was quite right when I joined the IMAGEN team, as their second follow‐up (at 
age 19, our FU data) was about to begin, and the introduction of CAPE‐42 (our basic tool for 
the measurement of psychotic‐like experiences) to the battery of assessments come just at the 
right time.  
The initial phase of my studies, years 2012-2014, was spent in familiarising with the extend of 
IMAGEN database; obtaining a fund of £10,000.00 to support the introduction of CAPE‐42; 
learning to apply neuroimaging analysis by attending SPM courses; practising neuroimaging 
analysis and the use of MATLAB scripts in limited data sets from age 14 and some preliminary 
CAPE data; refining the design of the studies; drafting initial versions of introductory chapters 
(biomarkers of psychosis, psychotic‐like experiences, CAPE questionnaire, cognitive tasks in 
schizophrenia) by conducting extended literature reviews.  
Data from our FU endpoint started becoming available from year 2015 and a new IMAGEN 
database become available, providing data with enhanced quality. I spent this year in 
compiling all anonymised data that were used in my main analysis. Customised spreadsheets 
with behavioural and neurocognitive data were prepared, while neuroimaging data were 
stored in KCL servers, to allow safe storage and back‐up and fast analysis via remote access.  
Yeas 2016 was spent in conducting the main bulk of neuroimaging and consecutive factorial 
and exploratory analysis. Writing of study methodology and results was conducted during year 
2017. Finally, the drafting of the thesis, plus the preparation and submission of related articles 
                                                          
* The term “prodromal” is used in the thesis interchangeably with sub‐clinical to indicate either subtle 
forms of symptoms and/or a potential of transition to more clinically significant manifestations; thus its 
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to high‐impact factor journals was carried over in year 2018, with publication process being 
ongoing at the time of submission, in May 2018. By the time of my oral examination, in July 
2018 one article describing findings from the reward task, was already accepted for publication 
in JAMA Psychiatry.  
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Overview of the Thesis 
In Chapter I,  a selective review of the literature on key predictors of psychosis is provided, 
considering that the hunt for early biological markers of psychosis has been a major driving 
force for the present research. I list a representative selection of the many clinical, 
epidemiological, cognitive, genetic and neuroimaging studies which illustrate the complexity of 
the psychosis phenotype.  
Chapter II, consists of two parts. In the first one, I review the literature on Psychotic‐Like 
Experiences (PLE), the paradigm which was employed as a proxy for the sub‐clinical 
manifestations of the psychotic phenotype. I examine the clinical, epidemiological and 
neuroimaging findings in individuals with this phenotype, and also the relationship of PLE with 
other aspects of the psychosis continuum. In the second part, I present the literature on the 
CAPE‐42 questionnaire, the screening tool for PLE in the general population which was used in 
my studies; validation and cut‐off levels for transition to psychosis are discussed, along with 
results from well‐known longitudinal cohorts which employed this tool.  
In Chapter III, I describe the face (FT) and reward (MID) tasks that were used in conjunction 
with functional neuroimaging in my studies and I summarize the wealth of fMRI data on those 
two tasks found in the literature of schizophrenia populations. As my study sample 
encompasses adolescents, I also provide a summary of neuroimaging data on the developing 
adolescent brain and some aberrant patterns observed in schizophrenia during this critical 
neurodevelopmental phase. 
In Chapter IV, I describe the methodology of my studies, including my hypotheses, participants, 
material and analytical methods.  
In Chapter V and Chapter VI, I present the results of the FT and MID neuroimaging studies 
respectively and the associated neurocognitive results; I also discuss the interpretation of 
those results, under the light of the relevant literature and contemporary models of psychosis.  
Finally, in Chapter VII, the main results of both studies are reviewed in order to provide a 
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Abstract 
Objective 
Psychotic‐Like Experiences (PLE) are subclinical manifestation of psychotic symptoms and may 
reflect an increased vulnerability to psychotic disorders. Contemporary models of psychosis 
propose that dysfunctional reward processing and emotional dysregulation is involved in the 
aetiology of psychosis.  
Objective 
To examine the neuroimaging profile of healthy adolescents with an increased presence of 
PLE, during a face processing and a reward processing task.  
Method 
1,434 adolescents were assessed at two timepoints using functional MRI during a Faces Task 
(FT) and a Monetary Incentive Delay (MID) Task at age 14 and 19 years. The sample was 
stratified into two groups of high PLE and low PLE based on their scores on the CAPE‐42 
questionnaire at age 19. The first level analysis focused on a pre‐defined contrast of [Angry 
Faces] – [Control Stimuli] for the FT and two pre‐defined contrasts of [Anticipation of Large 
Win] – [Anticipation of No Win] and [Feedback of Large Win] – [Feedback of No Win] for the 
MID task. The second level analysis examined between‐group differences using an a priori 
defined region of interest approach (ROIs). I performed a factorial analysis to examine the 
main effects of group, time and their interaction on brain activation. Additionally, I performed 
an exploratory analysis, by employing both a cross‐sectional design to compare brain 
activation levels between the high PLE and low PLE groups at ages 14 and 19, and a 
longitudinal design to compare brain activation levels between the two timepoints.  
Results 
FT: Adolescents presenting with elevated overall PLE scores at age 19 years exhibited an early 
state (BL) of hyperactivation in right insular cortical areas, during perception of angry faces; 
this was replaced by a later state (FU) of hypoactivation in right prefrontal and right limbic 
cortical areas and left striatal subcortical areas, during perception of angry faces. There was a 
decrease in activation of right limbic cortical areas, from BL to FU, in the high general PLE 
group.  
MID: Adolescents presenting with elevated overall PLE scores at age 19 years exhibited an 
early state (BL) of hypoactivation in left and right prefrontal and left limbic cortical areas, 
during reward feedback; this was replaced by a later state (FU) of hypoactivation in right 
ABSTRACT 11 
 
EVANGELOS PAPANASTASIOU  DOCTORAL THESIS 
striatal subcortical areas, during the reward anticipation. There was also an increase in 
activation of left and right prefrontal areas, from BL to FU, in the high general PLE group.  
Conclusions 
The FT results suggest evidence of aberrant changes during adolescent development with 
reduced limbic and insular activation over time; this might reflect an under‐recruitment of 
critical areas during perception of emotional faces.  
The MID task results suggest evidence of compensatory changes during adolescent 
development with increased prefrontal activation over time; this might allow cognitive control 
mechanisms to contextualise the PLE, so to prevent transition to clinically significant 
symptoms; an observation which is consistent with the aberrant salience model of psychosis.  
My findings reinforce the role of prefrontal, limbic and striatal brain areas in the aetiology of 
psychosis, beyond the bounds of the illness phenotype and without the confounds of the 
impact of the illness or the use of antipsychotic medication. 
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1.1. Introduction 
Mental disorders in Europe are present in 38% of the population contributing to 26% of health 
burden and being a major cause of disability 1. It is widely recognised that the increase in 
chronicity of mental illness is directly linked to poorer outcomes, which is broadly explained by 
neurodegenerative brain changes 2. Both in affective 3 and psychotic 4 disorders, a longer 
duration of untreated illness is associated with poorer response or treatment‐resistance. The 
idea that early intervention in psychiatric disorders can delay or even prevent transition to a 
clinical syndrome was first introduced in the field of psychosis 5 and is an important feature in 
the contemporary management of mental illness. Early intervention is based on the premise of 
identifying populations who are at high‐risk of developing mental disorders, based on their 
epidemiological, clinical or biological characteristics. The concept of the at‐risk‐mental‐state 
(ARMS), has evolved in psychosis to describe people with early prodromal symptoms who may 
later develop a clinical psychotic disorder 6. Transitory developmental expression of psychosis 
(psychosis proneness) may become abnormally persistent (persistence) and subsequently 
clinically relevant (impairment), depending on the degree of environmental risk the person is 
additionally exposed to 7†. Tools using dimensionally scored symptoms, such as the 
Comprehensive Assessment of At‐Risk Mental States (CAARMS) have been developed to allow 
for a better detection of those potentially vulnerable individuals 8. It is crucial to identify key 
biological markers of elevated risk in order to optimise prediction.   
Despite recent advances in the field of neuroimaging and genetics, and a wealth of relevant 
research with regards to psychiatric disorders, including psychosis, there has been very limited 
application to routine psychiatric practice to inform diagnosis and clinical decisions. The lack of 
a clear mechanism underpinning the pathophysiology of psychiatric disorders, and the use of a 
categorical nosology have been mooted as the key factors in hindering the identification of 
biomarkers in clinical use 9.  
1.2. Clinical and Epidemiological Features of Psychosis 
Several literature reviews have addressed the predictive value of various sub-clinical and 
clinical features, seen before the onset of psychotic disorders;  
 Premorbid adjustment in adolescents and Global Assessment of Functioning (GAF) in 
adolescents and adults (before and after First Episode Psychosis, FEP) are the best 
predictors of diagnosis following a FEP. GAF (before and after FEP) is the best predictor of 
outcome (adolescents and adults) 10.  
                                                          
† This developmental model of psychosis is further discussed in chapter II. 
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 The strongest risk factor for schizophrenia is familial risk with genetic loading. Other risk 
factors include pregnancy and delivery complications, infections during pregnancy, 
disturbances of early neuromotor and cognitive development and heavy cannabis use in 
adolescence 11. 
 Across studies, severity of sub‐threshold positive symptoms, poorer social functioning, and 
genetic risk for schizophrenia appear to be consistent predictors of conversion to 
psychosis, with algorithms combining these indicators achieving positive predictive power 
> 80% 12. 
 On average 76% (range 46‐92.6%) of the UHR patients made no transition to psychosis 
during follow‐up (range 6 to 40 months). An older mean age at baseline was associated 
with significant lower transition rates in publications with follow‐ups exceeding 1 year 13. 
 In their comprehensive review, Fusar-Poli et al. presented findings on clinical predictors of 
transition to psychosis from high‐risk states 6. The authors concluded that positive 
predictive values (PPV) ranged from 65 to 86% for various combinations of positive, 
negative and cognitive symptoms.  
 Psychotic Experiences (PE) predict onset of later psychotic disorder (at a rate of 0.6%) per 
year, particularly if persistent 14. Of those who report PE, ~20% go on to experience 
persistent PE whereas for ~80%, PE will remit over time 15.  
The role of cannabis as a risk factor for psychosis has been widely investigated: 
 Early use of cannabis did appear to increase the risk of psychosis (derived odds ratio=2.9, 
95% CI=2.4‐3.6). For psychotic symptoms, a dose‐related effect of cannabis use was seen, 
with vulnerable groups including individuals who used cannabis during adolescence, those 
who had previously experienced psychotic symptoms, and those at high genetic risk of 
developing SCZ 16. 
 There is an increased risk of any psychotic outcome in individuals who had ever used 
cannabis (pooled adjusted odds ratio=1.41, 95% CI=1.20–1.65). Findings were consistent 
with a dose‐response effect, with greater risk in people who used cannabis most 
frequently (2.09, 95% CI=1.54–2.84). This is independent of confounding and transient 
intoxicating effects 17.  
Childhood trauma (CT) has been associated with the development of psychosis, as stated by 
two selective reviews:  
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 Hallucinations and delusions have been implicated as factors in the relationship between 
CT and psychosis. This link can take multiple directions: early CT contribute to maladaptive 
psychological schemas that influence the appraisal of abnormal experiences such as 
fleeting hallucinations or paranoid thoughts; or alternatively hallucinations and delusions 
are variants of post‐traumatic intrusions, such as flashbacks and nightmares 18. 
 The causal association between CT and psychosis is strong (odds ratios in the order of 3) 
and significant when controlling for genetic risk; reverse causation (psychosis to CT) is 
unlikely to explain the association. Plausible neurobiological mechanisms linking adverse 
experiences to psychosis, include sensitization of the mesolimbic dopamine system,  
changes in the stress‐related brain structures and expression of genes regulating mood 19. 
Pre‐schizophrenia individuals have more social deficits compared with controls. Furthermore, 
beginning in childhood, poor social functioning may be a relatively sensitive and potentially 
specific predictor of schizophrenia. Key results for each domain of social functioning, which 
derived from a systematic review of the literature, are summarised here 20: 
 Poor undifferentiated social functioning is a moderately sensitive predictor of SCZ among 
children aged 7‐8 but not during infancy or preschool age. 
 Antisocial / externalizing behaviour is a reasonably sensitive and moderately specific 
predictor of SCZ among children aged 5‐12. 
 Social withdrawal / internalising behaviour is a moderately sensitive predictor of SCZ, 
beginning around age 11. 
 Peer dislike may be a sensitive but not specific predictor of SCZ among children aged 5‐11. 
The 3 following clinical studies are mentioned exceptionally, as they focused primarily in 
clinical predictors of psychosis:  
 The Basel Early Detection of Psychosis Clinical Study (Früherkennung von Psychosen, 
FEPSY, 2009) 21: the most powerful transition predictors within this population selected 
were attenuated psychotic symptoms (suspiciousness), negative symptoms (anhedonia / 
asociality), and cognitive deficits (reduced speed of information processing). With these 
predictors in mind and considering an integrated model for predicting transition to 
psychosis, the overall predictive accuracy was 80.9% with a sensitivity of 83.3% and a 
specificity of 79.3%. 
 The European Prediction of Psychosis Study (EPPS, 2010) 22: a prediction model was 
developed and included positive symptoms, bizarre thinking, sleep disturbances, a 
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schizotypal disorder, level of functioning in the past year, and years of education. With a 
PPV of 83.3%, diagnostic accuracy was excellent. A 4‐level prognostic index further 
classifying the general risk of the whole sample predicted instantaneous incidence rates up 
to 85% and allowed for an estimation of time to transition. 
 The North American Prodrome Longitudinal Study (NAPLS, 2011) 23: three variables were 
found to be associated with transitions from the at‐risk‐mental‐state to psychosis: high 
unusual thought content scores; low functioning; and having genetic risk with functional 
decline. A combination of 2 out of 3 of these features produces a reasonable predictive 
validity (PPV = 65.4%, specificity = 87.2%).  
In summary, several epidemiological features, ranging from the use of cannabis and childhood 
trauma, to social deficits and a variety of prodromal psychotic features have been associated 
with the emergence of psychosis; however, it has not been always possible to establish a clear 
causal link in these associations.  
1.3. Cognition and Psychosis 
Years before the onset of psychotic symptoms, individuals with schizophrenia, as a group, 
demonstrate mean IQ scores approximately one‐half of a standard deviation below that of 
general population 24. 
Cross‐sectional investigations of neurocognitive baseline assessments in high‐risk samples with 
unknown conversion status have produced rather inconsistent results. Most convincing 
evidence has established  abnormal performance during  processing speed measures (Digit 
Symbol Coding, Trailmaking Test‐B, Stroop Colour Naming), the Continuous Performance Test, 
verbal working memory measures, verbal memory and learning, and verbal fluency, though 
negative findings have also been reported in every instance 25. 
1.4. Genetics of Psychosis 
A number of recent and older reviews of Genome‐Wide Association Studies (GWAS) and Copy 
Number Variants studies (CNV) have attempted to identify candidate genes for schizophrenia 
(SCZ): 
 Associations between Hyman Leucocyte Antigen (HLA) polymorphisms on chromosome 6 
and SCZ risk have been evaluated for over 5 decades and re‐emerged in the GWAS era, 
with studies providing statistically significant results 26; 
 There is an involvement of the Major Histocompatibility Complex (MHC) genes in SCZ 
susceptibility 27; 
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 Risk genes associated with SCZ included zinc finger binding protein 804A (ZNF804A), MHC 
region on chromosome 6, neurogranin (NRGN) and transcription factor 4 (TCF4) 28; 
 Various candidate genetic loci were reported to have significant interactions with 
environmental factors in increasing SCZ risk 29; several examples are reported:  
 Gene*Cannabis: COMT Val158Met allele, Protein kinase B gene (AKT1 rs2494732, 
rs1130233) and LRRTM1 (rs673871), DAT1 gene; 
 Gene*Seasonability of Birth: Human Leucocyte Antigen (HLA)‐DR1, MTHFR C677T 
(rs1801133) 
 Gene*Stress: COMT Val158Met allele, MTHFR C677T; 
 Gene*Childhood Abuse/Trauma: BDNF Val66Met allele; 
 Gene*Obstetric Complications: AKT1 (rs2494735, rs3803300, rs1130233), BDNF 
(rs2049046, ss76882600), DTNBP1 (rs875462) and GRM3 (rs7808623). 
In summary, various genetic loci are thought to convey a genetic risk for SCZ / psychosis 
(including MHC, HLA, COMT, BDNF). Current research attempts to shed light in the convoluted 
interactions of these loci with environmental factors in increasing SCZ risk.  
1.5. Neuroimaging of Psychosis 
A number of recent reviews focused on the neuroimaging profile of prodromal psychosis (the 
At‐Risk‐Mental‐State (ARMS) or [Ultra]‐High‐Risk (HR or UHR) for psychosis), chronic psychosis 
(schizophrenia) and the relatives of psychotic patients.  
1.5.1. Reviews of Studies on Prodromal Psychosis Populations 
A selective review of Fusar-Poli et al. focused on the integration of findings across various 
imaging modalities (structural, functional and neurochemical imaging) 30. The authors report 
their core findings in prodromal psychosis populations:  
 Altered prefrontal activation during a task of executive working memory was directly 
related to striatal hyperdopaminergia; this provided evidence of an association between 
dopamine dysfunction and abnormal prefrontal function.  
 Medial temporal cortical dysfunction (during a memory task) and perturbed glutamatergic 
neurotransmission, both regarded as fundamental pathophysiological features of 
psychosis, were not linked.   
Additional evidence resulted from two more systematic reviews of studies on HR populations, 
coming from the same research team. Smieskova et al. 31,32 selected studies with structural, 
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functional and multimodal neuroimaging data of HR populations. They categorised subjects 
based on (a) the presence of hereditary factors (G‐HR) or clinically manifested symptoms (C‐
HR) and (b) transition (HR‐T) or non‐transition (HR‐NT) to psychosis. The following core results 
were described:   
 Structural findings. Deficits in temporal, cingulate and cerebellar regions were seen in G‐
HR, with additional prefrontal, insular and caudate deficits in C‐HR. Progressive prefrontal 
deficits related to transition to psychosis were noted in C‐HR. Decreased prefrontal, 
cingulate, insular and cerebellar gray matter volume (GMV) was described in HR‐T, 
compared to HR‐NT subjects. 
 Functional findings. Using the cognitive paradigms of working and verbal memory and 
social tasks, abnormalities in prefrontal, cingulate and middle temporal areas were seen in 
G‐HR, with additional parietal, superior temporal and insular abnormalities in C‐HR. 
Transition to psychosis was more detectable in C‐HR and linked to changes in prefrontal, 
hippocampal and striatal regions. Reduced brain activation in prefrontal and cingulate 
cortices was described in HR‐T, compared to HR‐NT subjects. Overall, neurofunctional 
deficits distinguishing HR subjects from healthy controls were spotted in prefrontal, 
temporal, parietal, striatal and cerebellar regions, during a variety of cognitive tasks. 
 Multimodal studies correlated psychotic symptoms with altered prefrontal and 
hippocampal activation and striatal dopamine and thalamic glutamate function. 
The above results were challenged by a recent selective review of neuroimaging findings in the 
ARMS 33. Wood et al. state that studies in this population show differences from healthy 
people, but not outside the normal range, and the overall lack of consistency question the 
utility of neuroimaging in predicting the development of psychosis. However, it was noted that 
activation of the stress system and increased striatal dopamine synthesis was indicative of 
later transition to psychosis.   
The authors of another review focused on the volume of pituitary gland (reflecting activation 
levels of Hypothalamus‐Pituitary‐Adrenal axis) in UHR for psychosis, FEP and SCZ populations 
34. Nordholm et al. found a trend of a larger pituitary volume in both Ultra‐High Risk (UHR) for 
psychosis subjects who had transitioned to psychosis and in FEP subjects compared to healthy 
controls; antipsychotics and female gender were also positively correlated with pituitary 
volume.  
In summary, neuroimaging studies on subjects with a proneness to psychosis have revealed 
structural and functional abnormalities compared to healthy controls. Functional ROIs, found in 
CHAPTER I: BIOMARKERS AS PREDICTORS OF PSYCHOSIS 19 
 
EVANGELOS PAPANASTASIOU  DOCTORAL THESIS 
the prefrontal, cingulate and temporal cortices, the insula, the cerebellum and the striatum 
more frequently show reductions in brain activation, during a variety of cognitive tasks 
including working and verbal memory and social tasks. Structural ROIs, found in all the above 
areas, show mainly reductions in GMV.  
1.5.2. Reviews of Studies on Schizophrenia Populations 
Numerous reviews focused on structural and functional neuroimaging findings of studies of 
populations with established diagnosis of schizophrenia, and multiple findings are reported 
below: 
 Anterior cingulate volumes were significantly reduced in SCZ populations compared to 
healthy controls 35; 
 White matter tractography: review of diffusion tensor imaging (DTI) studies in SCZ 
revealed abnormalities, such as decreased fractional anisotropy (FA) along with increased 
diffusivity within prefrontal and temporal lobes, as well as abnormalities within fiber 
bundles connecting these regions (including the uncinated fasciculus, the cingulum bundle 
and the arcuate fasciculus) 36;  
 Structural (loss of asymmetry in diffusion anisotropy in the uncinate fasciculus) and 
functional (reduced left lateralisation, increased right or bilateral brain activation) 
abnormalities in brain regions involved with language perception and processing were 
noted in SCZ patients 37;  
 Earlier studies In SCZ have observed functional abnormalities in regions known to be 
critically involved in social cognition, such as the medial prefrontal cortex (theory of mind 
tasks), the amygdala (emotion perception tasks) and the inferior parietal lobes (agency 
judgments) 38;  
 Negative symptoms were related to the functioning of the VLPFC and Ventral Striatum. 
Positive symptoms, particularly persecutory ideation, were related to functioning of the 
medial PFC, the amygdala, and the hippocampus/parahippocampal region. Disorganization 
symptoms, although less frequently evaluated, were related to the functioning of the 
DLPFC. No symptom domain had a consistent relationship with the middle or superior 
temporal regions 39; 
 A modest under‐recruitment of bilateral amygdalae during processing of emotionally 
aversive stimuli has been consistently found in patients with SCZ 40; 
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 Cerebellar hypoactivation was reported in the majority of group comparisons (SCZ vs 
controls) following an inverted U‐shape pattern across ages (maximum hypoactivation 
noted in the 3rd decade of life) 41; 
 Patients with SCZ‐spectrum disorders demonstrate ventral striatum (VS) hypoactivation 
during reward anticipation 42; 
In summary, neuroimaging studies on SCZ patients have revealed a wealth of structural and 
functional abnormalities compared to healthy controls, involving the prefrontal (DLPFC) and 
temporal cortices, the amygdala, the hippocampal and parahippocampal regions and the white 
matter tracts connecting those areas.  
1.6. Shared Biomarkers 
Interestingly enough, a number of biomarkers, appear to be shared between SCZ and other 
psychiatric disorders, such as Attention‐Deficit Hyperactivity Disorder (ADHD), Autistic 
Spectrum Disorders (ASD) and Bipolar Affective Disorder (BPAD):  
Cognition: various degrees of executive dysfunction can be seen in ADHD 43, SCZ and less in 
BPAD 44; 
Neuroimaging: GM and WM deficits are shared between ADHD 45, BPAD 46 and SCZ. Decreased 
thalamic volumes are findings in both ADHD and BPAD; decreased hippocampal volumes are 
findings in both BPAD and SCZ. Perturbed frontal lobe activation as well as altered connectivity 
between cortical and subcortical regions are seen in all disorders.  
Genetics: BPAD and SCZ share a certain degree of genetic load (ZNF804A, CACNA1C, NRGN, 
PBRM1) 28; whilst CNVs are encountered in both disorders, largest deletions and duplications 
are more likely found in SCZ rather than BPAD. CNVs (such as deletions of NRXN1) as important 
risk factors for ASD and SCZ, while common SNP alleles are seen in ASD, BPAD and SCZ 47. 
1.7. Conclusion 
I acknowledge that the majority of biomarkers described so far, cannot be assumed to 
represent ‘predictors’ of psychosis. Most of the reviews presented in this chapter, summarise 
the findings of studies focusing on either genetic or neuroimaging biomarkers of behavioural 
phenotypes. These studies have primarily included individuals who have already developed 
psychosis, either at an early or a late stage; and less frequently non‐psychotic subjects at risk 
of developing psychosis. I have however to accept that in the case of chronically psychotic 
patients, these biological features might very well represent epiphenomena of processes 
related to the pathophysiology of psychosis, which broadly remain unknown to us, or even be 
linked to brain alterations, due to the use of psychotropic medications. It is therefore 
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meaningful that the hunt for biological predictors of mental disorders could initially focus on 
those brain areas or genetic loci linked to the fully developed disorders, as I can hypothesize 
that some of those features might predate the development of the illness. To confirm this 
hypothesis, one will require longitudinal studies on general population, which will aim to 
identify subjects at UHR for developing an abnormal psychotic phenotype, based on their 
biological profile.  
In the meantime, a number of epidemiological studies of clinical features have tried to identify 
predictors of psychosis. Some of those studies have shown that prodromal psychotic 
symptoms in combination with the level of premorbid social functioning and the genetic risk 
for schizophrenia can have a positive predictive power in the area of 80% 12. It would be of 
great interest to see more of those studies developed in the future, with a special focus on 
brain and genetic features.  
There is a plethora of screening tools developed so far, spotting the pre‐psychotic states, 
designed for children and adolescents populations, and using behavioural data at most. Among 
the most widely used are the Community Assessment of Psychic Experience – a self‐reported 
questionnaire (CAPE‐42) 48 and the CAARMS 49.  
There is equally a multitude of cognitive tasks employed so far, alone or in combination with 
functional neuroimaging, for the study of psychotic or UHR populations. Cognitive deficits 
typically described in psychosis include a dysexecutive syndrome which encompasses 
impairments in working memory, planning, attention span and inhibitory control. In the more 
recent years, an increasing interest in other aspects of psychosis, such as social cognition and 
emotion processing has resulted in the expanding use of reward tasks and face emotion 
recognition tasks. As social cognition deficits are seen across the whole spectrum of the 
psychosis continuum and show strong associations with functional outcomes 50, there is scope 
for the application of reward tasks in the quest for neuroimaging biomarkers.  Similarly, as 
emotion dysregulation is seen at the core of the vulnerability to psychosis 51, use of face tasks 
could also provide important insights during the neuroimaging investigation of related 
disorders. 
Nevertheless, a reasonable observation is that very few (if any) of the proposed ‘predictors’ of 
psychosis in any modality (e.g. genetics, neuroimaging) have been submitted to analysis of 
prediction at the individual level. The status of any biomarker as a ‘predictor’ has been based 
on statistical associations which are largely dependent on the design of the study, rather than 
on empirical proof. When reverse causality is ruled out, a consistent association of X predicting 
Y, leads to an assertion that for any participant you can predict Y given X. This is exemplified on 
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the notion of PPV in UHR for psychosis populations, which can be often troubling as PPV 
depends on the prevalence of the condition; UHR is rare, transition to psychosis even rarer.  
There is an increased need to integrate those data into a comprehensive theory, which could 
account for the pathophysiology and aetiology of psychosis, with implications to early 
detection, diagnosis and management. A model for this can be the application of multimodal 
fusion methods in the study of schizophrenia. Various paradigms have been described so far, 
including function‐function (fMRI‐EEG/ERP), structure‐structure (GM‐WM), function‐structure 
(fMRI‐DTI), function‐genotype (fMRI‐SNPs), structure‐genotype (sMRI‐SNPs) 52. This approach 
allows for the study of maps of neuronal connections in human brain (the connectome) to 
either a cellular level (links with the proteome and genome) or to a macro scale, and could 
provide a more integrated vehicle to understand psychosis.  
1.8. Summary of Biomarkers of Psychosis 
Clinical and Epidemiological: prolonged use of cannabis, experience of prodromal psychotic 
symptoms, deficits in social functioning, traumatic experiences during childhood; 
Cognition: reduced IQ scores, deficits in executive functions including processing speed, 
working memory and verbal fluency; 
Neuroimaging: most of the abnormalities identified are shared between SCZ patients and UHR 
subjects, which places those alterations at the core of the psychosis continuum aetiology.  
 Structural abnormalities: GM and WM abnormalities, deficits in frontal, temporal and 
cingulate regions, smaller hippocampal volume.  
 Functional abnormalities: abnormal prefrontal and temporal cortices activation (fronto‐
temporal dysconnectivity) during executive and memory tasks, abnormal activation of the 
amygdalae during emotional tasks and cortico‐striatal dysconnectivity during reward tasks. 
Genetics: associations with numerous genetic loci (MHC, HLA, COMT, BDNF), which can also 
interact with environmental factors in increasing the risk of psychosis.  
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2.1. PLE, why are they important? 
Various terms have been used to refer to the sub‐clinical manifestations of the psychosis 
phenotype, including psychosis proneness, psychotic‐like experiences (PLE), attenuated 
psychotic symptoms (APS) and schizotypy. A developmental model of psychosis describes 
transitory symptoms (psychosis proneness) becoming abnormally persistent (persistence) and 
subsequently clinically relevant (impairment) 53. This model is in line with the view that 
psychotic symptoms are not “all‐or‐nothing” intrinsically pathological phenomena but fall 
within the spectrum of normal experiences, referred to as the extended psychosis phenotype 
or psychosis continuum 54. The model is supported by the high prevalence rate of delusional or 
hallucinatory experiences in the general population, substantially higher that the prevalence 
rates of psychotic disorders 55. The model also postulates that PLE are associated with 
increased risk of future onset of a psychotic disorder, particularly when they are persistent, 
taking also into account that PLE do not constitute a unitary phenomenon and present in 
different types with different trajectories and underlying causes 56. Per this consideration, PLE 
are overdetermined phenomena in the sense that they might be present for different reasons:  
 An expression of an underlying, more fundamental disturbance. 
 An expression of ‘clinical noise’ around a non‐psychotic syndrome and not necessarily 
associated with distress or disability. 
 Present in non‐clinical ‘normal’ individuals, not associated with distress or disability or 
increased vulnerability to psychotic disorder. 
As PLE share a number of risk factors with schizophrenia, they offer a useful non‐clinical 
phenotype to study the aetiology of psychotic disorders 57; furthermore lack of exposure to 
anti‐psychotic agents, and illness chronicity offers a unique opportunity to study the putative 
neural correlates of psychosis in drug‐naïve subjects. 
2.1.1. Epidemiology and Aetiology of PLE 
The prevalence of PLE has been the focus of several literature reviews. A meta‐analysis by Jim 
van Os et al. in 2010, revealed that PLE appear to be common in the general population having 
a median prevalence rate of 5% and a median incidence rate of 3%. Small differences between 
prevalence and incidence rates, along with data from follow‐up studies suggest that 75‐90% of 
PLE are transient and disappear over time 53. In a similar later review from 2012, Kelleher et al. 
estimated the median prevalence of psychotic symptoms among children aged 9 to 12 at 17% 
and among adolescents aged 13 to 18 at 7.5% 58. It appears that PLE, given their broader 
definition, are expected to present higher rates in the general population, compared to strictly 
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defined psychotic symptoms. Based on findings from the Netherlands Mental Health Survey 
and Incidence Study (NEMESIS), in years 1996‐1999, and having access to a sample of 7,076 
adults, Jim van Os et al. revealed that while 1.5% of this population fulfilled the criteria of a 
psychotic disorder, 4.2% reported delusions and/or hallucinations and up to 17.5% PLE 59,60.  
PLE can vary significantly across different ethnic groups; a study based on the UK Fourth 
National Survey of Ethnic Minorities, in years 1993‐1994, which obtained an overall sample of 
8,063 adolescents and adults, showed substantially reduced rates of hallucinations reported in 
South Asians (2.3%) and Whites (4%) compared to Caribbean (9.8%) 61. 
The effect of age in the emergence of PLE  was addressed by two large survey studies of more 
than 2,500 adolescents in Ireland, in years 2009‐2010: higher rates of PLE in younger 
adolescents were reported (21‐23%) compared to older ones (7%) 62. The authors, Kelleher et 
al., showed that the majority of adolescents who reported psychotic symptoms had at least 
one diagnosable non‐psychotic disorder, however this association was stronger for older 
adolescents (80%) compared to younger ones (57%).  
Risk factors associated with PLE, has also been the focus of several epidemiological studies and 
population surveys. Cannabis use by the age of 15 and weak psychotic symptoms at age 11 
were the two stronger predictors of schizophrenia outcomes at age 26, as shown in the 
Dunedin Study, in late 1980s, a birth cohort study of 1,037 individuals from New Zealand 63. 
Scott et al., utilised data from the Australian National Survey of Mental Health and Wellbeing, 
in year 1997, which encompassed an impressive overall sample of 10,461 adults. They 
reported that 11.7% of this population experiences at least on PLE, and higher rates were 
associated with younger age, migrants, never being married, being divorced/separated or 
unemployed, having high levels of urbanicity and low levels of socio‐economic status 64. A later 
study of 1,261 adolescents from the same authors (also deriving from the same cohort of the 
Australian population) revealed factors such as blended and sole parent families, elevated 
depressive symptoms, presence of depressive disorder and cannabis used in last month to be 
highly correlated with hallucinations 65. Based on the UK Second National Survey of Psychiatric 
Morbidity, in year 2000, Johns et al. pooled data from an overall sample of 8,520 adults, and 
linked the presence of psychotic symptoms to cannabis and alcohol dependence, victimisation, 
stressful life events, lower intellectual ability and neurotic symptoms; males were more prone 
to develop paranoid thoughts while females had higher rates of hallucinatory experiences 66.  
Apart from cannabis, victimisation (bullying) is among the risk factor more strongly associated 
with the presence of PLE. In a study of 2,524 German adolescents, cannabis use increased the 
cumulative incidence of psychotic symptoms up 4 years later, showing a dose‐related effect, 
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while self‐reported trauma at more severe levels was also associated with psychotic symptoms 
67,68. Similarly, in a study of 1,290 adolescents in the Netherlands, bullying and sexual trauma 
were found to significantly increase PLE 69. Other risk for PLE are prenatal and perinatal events, 
especially maternal diabetes 70, urbanicity and cognitive impairments at an early age 71 winter 
birth 72. 
In summary, the prevalence of PLE experience in the general population varies widely, with a 
conservative estimate not exceeding 10%. A variety of risk factors were identified, with most 
prominent protracted use of cannabis and bullying.  
2.1.2. Screening for PLE 
A variety of psychometric scales have been used to assess PLE. The most widely employed and 
validated is the CAPE (Community Assessment of Psychic Experiences Questionnaire) which 
was developed by Jim van Os and colleagues 73, based on PDI (Peters et al Delusions Inventory) 
74. The extended version of CAPE consists of 42 and is a self‐report questionnaire with good 
reliability and validity 75 allowing for detection of 3 clusters of symptoms (depressive, positive 
and negative) with good discriminant validity 76. Alternative 4‐factors (with the addition of 
social delusions) and 5‐factors (with a further addition of popular psychic beliefs) models could 
find utility in further distinguishing positive symptoms 77. [CAPE questionnaire is discussed in 
detail in section 2.2] 
In a validation study of 334 adolescents, screening of PLEs was performed with the 7‐item 
Adolescent Psychotic‐Like Symptom Screener (APSS), a short self‐report questionnaire. The 
study revealed that the question about auditory hallucinations, had an optimum positive and 
negative predictive value, not only for the tested item, but also for any PLE 78. 
It is noteworthy that many clinicians have also expressed reservations to the extent that self‐
reported PLE genuinely represent attenuated psychotic symptoms (APS). In a study of 123 
subjects seeking help at a service for the early detection of psychosis, PLE were assessed with 
the PDI and the revised Launay‐Slade Hallucination Scale (LSHS) and APS were assessed with 
the Structured Interview for Prodromal Syndromes (SIPS) 79. It was concluded that the criterion 
validity of PLE for APS was insufficient, so the prevalence of APS (40.7%) could not be deduced 
by the larger prevalence of PLE (98.4%). Consequently, the authors considered that the 
population prevalence rate of APS has to be assumed to be lower than indicated by 
epidemiological studies of PLE.  
A recent systematic review included a total of 76 papers on definition and assessment of PLE. 
80. The review listed a phethora of assessment tools used to quantify for PLE, and comprises 
excellent and up‐to‐date summary of the relevant literature. Lee et al. concluded that “as PLE 
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are poorly understood, there are great variations and assessment tools adopted by different 
studies”. They could not identify a golden standard for the assessment of PLE and they noticed 
the absence of specific phenomenological definition, as most assessment tools define PLE 
quantitatively.  
In summary, a wide variety of tools have been developed so far for the assessment of PLE. 
Despite inherited limitations, some of these scales, such as the CAPE questionnaire, can provide 
reliable and valid detection and measurements of PLE.  
2.1.3. Clinical Features of PLE 
A variety of psychopathological features have been linked to the presence of PLE. Some 
examples are described below:  
 Poor mental health, suicidal ideation and deliberate self‐harm behaviour 81,82;  
 Impairments in a verbal theory of mind task were positively associated with schizotypal 
symptoms and first‐rank psychotic symptoms 83; 
 Subtle dyskinesia, which was suggestive of a basal ganglia pathology 84;  
 Internalising (anxiety, depression, social withdrawal) and externalising (hyperactivity, 
aggression, antisocial / oppositional behaviour) psychopathology 85; 
 Longitudinal deterioration in problematic internet use and reality substitute was linked to 
the PLE phenotype, despite similar baseline levels 86;  
 Mixed‐ rather than left‐ handedness was related to psychosis proneness 87;  
 Personality traits such as neuroticism (positively linked to all clusters of PLE) and openness 
to experience (positively linked to persecutory ideas and magical thinking); these 
associations also survived control for depression 88;  
High presence of PLEs, is associated with increased levels of stress which can in turn give raise 
to reactive psychopathology; however, the nature of these associations remains unknown and 
needs to be explored further.  
2.1.4. Characterisation of PLE 
Several studies proposed clusters or dimensions of PLEs. Examples include the following: 
 3‐factors model: depressive, positive and negative symptoms 76; 
 2‐factors model: schizophrenia nuclear symptoms, schizotypal signs 89; 
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 4‐factors model: bizarre experiences, perceptual abnormalities, persecutory ideas, magical 
thinking 90; 
 5‐factors model: hallucinations, delusions, paranoia, grandiosity and paranormal beliefs 
91,92; 
 6‐factors model: paranoia, hallucinations, cognitive disorganisation, grandiosity, 
anhedonia, parent‐rated negative symptoms 93. 
This variety of these categorisations can be explained by the use of different tools to assess 
PLE, or by the variability in the sample studied. It is of note that the 3‐factor clustering 
(positive, negative and depressive cluster) most commonly used with CAPE-42, bears a 
resemblance to the three scales (positive, negative and general psychopathology) of the 
Positive and Negative Syndrome Scale (PANSS)94, which is used for assessment of psychotic 
symptomatology in clinical populations. In my studies I followed this widely adopted 3‐factor 
model, but I also introduced a composite measure consisting of three items (persecutory 
ideation, bizarre ideas or receiving messages from media and auditory hallucinations) carrying 
an increased clinical significance and optimal predictive value for transitions to psychosis [see 
my specific stratification rationale in CAPE 3‐Items Score, Specific Stratification].   
2.1.5. Neuro-Cognitive features of PLE 
Higher rates of PLEs are associated with a number of neuro‐cognitive features:  
 Verbal fluency deficits: an association observed in men but not in women 95; 
 Total IQ score: the association between PLE rates and total IQ score follow an inverted U‐
shape pattern; however higher PLE rate are more strongly associated with below average 
IQ than with above average IQ 96; 
 Impairments in receptive language, motor and executive function, speed of processing, 
non‐verbal working memory 97,98; deficits in divided‐attention tasks 99; 
 Facial Emotion Recognition deficits, especially poor recognition of sad faces 100; 
 Individuals with high aberrant salience (the incorrect assignment of importance to neutral 
stimuli) and low self‐concept clarity (clear and internally consistent beliefs about one‐self) 
had the highest levels of PLE 101. 
The deficits described above resemble similar findings in psychotic populations and are 
generally consistent with the neuro‐cognitive literature of schizophrenia. This is not surprising, 
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given that most of the affected cognitive domains are mediated by large regions of the frontal 
lobes, showing aberrant activation across the whole spectrum of psychotic disorders.  
2.1.6. Neuroimaging studies of PLE / UHR for psychosis 
A growing number of studies from recent years (2010s onwards) have investigated the neural 
profile of individuals with high rates of PLE (otherwise labelled as ultra‐high risk for psychosis 
subjects), employing structural and functional neuroimaging methods combined with a variety 
of cognitive tasks.  
 Jacobson et al., the investigators of a study of 25 adolescents, aged 11‐13, employed an 
inhibitory task, and reported that PLE were associated with: (a) Reduced activity within 
right frontal and bilateral temporal cortex during response inhibition; (b) Reduced activity 
within the anterior cingulate, insula and middle frontal gyrus during error‐related 
processing; (c) Gray Matter increases within the middle and superior temporal gyri, 
angular gyrus, orbitofrontal gyrus; (d) White Matter increases along the inferior fronto‐
occipital fasciculus, cingulum and inferior longitudinal fasciculus 102. 
 An additional report comes from Juckel et al. who compared 13 young adults with UHR for 
psychosis to equal number of controls, during a reward test. The authors concluded that 
compared to the neutral condition, anticipation of reward loss‐avoidance elicited 
significant activation of the ventral striatum (VS) in both healthy subjects and subjects with 
UHR for psychosis, but there was only a statistical tendency for less activation during loss‐
avoidance anticipation in prodromal compared to healthy subjects 103. 
 In another article, Roiser et al. detailed the study of 18 individuals with UHR for psychosis 
compared to equal number of controls and employing a reward‐based salience test, 
reported that UHR subjects were more likely to attribute motivational salience to 
irrelevant stimulus features and this bias was related to the severity of their delusion‐like 
symptoms 104. Ventral striatal responses to irrelevant stimulus features were also 
correlated with delusion‐like symptoms in the UHR group. Striatal dopamine synthesis 
capacity correlated negatively with hippocampal responses to irrelevant stimulus features 
in UHR individuals, but his relationship was positive in controls.  
 Additional reports derived from a study of 600 undergraduate students screened with the 
CAPE questionnaire; Modinos et al., identified two groups with high and low PLE (total 
n=34) who were tested through a number of affective stimuli (neutral pictures, negative 
pictures) 51. High PLE subjects showed stronger activation than low subjects in a number of 
prefrontal regions during reappraisal (reinterpretation of negative pictures, so they no 
longer elicited negative emotional responses). The amygdala response to negative stimuli 
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was decreased through reappraisal only in the low group. Functional connectivity analysis 
revealed less prefrontal‐amygdala coupling in high psychosis‐proneness subjects. Another 
study from the same sample (total n=40), employed a multivariate pattern classification 
based on brain activation during emotional processing and identified group differences 
within an emotional circuitry including the amygdala, insula, anterior cingulate and medial 
prefrontal cortex 105. The authors advocate that emotional dysregulation, thought to result 
from a disruption in interactions between prefrontal emotion‐control regions and 
subcortical (i.e. amygdala) emotion‐generations regions, which is already reported in 
schizophrenia, can also be seen in UHR populations and might be at the core of 
vulnerability to psychosis.  
 Another research team conducted a study of 21 non‐medicated UHR subjects compared to 
24 healthy controls 106. During reward anticipation, the UHR sample exhibited additional 
activation in the posterior cingulate cortex, and the medio‐ and superior frontal gyrus. 
Positive symptoms were correlated with the anticipation signal in the VS and the right 
anterior insula, while negative symptoms were inversely linked to outcome‐related signal 
within the VS, and depressive symptoms to outcome‐related signal within the medial 
orbitofrontal cortex. The authors, Wortuba et al., advocate the presence of a reward-
associated dysregulation that can be compensated by recruitment of additional prefrontal 
areas.  
 Winton-Brown et al. conducted another study of 29 UHR for psychosis subjects compared 
to 32 controls divulged that during reward anticipation. UHR subjects showed greater 
activation than controls in the ventral pallidum bilaterally 107. Dynamic causal modelling 
(DCM) revealed that reward‐induced modulation of connectivity from the ventral 
striatum/pallidum to the midbrain was greater in UHR subjects than control, and that in 
UHR subjects the strength of connectivity in this pathway was correlated with the severity 
of their abnormal belief. In conclusion, ventral striatal/pallidal function is altered in people 
with UHR for psychosis and this is related to the lever of their psychotic symptoms.  
 Most recently, a study by Bourque et al. that utilized a smaller sample from the IMAGEN 
cohort ‡ revealed that relative to control (n=135), youth with high PLE rates (n=27) at age 
14 demonstrated increased hippocampus/amygdala activation during processing of neutral 
faces; reduced dorsolateral prefrontal activation (DLPFC) during failed inhibition; increased 
                                                          
‡ My overall sample consisting of 1,434 healthy adolescents, was obtained from the IMAGEN database. 
This provided neuroimaging, genetic and clinical data of 2,000 healthy adolescents from eight European 
cities, followed at the ages of 14 and 19. [Details are described in section 4.2.] 
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anterior/middle cingulate gyrus activation and decreased fusiform gyrus activation during 
the anticipation phase of an MID task 108.  
In summary, a wealth of neuroimaging studies proclaim a mixture of aberrations in brain 
activation and connectivity during various cognitive tasks; among the most common findings 
are reduced activation in DLPFC (including the middle frontal gyri), temporal areas (including 
the insula and fusiform gyrus) and limbic areas (including the anterior/middle cingulate gyri) 
during inhibitory control; aberrant hippocampal/amygdala activation during processing of 
faces; abnormal striatal activation during reward tasks; and disrupted connectivity between 
prefrontal and subcortical areas during affective tasks. Most of the above-mentioned findings 
are also reported in SCZ populations, which provides additional evidence for the biological basis 
of the continuum model of psychosis.  
2.1.7. Clinical Outcome of PLE 
Common outcomes associated with PLE are depression, distress and poor functioning; it 
appears that bizarre experiences and persecutory ideas show greater associations with poor 
outcome 109‐111. Schizotypy significantly moderated the association between PLE and subjective 
distress; more PLE reported, yet less distress associated with PLE 112. Persistence of PLE was 
associated with a greater use of emotion‐oriented coping, whereas a decrease in PLE over time 
was associated with an increased use of task‐oriented coping 113. 
2.1.8. PLE and Psychosis 
2.1.8.1. Schizophrenia and PLE 
Individuals with high rates of PLE have common features with SCZ patients. Non‐clinical 
psychosis phenotype is familial, heritable, co‐varies and shares an extensive number of risk 
factors with schizophrenia‐spectrum disorders 57. PLE and psychotic disorders not only share 
epidemiological, environmental and developmental risk factors (urbanicity, migration, ethnic 
minority, socio‐economic background, employment/marital status, childhood trauma, 
victimisation, domestic violence, substance use, obstetric complications, maternal infection, 
neuro‐motor deficits), but also a number of common neuro‐anatomical and neuro‐functional 
abnormalities (hypo‐frontality, fronto‐temporal dysconnectivity, gray and white matter 
abnormalities), deficits in cognition and language (verbal fluency, receptive/expressive 
language, speed of processing) and co‐morbid psychopathology (depression, anxiety, 
suicidality, self‐harm, antisocial behaviour) 54. PLE convey an increased risk for the 
development of psychotic disorder, however there are different types of PLE with different 
likely trajectories and underlying causes 56. This observation gives rise to the hypothesis that 
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PLE and other psychotic disorders, though not unitary phenomena, could have a common 
genetic basis and consequently share similar dysfunctional neural circuits.  
Cognitive impairments in SCZ have been broadly recognised as a core future of the illness 114. 
Severe impairments are noted in executive functioning, motor speed and verbal fluency, while 
moderate impairments are also present in visuo‐motor skills and working memory 115. 
Furthermore, social cognition can be impaired in schizophrenia 116 and mediates a significant 
relationship between neuronal activity, cognition and schizophrenia 117.  
If PLE and SCZ are part of the same continuum of psychotic disorders, this hypothesis could be 
extended to encompass cognitive impairments seen within the psychosis spectrum; this could 
also be further extended to linking some of those cognitive deficits with the aetiology of 
psychosis. In a recent study of adolescents with an extended psychosis phenotype, the 
presence of psychotic symptoms was associated with impairment on processing speed tasks 
and in non‐verbal working memory 98. Another study showed an association of PLE in 
adolescents with impaired attention on the divided‐attention task, which demands increased 
attentional effort 99. An EEG study in adolescents revealed a deficit in receptive language 
(characterised by a reduction in P300 amplitude) related to the presence of PLE 118. Poor facial 
emotional recognition was also linked to PLE in a school‐based sample of adolescents 100.  
A number of various other conditions or traits associated with PLE and discussed already, point 
towards the direction of linking these symptoms to the development of future psychotic 
illness. Impairments in the theory of mind may represent a developmental landmark 
associated with positive schizotypy and PLE 83. Similarly, schizotypy was found to be associated 
with more PLE and also to significantly moderate the association between PLE and subjective 
distress 112. Both externalising and internalising psychopathology was associated with PLE in a 
longitudinal general population child cohort 85. Subtle dyskinesia was associated with higher 
scores of PLE in a general population sample of 19‐year‐old participants 84. Winter seasonality 
of birth was also having an effect on the presence of PLE in adolescents 72.  
In summary, common epidemiological and neuro-cognitive features of the PLE and 
schizophrenia phenotype point towards a link, which can be understood in the context of a 
unifying psychosis continuum.   
2.1.8.2. FEP and PLE 
Studies in patients with first‐episode psychosis (FEP) introduced another line of research 
employing Diffusion Tensor Imaging (DTI) tractography, a specific study of white matter 
abnormalities. Fractional anisotropy (FA) reductions, a measure of white matter 
dysconnectivity, were present in two of three main tracts connecting frontal and temporal 
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regions (namely the superior longitudinal fasciculus and the uncinate fasciculus, but not the 
cingulum) in FEP subjects 119. The degree of these abnormalities was also directly associated 
with clinical short‐term outcome. Earlier studies also reported abnormalities of uncinate 
fasciculus in FEP and recent onset schizophrenia individuals 120,121. It is of note that reduced left 
uncinate fasciculus FA was also associated with deficit schizophrenia, thus providing a possible 
mechanism for the understanding of negative symptomatology 122. Subjects at risk of psychosis 
and in FEP share common features of superior temporal lobe dysfunction and fronto‐temporal 
dysconnectivity 123. 
In summary, If PLE represent a prodromal psychotic phenotype, subjects with PLE are 
anticipated to share some of the neuro-imaging findings of FEP, such as fronto-temporal 
dysconnectivity.  
2.1.8.3. UHR for Psychosis and PLE 
A significant number of studies have focused on subjects of ultra‐high‐risk (UHR) for 
developing psychosis, aka the at‐risk mental state (ARMS) during the last decade. In the 
general population, mixed and non‐specific expression of psychosis, depression, anxiety and 
sub‐threshold mania is common and mostly transitory. When combined with distress, it may 
be considered as the first, diagnostically neutral stage of potentially more severe 
psychopathology, which only later may acquire a degree of diagnostic specificity and possible 
relative resistance to treatment 124. UHR for psychosis status is recognised as part of the 
extended psychosis phenotype, with prevalence estimated at 7.5% 14. This stream of research 
is in line with the neurodevelopmental model of schizophrenia; the roots of the disorder lie in 
the abnormal development and maturation of the central nervous system 125,126. 
Contemporary data suggest that rates of subjects at UHR that will eventually progress to 
psychosis range between 18% (at 6 months follow‐up) and 36% (at more than 3 years follow‐
up) 127 . Neuropsychological and brain imaging findings are described in the early stages of 
psychosis and schizophrenia 128; this gives rise to the hypothesis that there are a number of 
processes at psychosis onset that may represent biomarkers of future illness. These 
neurobiological markers focus on maturational processes, implicating the integrity of frontal 
and temporal cortices.  
Neurocognitive data: Among other studies, a longitudinal cohort of 230 individuals followed 
up for 7 years on average, identified poorer neuro‐cognitive performance on verbal learning 
and memory, processing speed and attention and verbal fluency, as predictors of poor 
functional outcome 129.  
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Neuroimaging data: A series of neuroimaging studies employing sMRI, fMRI and Positron 
Emission Tomography (PET) revealed that increased vulnerability to psychosis is associated 
with brain changes, which are qualitatively similar to those seen in psychotic disorders and 
appear inter‐related 130‐132. More specifically, UHR subjects showed reduced prefrontal volume; 
differential activation in prefrontal and medial temporal cortex; altered connectivity and 
reduced white matter integrity in fronto‐temporal pathways; reduced thalamic glutamate 
levels; and elevated striatal dopamine function. Clinical follow up at 24 months revealed that 
reduced medial temporal volume, increased prefrontal, medial temporal, and midbrain 
activation, and elevated dopamine function at baseline predicted later onset of illness. 
Comparison of baseline and follow up scans indicated that the onset of psychosis was 
associated with longitudinal decreases in medial temporal volume and in thalamic glutamate 
levels, and increases in striatal dopamine function. Findings from another sMRI study revealed 
cortical thinning in the prefrontal cortex, anterior cingulate cortex, inferior parietal cortex, 
parahippocampal cortex and superior temporal gyrus, areas that correspond to the structural 
abnormalities found in schizophrenia 133. If PLE represent indeed an UHR for psychosis, I would 
expect similar brain changes in individuals with this phenotype. [Please refer to section 2.1.6. 
for more details] 
Transition to psychosis in UHR individuals is associated with prefrontal and subcortical 
dysfunction. In a 2‐year follow‐up study, UHR subjects who subsequently developed psychosis, 
showed increased activation in bilateral prefrontal cortex (PFC), midbrain/basilar pons, the left 
hippocampus, greater midbrain‐PFC connectivity and elevated brainstem dopaminergic 
function 134. Review of the literature suggest that (a) vulnerability to psychosis is associated 
with consistent grey matter (GM) decreases in prefrontal and temporo‐limbic areas (b) the 
onset of full disease is accompanied by temporo‐insular, anterior cingulate and cerebellar GM 
reductions (c) alterations in temporal regions underlie the clinical onset of psychotic symptoms 
135. All the above‐mentioned brain areas have attracted increased scientific interest, towards 
identifying biomarkers of psychotic illness. 
In summary, PLE represent the clinical manifestation of the UHR for psychosis phenotype, 
which in turn conceptualizes a group of individuals with increased risk of transition to 
psychosis. Those individuals initially present with subtle prodromal psychotic symptoms; 
however, they can also have a variety of neurocognitive deficits and associated neuroimaging 
findings which are consistent with similar features seen in psychotic patients.  
2.1.8.4. Progression to Psychosis and PLE 
A wealth of research, over the past 3 decades, supports the hypothesis linking the presence of 
PLE with the emergence of future psychotic disorders:  
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 High scores on perceptual abnormalities and magical thinking in adolescence predicted 
psychosis 10 years later 136; 
 Self‐reported psychotic symptoms at age 11 predicted a high risk of schizophreniform 
diagnosis at age 26 137; 
 Exposure to baseline psychotic symptoms and urbanicity together doubled the rates of 
such experiences following a 3.5 years follow‐up 138. 
 The 3‐year persistence rates of PLE varied between 26% (NEMESIS) and 31% (EDSP), while 
the presence of developmental exposures (cannabis, trauma, urbanicity) increased rates of 
such persistence up to 83% and 51% respectively 139; 
 High levels of PLE at age 5 and 14 predicted high levels of delusional‐like experiences at 
age 21 140,141; 
 Persistent subclinical psychosis for 3 years increases the risk of transition to clinical 
psychosis at >8 years in a dose‐response fashion 142; 
Developmental trajectories of PLE have also been the focus of more recent studies. A large 
study of more than 7,500 adolescents (TRAILS) revealed four groups with distinct 
developmental trajectories of mild positive psychotic experiences (mild, decreasing, 
intermittent, persistent) 91,92. The persistent trajectory was associated strongly with cannabis 
use, childhood trauma, developmental problems and ethnic minority status, and consistently 
displayed strong associations with factors known to predict transition from subclinical 
psychotic experiences to clinical psychosis. A similar study with a smaller sample of 409 
adolescents showed instead three developmental trajectories of PLE: a low; an increasing 
(associated with use of tobacco, cocaine, cannabis and drugs); and a persistent (associated 
with frequent victimisation and elevated depression and anxiety scores) 143. A birth cohort of 
7,387 adolescents (ALSPAC) showed that the majority (80.6%) presented with low PLE rates, 
while those with higher rates progress to either a decreasing (1.7%), intermittent (16.8%) or 
persistent (0.9%) trajectory of PLE and were more likely to come from adverse backgrounds 
and have disturbed childhood development 144. 
In their discussion article, Spauwen and van Os employed the psychosis proneness model to 
account for the association between high rates of exposure to urbanicity and psychosis 145. 
They suggested that a number of environmental factors (urbanicity) interact with genetic risk 
factors to lead to increased rates of expression of psychotic phenotypes, reaching a first peak 
at puberty. Besides, the presence of an urban environment appears to perpetuate high rates of 
psychosis, with contrast to a rural one.  
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In summary, presence of PLE infers an increased risk of transition to psychosis, which can be 
further potentiated by environmental risk factors, such as use of cannabis, psychological 
trauma and urbanicity. Early detection of PLE, in combination with other biomarkers, is 
therefore paramount to identify subjects at UHR for psychosis and accordingly implement early 
interventions, which could potentially deter UHR subjects from developing psychosis.  
2.1.9. Summary of PLE 
The concept of PLE has found applications as:  
 Evidence for the developing character of psychotic symptoms, ranging from pre‐clinical / 
prodromal (PLE) to clinical (psychotic symptoms) manifestations. 
 A non‐clinical paradigm in pursuit of the aetiology of psychosis, consistent with the neuro‐
developmental model of psychosis (interaction between genetic and environmental risks). 
 A tool to detect early indications of proneness to developing a future psychotic illness, in 
accordance with the continuum model of psychosis (UHR for psychosis or the ARMS). 
Research in the field of PLE could be informed by related research in FEP and UHR for 
psychosis populations. The hunt for biomarkers related to PLE is relevant and exciting, and use 
of functional neuroimaging can provide a useful path to this direction. This emphasized the 
importance of my research in investigating the neural correlates of PLE.  
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2.2. The Community Assessment of Psychic Experience Questionnaire  
The Community Assessment of Psychic Experiences Questionnaire (CAPE) was developed by 
Jim van Os and colleagues 73, based on Peters et al Delusional Inventory (PDI) 74, as a screening 
tool for the detection of PLE in the general population.  
CAPE is an extended though self‐explanatory and easily self‐administered questionnaire. In its 
extended form, it consists of 42 items, which can be grouped in three dimensions of 
symptoms: positive (bizarre and social delusions), negative and depressive. CAPE 42 has 
adequate validity and reliability in detecting these clusters of symptoms in non‐clinical 
populations. A detailed description of CAPE‐42 questionnaire (which was used in my studies) 
can be found in APPENDIX I. 
Table 1: CAPE-42 Clusters 
1 Depressive 
Symptoms 
2 Positive Symptoms 3 Negative Symptoms 
2a Bizarre 
Symptoms 
2b Social Delusions 






Q3 Not animated 
Q9  Pessimism Q15 Telepathy Q6 
False 
Appearance 
Q4 Not talkative 










Q20 Voodoo Q10 Conspiracy Q16 





Q22 Odd Looks Q11 Being important Q18  
Lack of 
motivation 
Q38 Guilty Q24 
Thought 
Withdrawal 




Q26 Thought Insertion  
 
 







  Q25 Lack of activity 
  Q30 Thought Echo   Q27 
Lack of emotional 
intensity 
  Q31 External Control   Q29 
Lack of 
spontaneity 
  Q33 
Auditory 
Hallucinations 
  Q32 Blunted emotions 
  Q34 Voices Conversing 
 
 
 Q35 Lack of hygiene 
  Q41 Capgras 
 
 
 Q36 Unable to finish  
  Q42 
Visual 
Hallucinations 
  Q37  Lack of interests 
 
2.2.1 Validation Studies of the CAPE 
The Athens Study of Psychosis Proneness and Incidence of Schizophrenia (ASPIS), in year 
2001, explored schizotypy and psychosis dimensions in newly recruited air force conscripts in 
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Greece. Using a sample of 932 young men, the authors of a validation study measured 
experiences of positive, negative and depressive features of psychosis 76. Confirmatory factor 
analysis (CFA) revealed that a three‐factor model was a better fit to the data. All three 
dimensions co‐varied with each other, with correlations between the three dimensions in the 
range of 0.7, and correlation between the dimensions of frequency and distress (severity) was 
0.71. The CAPE positive symptom score displayed stronger association with the Perceptual 
Aberration Scale (PAS) and the Symptom Checklist (SCL‐90) Paranoia Subscale; the CAPE 
negative symptom score displayed stronger association with the Schizotypal Personality 
Questionnaire (SPQ); and the CAPE depressive symptoms score displayed stronger association 
with the SCL‐90 Depression Subscale.  
A large cohort of 31,822 adult Swedish women, taking part in the follow‐up phase of the 
Scandinavian Women’s Lifestyle and Health Cohort, in year 2003/2004, gave rise to another 
validation study. Factorial analysis of CAPE data, which focused on the positive psychotic 
experience items resulted in five separable but correlated trait dimensions, which reflected the 
presence of paranoia, grandiosity, magical thinking delusions and hallucinations 146. High 
scores on any dimension were associated with a higher probability of questionnaire‐assessed 
lifetime major depressive episodes or generalised anxiety disorder (only to a smaller degree 
for grandiosity). A similar study from the same authors in a large sample of 1,012 Swedish 
young adults and adolescents who completed the CAPE online, supported a three‐factorial 
structure for PLE, including paranoia, delusions and hallucinations and excluding grandiosity 
and common paranormal beliefs 147. 
The Continuum of Mental Disorders Study (COMED), in year 2006, was a longitudinal family 
study based on the general population of the city of Sittard, the Netherlands. Utilising a 
validation sample of 765 individuals (510 at follow‐up), the authors compared CAPE42 scores 
with Brief Psychiatric Rating Scales (BPRS) scores and Structured Interview for Schizotypy (SIS‐
R) outcomes at baseline and follow‐up (7.7 months) 75. Self‐reported positive and negative 
dimensions of psychosis (CAPE42) at baseline were specifically and independently associated 
with their equivalent interview‐based dimensions (BPRS and SIS‐R) at follow‐up (standardised 
effect sizes 0.4‐0.5). [Please refer to the following section for more details] 
A team of researchers from Canada, in 2007, performed a validation study by examining the 
internal consistency of the CAPE questionnaire in a sample of 2,275 individuals from the 
general Montreal community, who completed it in either French or English 77. The internal 
consistency of all three subscales (positive, negative, depressive symptoms) was good, with 
Cronbach’s coefficient alpha equal to 0.822; 0.805 and 0.795 respectively. CFA showed 
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Adjusted Goodness of Fit Indices (AGFI) close to 0.90, indicative of a good fit between the 
observed sample covariance matrix against the matrix estimated from a null model.  
The Genetic Risk and Outcome of Psychosis (GROUP) project, in year 2011, was a longitudinal 
observational study in the Netherlands, focusing on the factors that make people vulnerable 
to develop psychosis. A validation study from this sample investigated the psychometric 
properties of CAPE questionnaire and SIS‐R and aimed to enhance measurements through the 
use of multidimensional measurement models 148. Data were collected in 747 siblings of 
schizophrenia patients and 341 healthy controls. Both instruments showed good psychometric 
properties and were measurement invariant across siblings and controls. The latent traits 
measured by the instruments showed a correlation of 0.62 in siblings and 0.47 in controls. 
[Please refer to the following section for more details].  
An additional validation study from Spain, in year 2012, utilised a sample of 660 students and 
97 patients with psychosis. 149. Exploratory factor analysis (EFA) supported a three‐dimensional 
model which was different from the traditionally used dimension (positive, negative and 
depressive symptoms). Internal consistency values for these new dimensions ranged between 
0.78 and 0.89 in the sample of students and between 0.84 and 0.93 in the sample of patients. 
A similar study from Chile, in year 2015, explored the dimensionality of CAPE‐15, a shortened 
version of CAPE‐42 questionnaire, in a sample of 727 secondary school students and 245 
university students 150. Applying an Exploratory Structural Equation Models (ESEM) approach, a 
best fit was shown for a hierarchical model, composed of a general factor plus three specific 
factors (persecutory ideation, bizarre experiences and perceptual abnormalities).  
A cross‐sectional online survey of 1,610 Australian university students, in year 2013, examined 
the internal structure of the positive scale of CAPE‐15 151. A three‐factor model, including 
persecutory ideation, perceptual abnormalities and bizarre experiences, produced the best fit, 
with high levels of internal consistency.  
Researchers from the Netherlands, in year 2014, estimated Measurement Invariance (MI), 
comparing a sample of CAPE questionnaires assessed by paper and pencil (n=796) to a sample 
of questionnaires assessed by the internet (n=21,590) 152.The findings did not support 
measurement invariance with respect to assessment method. However, internet sample 
members who scored 2 standard deviations above average (so with a high vulnerability for 
psychotic symptoms) would be expected to score 4.8 points lower on the CAPE total score.  
Finally, a recent meta‐analysis from 2016, focusing on the psychometric properties of CAPE 
scores (reliability and validity), included 18 factor analytic studies to study CAPE’s internal 
reliability 153. The authors concluded that CAPE scores were psychometrically reliable and a 3‐
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factor model, consisting of positive, negative and depressive subscales was supported; a three‐
parties structure for both the positive dimension (consisting of bizarre experiences, delusional 
ideations and perceptual abnormalities) and the negative dimension (consisting of social 
withdrawal, affective flattening and avolition) were also supported.  
In summary, the plethora of validation data suggest that CAPE questionnaire has a good 
validity, reliability and internal consistency, in detecting psychotic experiences in non-clinical 
populations and could be used as a simple and cost-effective instrument to identify individuals 
at increased risk of developing psychosis.  
2.2.2. Longitudinal Cohorts employing the CAPE 
2.2.2.1. EFPTS  
The East Flanders Prospective Twin Survey in Belgium (EFPTS) has prospectively recorded all 
multiple births in the province of East Flanders since 1964. The final sample consisted of 566 
female subjects (283 pairs of twins, 172 monozygotic ‐MZ and 111 dizygotic ‐DZ) with mean 
aged of 27.3 years (aged 18‐45). Participants were interviewed five times (T0‐T4) at 
approximately 3‐ to 4‐monthly intervals. CAPE questionnaire was used to assess subclinical 
psychotic experiences, while the Structured Clinical Interview for DSM Disorders (SCID) and the 
Symptom Checklist (SCL‐90‐R) were also used to validate psychotic experiences. Some of the 
Some of the reported findings were: 
 Cross‐twin, cross‐trait analysis was conducted to investigate the association between 
repeated continuous measures of self‐reported psychotic experiences (assessed with 
CAPE) in one twin and clinical interview categorical measures of psychotic symptoms 
(assessed with SCID‐I), in the other twin. The results showed that in MZ but not DZ pairs 
the cross‐twin associations were large, significant and of similar magnitudes as the within‐
twin associations, both showing validity of CAPE and revealing a genetic effect. In addition, 
the cross‐twin associations were significantly larger for younger MZ twins than older MZ 
twins, providing evidence for a developmental effect 154.  
 An investigation of the patterns of developmental course of subclinical psychotic 
experiences revealed a Persistent and a Low group with regard to the expression of 
subclinical psychotic experiences. The Persistent group reported significantly higher levels 
of depressive and negative symptoms and worse functioning in daily life. Childhood 
trauma and stressful life events over the study period predicted inclusion in the Persistent 
group. 45% off the MZ twins of the Persistent group, had also a co‐twin in the same group 
155.  
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 508 female twins completed both prospective and retrospective questionnaires regarding 
childhood adversity and psychotic trait liability. The effect of childhood adversity was 
significantly moderated by genetic vulnerability for depression. This moderation was 
mediated by depressive experience but not by stress sensitivity 156. 
 CFA in the female twin sample, replicated a five‐dimensional model best describing the 
phenotype of positive psychotic experiences, consisting of Hallucinations, Delusions, 
Paranoia, Grandiosity and Paranormal Beliefs 157. 
 The Experience Sampling Method (ESM; repetitive random sampling of momentary 
emotions, psychotic experiences and context) was used to assess emotional and psychotic 
daily life stress reactivity. Higher levels of emotional stress reactivity (a decrease in positive 
and an increase in negative affect in response to stress), and increased psychotic reactivity 
to daily stress was found in individuals with persistent psychotic experiences over time 
compared to individuals with transient psychotic experiences 158. 
2.2.2.2. HBSC 
The Health Behaviour in School-Aged Children study (HBSC), was a general population study 
aiming to investigate the health, health behaviours and the relevant social context of youth in 
Europe and North America. The sample consisted of 5,422 adolescents aged 12‐16, assessed 
between October and November 2005. The CAPE questionnaire was used to assess psychotic 
experiences. Some of the reported findings were: 
 EFA followed by CFA in two large adolescent general population sample (5,422 and 2,230 
individuals) suggested that psychotic experiences were best represented by 5 underlying 
dimensions: hallucinations, delusions, paranoia, grandiosity and paranormal beliefs. 
Prevalences differed strongly, hallucinations having the lowest and paranoia having the 
highest rates. Girls reported more experiences on all dimensions, except grandiosity, and 
from age 12 to 16 years, rates increased. Hallucinations, delusions, and paranoia, but not 
grandiosity and paranormal beliefs, were associated with distress and general measures of 
psychopathology 159. 
 In a cross‐sectional sub‐study of 4,552 adolescents, an association between cannabis use 
and subclinical positive symptoms was confirmed and remained significant after extensive 
adjustment for potential confounders. Strongest associations noted for the discontinued 
use group and the heavy use group 160.  
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2.2.2.3. COMED 
The Continuum of Mental Disorders study (COMED) was a longitudinal family study based on 
the general population of the city of Sittard, the Netherlands, in year 2006. The study 
comprised 2 measurement points: T1 and T2, with a mean interval of 7.7 months between 
them. The total general population sample for T1 comprised 768 participants aged 17‐77 
years, pertaining to 116 families. CAPE questionnaire was among the tools used to assess this 
population of genetically related individuals, also including Cognitive Failure Questionnaire 
(CFQ) and SIS‐R. Some of the reported findings were: 
 Proneness to subjective cognitive failures possibly contributes to the development of 
persistence of negative symptoms and can be seen as potential risk factor for negative 
symptoms of psychosis. This overlap was due to individual effects rather than familial 
liability 161.  
 Comparing this general population sample with different patient groups in a community 
mental health service (suffering with either psychotic, mood or anxiety disorders), resulted 
in significant differences in positive psychosis items scores. Patients with psychotic 
disorders had the greatest difference in positive psychosis items compared to non‐
patients, whereas patients with mood and anxiety disorders had the highest depressive 
symptom scores and positive symptom scores that were intermediate to that of non‐
psychotic patients and patients with psychotic disorders 162.  
2.2.2.4. GROUP  
The Genetic Risk and Outcome of Psychosis project (GROUP) was a longitudinal observational 
study in Netherlands, in year 2011, focusing on the factors that make people vulnerable to 
develop psychosis. The full GROUP sample (data release 2.0) consisted of 1,100 patients with 
psychotic disorders, 1,057 healthy siblings of these patients, 919 parents of these patients, 19 
parents of patients who were also diagnosed with psychotic disorder, 562 healthy controls and 
27 parents of these healthy controls. Eligible healthy individuals who took part, were aged 18‐
50, free of psychotic illness and had no first‐degree family member with a lifelong psychotic 
disorder. CAPE and SIS‐R were the main tools used to assess this population. Some of the 
reported findings were: 
 217 patients with psychotic disorders, 281 of their siblings and 176 healthy individuals 
were assessed according to the Five‐Factor Model (FFM) personality traits by using the 
Neuroticism‐Extraversion‐Openness Five‐Factor Inventory (NEO FFI). Clinical psychotic 
symptoms were assessed by using the Positive and Negative Symptoms Scale, whereas 
sub‐clinical symptoms were assessed by the CAPE questionnaire.  Particularly lower 
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agreeableness, and to a lesser degree, higher neuroticism and lower extraversion were 
associated with more severe symptoms in patients. Furthermore, higher neuroticism and 
higher openness were associated with higher levels of subclinical psychotic experiences in 
all three groups. Strongest associations were noted in patients. These findings were 
suggestive that levels of neuroticism increase with the level of familial risk for psychosis 163. 
 813 healthy siblings of patients with a non‐affective psychotic disorder, 822 patients and 
527 healthy controls were examined with regards to depressive symptoms and their 
association with positive and negative symptoms. Depressive episodes in all three groups 
were assessed by the Comprehensive Assessment of Symptoms and History (CASH). 
Positive and negative symptoms were assessed by the CASH in the patient group, and by 
CAPE questionnaire in siblings and healthy controls. Patients reported more lifetime 
depressed mood and more depressive episodes than both siblings and controls. Siblings 
had a higher chance of meeting lifetime depressive episodes than the controls; no 
significant differences in depressed mood were found between siblings and controls. In all 
three groups, the number and duration of depressive symptoms were associated with sub‐
clinical negative symptoms. In patients and siblings, the number of depressive symptoms 
was furthermore associated with sub‐clinical positive symptoms. Finally, lifetime 
depressed mood (but not depressive episodes) showed familial clustering 164. 
2.2.2.5. TRAILS  
Tracking Adolescents’ Individual Lives Survey (TRAILS), was a prospective cohort study among 
adolescents in the Dutch general population. The three data collection waves were T1 (2001‐
2002, N=2,230, mean age 11.1 years); T2 (2003‐2004, N=2,149, mean age 13,6 years) and T3 
(2005‐2007, N=1,816, mean age 16.3 years). CAPE questionnaire was used to assess psychotic 
experiences at T3. Parental psychopathology was measured with the Brief TRAILS Family 
History Interview. Some of the reported findings were:  
 General parental psychopathology was associated with CAPE score (OR = 1.08; P < 0.043 
for highest quintile) and suggestively predicted psychosis persistence (OR, 1.16; P < 0.072). 
Psychotic parental psychopathology was suggestively associated with CAPE score (OR, 
2.25; P < 0.063 for highest quintile), predicted membership of the Persistent group (OR, 
3.72; P < 0.039) and suggestively predicted membership of the Decreasing group (OR 2.04; 
P < 0.051). Childhood trauma was associated with CAPE score and with all developmental 
trajectories of subclinical psychosis. There was no evidence of an interaction between 
trauma and parental psychopathology 165. 
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2.2.2.6. GNPS 
The Greek National Perinatal Survey (GNPS) was a prospective study of all 11,048 births 
throughout Greece conducted in April 2013. The Greek Birth Cohort derived as a longitudinal 
data collection of this sample during years 1990 (6,594 children aged 7) and 2001 (3,500 
individuals aged 18). CAPE questionnaire was used in adolescents to capture variation in the 
positive and negative dimensions in non‐clinical psychotic experiences, and additionally in 
depression. Some of the reported findings were:  
 The use of cannabis was positively associated with both positive and negative dimensions 
of psychosis, independent of each other, and of depression. An association between 
cannabis and depression did not survive adjustment for the negative psychosis 
dimensions. First use of cannabis below age 16 years was associated with a much stronger 
effect than first use after age 15 years, independent of life‐time frequency of use. The 
association between cannabis and psychosis was independent of the distress associated 
with the experiences 166. 
 A significant adjusted interaction between childhood maltreatment and later cannabis use 
was evident, indicating that the psychosis‐inducing effects of cannabis were stronger in 
individuals exposed to earlier sexual or physical mistreatment 167. 
2.2.2.7. Summary of Longitudinal Cohorts 
Six longitudinal cohorts of non‐clinical populations from the Netherlands, Belgium, Greece and 
Europe / North America employed CAPE questionnaire to measure prodromal psychotic 
manifestations. Those studies confirmed several clinical and epidemiological features 
(cognitive deficits, depressive features, use of cannabis, childhood trauma, parental general 
and psychotic psychopathology) as risk factors predisposing to the future emergence of 
psychosis. On the opposite direction, the psychosis proneness phenotype was also associated 
with increased rates of depressive and negative symptoms, as raised levels of distress and 
general psychopathology. Taken together, this wealth of data supports the use CAPE as an 
excellent tool for the measurement of PLE in longitudinal designs.  
2.2.3. Other Exploratory Studies with the CAPE 
The CAPE questionnaire was used in a non‐clinical population of 632 female student subjects in 
France, to explore the pattern of associations between cannabis use and dimensions of 
psychosis. Three correlated dimensions of positive, negative and depressive experiences were 
identified using principal components factor analysis. The frequency of cannabis use was 
independently associated with the intensity of both positive and negative psychotic 
experiences. No significant association was found between cannabis use and the depressive 
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dimension, or between alcohol use and any of the three positive, negative and depressive 
dimensions 168. 
A study 140 young non‐psychotic help‐seekers (the PACE clinic, Melbourne, Australia), 
employed CAPE scores to identify subtypes of PLE and their associations with poor clinical 
outcomes. Three factors were identified: bizarre experiences, persecutory ideas and magical 
thinking; the first two showed the strongest associations with distress, depression and poor 
functioning 169. Similar results were noted in a much larger cohort of 1,882 high‐school and 
university students from Australia, during a cross‐sectional survey conducted from the same 
authors [full set in 170, subsets in 90,171]. Among the four factors identified, bizarre experiences 
and paranoid ideation were more strongly associated with distress, depression and poor 
functioning than perceptual abnormalities and grandiosity.  
Investigators of a Swedish study examining a large sample of 1,012 adolescents and young 
adults, scrutinised the relation between Working Memory (WM), assessed with two online 
computer tasks, and PLE, assessed with the CAPE. Low WM capacity was modestly associated 
with increased reports of bizarre experiences and depressive symptoms, after controlling for 
age, gender and global symptoms scores. When analysis focused on age groups, low WM was 
exclusively associated with bizarre experiences in young adults and with depressive symptoms 
for older adults 172.  
Finally, researchers from Spain conducted an experimental study of 54 patients with a First 
Episode Psychosis (FEP) and 150 healthy subjects in order to assess the presence of speech 
illusion in neutral white noise. For the assessment of psychopathology, PANSS was used in 
patients and SIS‐R and CAPE questionnaire in controls. Patients had a much higher rate of 
speech illusions, which was only partly accounted by differences in IQ. Differences were 
particularly marked for signals in random noise that were perceived as affectively salient.  
Speech illusion tended to be associated with positive symptoms in patients, particularly 
affectively salient illusions. In controls, speech illusions were not associated with positive 
schizotypy or self‐reported psychotic experiences 173. 
In summary, a number of exploratory studies have employed CAPE to examine associations 
between various symptom clusters (positive / negative / depressive or bizarre / persecutory / 
magical ideas) and several epidemiological and clinical features (use of cannabis, functional 
outcomes, general psychopathology) in normal individuals.  
2.2.4. Studies on Cut-Off Levels of the CAPE 
During a study of 246 Dutch patients having a first contact with mental health services, CAPE‐
42 scores were used as a screening tool for FEP. A total 26 patients were diagnosed with 
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psychosis according to the Mini Schedule for Clinical Assessment in Neuropsychiatry (Mini 
SCAN). Only 10 of them were recognised by clinical routine, and 16 psychotic patients were 
not properly identified. Using an optimal cut‐off value of 50 on the frequency or distress 
dimension of the positive subscale of the CAPE‐42 detected 14 of these misdiagnosed patients. 
The sensitivity at this point was 77.5 and the specificity 70.5 174.  
An additional report of 165 individuals aged 13‐24 years who were referred to an early 
intervention outpatient service in Vienna, compared scores of the CAPE and the 
Comprehensive Assessment of At‐Risk Mental State (CAARMS) 48,175. Of the overall sample, 
50.9% of individuals were CAARMS‐positive and 49.1% were CAARMS‐negative. The Receiver 
Operating Characteristic (ROC) analysis provided the following cut‐off points §:  
 The cut‐off value of 2.20 on the positive dimension (frequency + distress, 20 items) 
showed a sensitivity of 67%, a specificity of 73%, a positive predictive value of 72% and a 
negative predictive value of 68%.  
 The cut‐off value of 1.80 on the positive dimension (frequency + distress, 20 items) 
showed a sensitivity of 83%, a specificity of 49%, a positive predictive value of 63% and a 
negative predictive value of 74%. 
 The cut‐off value of 0.47 in the positive dimension (frequency, 15 items) showed sensitivity 
of 77%, specificity of 58%, a positive predictive value of 66% and a negative predictive 
value of 71%.  
 The cut‐off value of 0.47 in the positive dimension (distress, 15 items) showed sensitivity 
of 73%, specificity of 63%, a positive predictive value of 69% and a negative predictive 
value of 66%. 
In summary, the CAPE questionnaire can have potential applications as a tool for the detection 
of transition to psychosis; cut-off values widely vary across settings and depend on the different 
sub-scales used. It is of note however that a positive dimension frequency + distress cut-off 
value in the area of 2.0 / CAPE item provides adequate positive predictive value for transition to 
psychosis. Special care was taken during stratification in my studies, so my high PLE groups 
scored above this threshold, thus qualifying as an equivalent to the psychosis proneness 
phenotype.  More extended longitudinal cohorts are required in order to ascertain CAPE as a 
predictive tool for psychosis and determine cut-off levels suggestive of a high risk for such a 
transition. 
                                                          
§ Cut‐off values were calculated per CAPE item and adjusted to the rating convention we applied in my 
studies: frequency + distress [0‐7]; frequency [0‐3]; distress [0‐4].  
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2.2.5. Summary of CAPE 
CAPE questionnaire has a good validity, reliability and internal consistency, in detecting PLE in 
non‐clinical populations and could be used as a simple and cost‐effective instrument to 
identify individuals at UHR for psychosis. Data from well‐known cohorts support the use CAPE 
as an effective tool for the measurement of PLE in longitudinal designs. Similarly, exploratory 
studies have employed CAPE to examine associations between various symptom clusters and 
several epidemiological and clinical features in normal individuals. CAPE can have potential 
applications as a tool for the detection of transition to psychosis; however, calculating cut‐off 
values widely varies across settings and depends on the different sub‐scales used. These 
observations confirm my choice to use CAPE questionnaire as a measuring tool for PLE in my 
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3.1. Cognitive difficulties in Schizophrenia 
Usually seen as the ‘last frontier’ in the treatment of schizophrenia, cognitive difficulties have 
long been recognised as part of the various clinical presentations of the illness. Since Emil 
Kraepelin coined the term ‘dementia praexox’, he implied that a certain degree of cognitive 
decline should be viewed at the core of psychotic symptomatology. Patients with 
schizophrenia suffer with various degrees of deficits in several cognitive domains, which 
usually present from an early age; these include mild impairments in perceptual skills, 
recognition memory and verbal IQ, moderate impairments in attention, recall and working 
memory and severe impairments in executive functioning, verbal fluency and motor speed 176. 
Impaired cognition together with negative symptoms are the major cause of the marked 
functional disability that is often associated with schizophrenia 177. 
Cognitive differences between schizophrenia patients and healthy people have emerged 
systematically during decades of neuropsychological research, pointing towards the presence 
of endophenotypes within the broad schizophrenia population 178. Poor phenotype definition 
was recognised as one of the main obstacles for aetiological research in schizophrenia 179; thus, 
neuro‐cognition might be the vehicle to investigate the heterogeneity of this complex disorder. 
Employing functional neuroimaging in combination with neurocognitive testing, can reveal 
dysfunctional brain networks associated with particular cognitive deficits and also help to 
elucidate the potential neural correlates of some of the broader schizophrenia 
psychopathology. 
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Multiple genotypes (genetic variants) correspond to fewer endophenotypes (clusters of symptoms / 
deficits), all of which might be classified under a single phenotype (diagnostic category). 
3.2. Face Tasks in Schizophrenia and Psychosis 
Face Tasks (FT) aim to test detection and identification of facial emotional states, which can 
both affect social cognition. A broad neural network, responsible for social perception, 
cognition and behaviour has been described, encompassing the amygdalae, the ventromedial 
prefrontal cortex (VMPFC), the cingulate cortex, somatosensory cortices, the fusiform gyrus 
and the superior temporal sulcus (STS). Perception of facial emotion, as an essential 
component of social perception, is mediated by this network 180. 
Prosopagnosia, the inability to accurately recognise faces and detect facial emotional states, 
can be related to occipital lobe pathology, and has been early and broadly encountered in SCZ 
181. SCZ patients have long been recognised as having deficits in emotion processing, which was 
manifested as dysfunction in the domains of emotional expression, emotional experience 
(including hedonic responses) and emotional recognition (the ability to accurately identify and 
interpret emotions from other sources, including facial expressions) 182; this was attributed to 
inefficient information processing in a broader neural circuit, including the VMPFC, the 
cingulate cortex, temporal areas and the amygdala 183. While healthy controls may activate the 
amygdala in response to scary / fearful / emotionally charged faces, patients with SCZ may not; 
on the opposite side a neutral face that will normally induce little activation of the amygdala in 
a healthy person, can lead to an hyperactivation in a SCZ patient. This may represent a 
distortion of reality and an inability to interpret social cues, leading to further deficits in 
judgment and reasoning, or even being linked to more severe psychopathology, such as 
delusional misidentification 184. Consequently, negative and affective symptoms of 
schizophrenia may be linked to reduced emotional processing of positive cues. On the other 
hand, inappropriate emotional processing of neutral cues could be associated with the 
development of increased suspiciousness and persecutory beliefs and further lead to impaired 
interpersonal functioning 185.  
3.2.1. Findings from fMRI Studies employing Face Tasks in Schizophrenia  
A recent meta‐analysis, from year 2012, investigated the amygdala recruitment in SCZ in 
response to aversive emotional material. Anticevic et al. pooled data from 35 trials, employing 
a variety of face tasks (affect classification / matching / labelling / rating, gender 
discrimination, mood induction, passive viewing, valence decision / discrimination). They 
demonstrated that patients with SCZ showed statistically significant, but modest, under‐
recruitment of bilateral amygdala (mean effect size = ‐0.20 standard deviations from mean); 
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however, this effect was dependent on the use of a neutral vs emotion interaction and was not 
apparent if amygdala activation was evaluated in a negative emotional condition only 40.   
Tseng et al., in a more recent meta‐analysis, from year 2015, investigated the multisensory 
integration (MSI) in patients with SCZ by gathering data from 29 behavioural and 
neuroimaging trials. MSI is a spontaneous perceptual‐cognitive process by which relevant 
information from multiple sensory modalities is extracted to generate a holistic experience. 
The authors concluded that brain functional alterations in the superior temporal cortex and 
inferior frontal cortex (i.e. attenuated responses during emotionally incongruent stimuli) 
appear to underlie the deficits in both non‐emotional and emotional MSI in schizophrenia 
patients 186. These results are in line with the observation made by other authors that 
emotional dysregulation, thought to result from a disruption in interactions between 
prefrontal emotion-controlling regions and subcortical (e.g. amygdala) emotion-generating 
regions, may be at the core of vulnerability to psychosis 51.   
Several studies using fMRI compared SCZ patients to healthy controls, during a variety of face 
tasks. A summary of their findings is listed below:  
 Unlike controls, SCZ patients have not demonstrated amygdala activation during sad facial 
stimuli, despite matched ratings to normal controls indicating a similar negative effect 187. 
 Positive face discrimination activated the bilateral amygdalae of both controls and SCZ 
patients, with more prominent activation of the right amygdala shown in the SCZ group. 
Negative face discrimination activated the bilateral amygdalae in the SCZ group but only 
the right amygdala in the control group, without any significant group differences 188. 
 During a face discrimination and labelling task, controls showed a significantly increased 
activation of the right middle frontal gyrus with rising task difficulty. SCZ patients 
demonstrated a significantly decreased activation of the anterior cingulate cortex during 
facial affect discrimination, a decreased activation of the amygdala‐hippocampal complex 
bilaterally during facial affect labelling and an increased activation of the middle frontal 
gyrus bilaterally 189. 
 During a facial affect and identity discrimination task, SCZ patients failed to activate the 
right lateral fusiform gyrus, compared to controls 190; however, during a face identification 
task, SCZ patients showed the same degree of activation of FFA, compared to healthy 
controls 191. 
 SCZ patients showed reduced limbic activation compared with controls during an emotion 
identification task. While in controls greater amygdala activation was associated with 
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correct identifications of anger and fear expressions, SCZ patients showed the opposite 
effect, portending misidentification 192. 
 SCZ patients showed a relative decrease in amygdala activation to fearful faces compared 
with neutral faces, which resulted from an increase in amygdala activation to the neutral 
faces, and not from a decreased response to the fearful faces 193. 
 Paranoid SCZ patients showed significantly reduced activation in the right amygdala, the 
right FFA and the left VLPFC, as compared to controls and reduced activation in the left 
VLPFC as compared to non‐paranoid SCZ patients 194. 
 During a face encoding task, controls displayed higher activation in the right FFA, more 
accuracy and shorter reaction times to famous and unfamiliar faces, compared to SCZ 
patients 195. 
 During a gender discrimination task, SCZ patients demonstrated increased FFA activation 
compared to controls, while processing spatial frequency‐degraded faces 196. 
 During an emotional valence discrimination task (EVDT) and an age discrimination task 
(ADT), controls showed activation in the fusiform gyrus, occipital lobe and inferior frontal 
cortex relative to the resting baseline condition; the increase was greater in the amygdala 
and hippocampus during the EVDT than during the ADT. In SCZ patients, minimal focal 
response was observed for all tasks relative to the resting baseline condition 197. 
In summary, most imaging studies employing face tasks, showed differences in activation 
between schizophrenia patients and controls in amygdalae, especially with regards to the 
recognition of angry and fearful faces. Other areas of interest were identified in the VLPFC 
(including the middle frontal gyri), the anterior cingulate gyri and the FFA. Those differences 
showed multiple directions; however, schizophrenia patients appear to overall demonstrate 
decreased activation in the majority of the areas described above.   
An overview of Brodmann Areas (BAs) hosting Regions of Interest (ROIs) showing differences in 
brain activation between schizophrenia patients and controls, during face tasks, is described in 
APPENDIX II.  
3.3. Reward Tasks in Schizophrenia and Psychosis 
Reward tasks target the human brain reward circuit, mediated by a number of mesolimbic 
structures, including the hypothalamus, the substantia nigra (SN), the nucleus accumbens 
(NA), the ventral tagmental area (VTA), the amygdala and the hippocampus. Deficits in reward 
CHAPTER III: COGNITIVE TASKS AND THE NEUROIMAGING OF SCHIZOPHRENIA 53 
 
EVANGELOS PAPANASTASIOU  DOCTORAL THESIS 
processing characterize a broad array of neuropsychiatric disorders, including schizophrenia 
198. 
The most prominent contemporary models of psychosis propose dysfunctional reward 
processing to be key in the aetiology of the illness 199. Dopamine dysregulation appears to be 
the final common pathway to psychosis in schizophrenia; this can alter the appraisal of stimuli, 
through a process of aberrant salience. The aberrant salience model proposes the emergence 
of psychotic symptoms when chaotic dopamine firing attributes significance to irrelevant 
stimuli (e.g. an aberrant sense of novelty); hallucinatory experiences reflect the abnormal 
salience of the internal representations of perception language and memories; delusions are a 
cognitive scheme that the patient develops to explain aberrant salience experience 200.  
Furthermore, negative symptomatology in schizophrenia was associated with reduction in 
ventral striatal activation in anticipation of rewards or punishments 201. Patients with FEP 
exhibit abnormal physiological responses associated with reward prediction error in the 
dopaminergic midbrain, striatum and limbic system and subtle abnormalities to discriminate 
between motivationally salient and neutral stimuli 202.  
The presence of psychosis symptoms is associated with decreases in striatal activation during 
reward tasks and a reduction in prefrontal cognitive control regions. However, the frequency 
and intensity of psychotic symptoms differs from the general population sample through UHR 
to schizophrenia and the latter is further differentiated by the presence of functional 
deterioration 203. Contemporary neuroscience has emphasized the role of PFC in maintaining 
‘rules’ in order to evaluate incoming information as well as internal states to steer responses 
toward a current goal; If the cognitive control hypothesis is correct, then one might anticipate 
that dysfunctional changes in subcortical reward processing in healthy adolescents are 
compensated for by intact cognitive control mechanisms. A large body of evidence have 
accounted higher cognitive deficits, seen across the psychosis spectrum, to impaired cognitive 
control 204.  
A combination of aberrant salience and cognitive control hypothesis suggests that the 
presence of aberrant salience may generate abnormal experiences and these are 
contextualised appropriately, with no significant functional consequences, if cognitive control 
mechanisms are operating correctly. This would still result in elevated levels of PLE and 
possible UHR status, with no transition to psychosis. Failure of the cognitive control 
mechanisms would however impact on the emergence of clinically relevant symptoms with 
consequent functional deterioration – and this would be evidenced as psychotic illness.  
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3.3.1. Findings from fMRI Studies employing Reward Tasks in Schizophrenia 
Several studies using fMRI compared schizophrenia patients to healthy controls, during a 
variety of reward tasks. A summary of their findings is listed below:  
 SCZ patients treated with typical (not atypical) antipsychotics showed reduced activation 
of the ventral striatum (VS) during anticipation of monetary gain, particularly if they 
reported a high severity of negative symptoms 205. 
 Un‐medicated SCZ patients showed reduced VS activation during the presentation of 
reward‐indicating cues; this was inversely correlated with the severity of negative (and 
trend‐wise positive) symptoms 206. 
 SCZ patients showed inappropriately strong activation in the VS in response to a neutral 
stimulus in a threatening condition 207. 
 Psychotic patients exhibited abnormal physiological responses associated with reward 
prediction error in the dopaminergic midbrain, striatum, and limbic system 202. 
 During reward anticipation, healthy volunteers showed higher VS activation. SCZ patients 
treated with typical antipsychotics (but not olanzapine), showed decreased left VS 
activation, which was correlated with negative symptoms 208. 
 Un‐medicated SCZ patients showed exaggerated activation in the medial PFC as a response 
to negative outcome in reward trials; in contrast, they showed reduced neural responses 
to successful versus unsuccessful avoidance of loss in the VS. Increased severity of 
delusions in schizophrenia patients was associated with a decrease in medial PFC 
activation elicited by successful versus unsuccessful avoidance of loss 209. 
 SCZ patients treated with atypical antipsychotics showed a mesolimbic dopamine 
hyperactivity and reduced prefrontal activation. During reward expectation, only controls 
showed increased activation in the anterior cingulate cortex with increasing reward. 
During outcome, controls showed a U‐shaped activation curve in the right VLPFC 210. 
 In SCZ patients, VS activation during reward anticipation was negatively correlated with 
apathy, while receipt of reward was negatively correlated with the severity of depressive 
symptoms 211. 
 In a Monetary Incentive Delay (MID) task, controls but not schizophrenia patients showed 
greater activation for gains in the medial PFC and the lateral PFC, lateral temporal cortex 
and amygdalae 212. Ratings of negative symptoms in SCZ patients correlated with sensitivity 
to obtained losses in the medial PFC, sensitivity to obtained gains in the lateral PFC, and 
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sensitivity to anticipated gains in the left VS. Ratings of positive symptoms in SCZ patients 
also correlated with sensitivity to obtained gains in the lateral PFC. 
A recent meta‐analysis investigating ventral striatal activation during reward processing in 
psychosis, pooled data from 23 trials, employing various reward conditions (anticipation, 
feedback, prediction error) 42. The authors found significant bilateral VS hypoactivation during 
reward anticipation in patients compared to healthy controls, which was more severe in 
subjects with high scores of negative symptoms. Patients also showed hypoactivation during 
reward feedback.   
In summary, most imaging studies employing reward tasks, showed differences in activation in 
schizophrenia patients versus controls in Bilateral VS, the PFC (medial, lateral and VLPFC), the 
temporal cortices and the anterior cingulate cortices. The nature of these differences varied 
between studies; however, schizophrenia patients appear to overall demonstrate decreased 
activation during gain, and reduced discrimination between salient and neutral stimuli.  
An overview of Brodmann Areas (BAs) hosting Regions of Interest (ROIs) showing differences in 
brain activation between schizophrenia patients and controls, during reward tasks, is described 
in APPENDIX II.  
3.4. The developing brain 
Childhood and adolescence are periods or rapid development and critical change for the brain. 
The neurodevelopmental model of schizophrenia, one of the most widely accepted and 
prevailing ideas in psychiatry, postulates that the illness is the end of abnormal brain 
maturation processes, throughout the life span 213. Knowledge of normal brain development is 
essential to understanding any abnormal changes leading to the development of 
psychopathology. This is extremely relevant to my studies, as I am observing a sample of 
healthy adolescents between the ages of 14 and 19, with focus on individuals with a psychosis 
proneness phenotype.  
A number of studies employing structural MRI have scanned large numbers of children and 
adolescents repeatedly over time, as the brain develop, tracking volumetric changes in Gray 
and White Matter (GM, WM) and thus providing a unique developmental perspective on 
neuropathology 214‐218. Various BAs showed significant structural changes from childhood to 
adolescence and adulthood, as primarily measured by the Distance from Centre Difference 
(DFC) and the Gray Matter Density (GMD). The DFC measure was developed primarily to 
measure group differences in local growth. DFC reflects radial expansion measured from the 
centre of the brain approximately at the midline decussation of the anterior commissure to 
each of the 65,536 brain surface points. It is of note that the measure at each point for each 
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individual is reflective of anatomical location in addition to radial expansion; thus, only relative 
differences in DFC are meaningful in terms of growth 216. 
3.4.1. Normal GM Development 
The total volume of GM in each lobe and in brain overall, exhibits a pre‐pubertal increase, 
followed by post‐pubertal loss. GM volume follows an inverted U‐shaped trajectory in frontal, 
parietal and temporal lobes (FL, PL, TL). The earliest cross‐sectional paediatric brain MRI 
studies of normal developmental changes reported that GM volumes generally declined after 
6‐7 years of age and continued to decrease during adolescence. Later studies revealed a 
shifting pattern of GM loss, appearing first (at 4‐8 years of age) in dorsal, parietal and primary 
sensorimotor regions near the interhemispheric margin and spreading laterally and caudally 
into temporal cortices and anteriorly into dorsolateral and prefrontal cortices. WM volumes 
increase roughly linearly throughout the first four decades of life, with a peak around the mid‐
forties when the speed of certain fine motor skills is also optimal 215.  
GM development is heterogeneous across the major lobes; FL have peak GM volumes around 
age 11, while the TL continue to increase in volume until age 14, and the cerebellum show the 
most protracted developmental time‐course. Females achieve peak GM volumes typically 1‐2 
years earlier than males, particularly for FL, TL and PL 215. 
Maturation‐related loss of cortical GM density continues over time across the entire age span, 
with rapid attrition of FL GM in late adolescence. Primary sensorimotor cortices and the frontal 
and occipital poles mature first, and the remainder of the cortex develops in a parietal to 
frontal (back‐to‐front) direction. The superior temporal cortex, which contains association 
areas that integrate information from several sensory modalities matures last suggesting that 
the higher‐order association areas mature only after the lower‐order sensorimotor regions, 
whose function they integrate, have matured 215. The first areas to mature are those with the 
most basic function, such as those processing the senses and movement. Areas involved in 
spatial orientation and language (parietal lobes) follow, around the ages of puberty (11‐13 
years). Areas with the most advanced functions – integrating information from the senses, 
reasoning and other executive functions (e.g. prefrontal cortex) – mature last, in late 
adolescence. This sequence also provides evidence that phylogenetically older critical areas 
mature earlier than the more recently evolved higher‐order association cortices, which 
integrate information from earlier maturing cortex 214.  
Several studies 216‐218 have provided more detailed lists of Brodmann Areas (BAs) with Regions 
of Interest (ROIs) showing the greatest maturation changes from childhood to adolescent and 
from adolescence to adulthood. An overview is described in APPENDIX III.  
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3.4.2. GM Development in Psychosis 
Profound and global GM loss with ventricular expansion in seen in Childhood Onset 
Schizophrenia (COS) 215; GM loss in COS progressed in a back‐to‐front (parieto‐frontal‐
temporal) direction during adolescent years. This is strikingly similar to the pattern of GM loss 
(maturation) seen during normal cortical development, but abnormally accelerated. Profound 
GM loss in schizophrenia raises a debate about whether this is just a perceived loss resulting 
from the encroachment of continued white matter growth, a process that normally extends 
through the fourth decade; in fact, myelination may continue over the entire lifespan, with 
deteriorative processes beginning to out‐weight positive changes by the mid‐forties. This 
process appears to progress in a front‐to‐back (fronto‐parietal) direction and growth rates 
were correlated with functional prognosis. These findings suggest that the progressive GM 
deficits seen in schizophrenia are not likely to be the result of WM overgrowth, because WM 
growth is itself slowed down.  
The Edinburgh High Risk Study (EHRS) have scanned a total of 220 subjects, including 150 UHR 
individuals for familial reasons, 34 FEP patients and 36 normal controls. Data from the EHRS 
have revealed changes in GMD in FEP patients and UHR subjects, compared to normal 
controls:  
 Reductions in GMD in FEP patients compared to normal controls in the right anterior 
cingulate, right medial frontal lobe, left middle temporal gyrus, left post‐central gyrus and 
the left limbic lobe 219.   
 Reductions in GMD in UHR subjects compared to controls the in the anterior cingulate and 
in the left parahippocampal gyrus 220. 
 UHR individuals who had transient or isolated psychotic symptoms showed a different 
spatial pattern of reductions in GMD than those who were free of psychotic symptoms 
within group comparisons. In addition, those individuals at UHR with transient psychotic 
symptoms who later developed schizophrenia also showed a different spatial pattern of 
reduction in GMD in the left temporal lobe and right cerebellum, compared to UHR 
subjects with transient psychotic symptoms who did not developed schizophrenia 221. 
 In UHR subjects, changes over time in the inferior temporal gyrus gave a 60% positive 
predictive value (likelihood ration >10) of developing schizophrenia to the overall 13% risk 
in all subjects 222.  
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In summary, the EHRS demonstrated that changes in GMD could be used as part of a predictive 
test for schizophrenia, in people at enhanced risk for familial reasons. However, due to the 
limited number of subjects employed in the study, no robust conclusions could be drawn.  
Details are summarized in APPENDIX IV.  
3.5. Summary of SCZ cognitive tasks and the developing brain 
In studies of face tasks, SCZ patients showed decreased activation compared to controls in the 
amygdalae, the VLPFC and the FFA, especially during the recognition of angry and fearful faces. 
In studies of reward tasks, SCZ patients demonstrated decreased activation compared to 
controls in the VS, the MPFC and the LPFC during gain and reduced discrimination between 
salient and neutral stimuli.  
Profound and global GM loss with ventricular expansion in seen in Childhood Onset SCZ; 
besides, reductions in GMD have been documented both in FEP patients (in cingulate, frontal 
and temporal cortices) and UHR subjects (in cingulate and parahippocampal cortices). Changes 
in GMD could be used as part of a predictive test for psychosis.  
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4.1. Aim of the study 
In previous chapters I first followed the path of the hunters of biomarkers for psychosis, in the 
fields of epidemiology, genetics and neuroimaging (chapter I); I examined the literature of PLE, 
with emphasis on clinical, epidemiological and neuroimaging findings (chapter II, first part); I 
have then presented the characteristics and previous applications of CAPE, a valid and reliable 
tool for the assessment of PLE, used in my studies (chapter II, second part). I finally discussed 
neuroimaging findings from two broadly used cognitive tasks in SCZ, employed in my studies 
(chapter III, first part) and changes seen in the developing brain from childhood through 
adolescence to adulthood, to better understand the critical developmental phase my research 
subjects aged 14 to 19 were going through.  
The aim of this study was to examine the neuroimaging profile of healthy adolescents with an 
increased presence of PLE, representative of the prodromal psychotic phenotype. In the 
previous chapter, the wealth of data on the deficits in emotional and reward processing seen 
in patients with psychosis was presented; and how crucial these deficits are considered by 
contemporary cognitive models on the aetiology of psychosis. A combination of aberrant 
salience (attribution of inappropriate meaning to irrelevant stimuli) with reduced cognitive 
control (which is required to contextualise appropriately these abnormal experiences) can lead 
to reality distortion and generate symptoms of psychosis. Thus, these two cognitive paradigms 
were employed as avenues to study the neural correlates of PLE. To assess the aberrant 
salience hypothesis, a reward task focusing on brain activation during anticipation and 
feedback of monetary gain was employed; as I have discussed in previous chapters, the 
presence of psychosis symptoms was associated with a reduction in striatal activation during 
reward tasks and a reduction in activation of prefrontal cognitive control regions. The cognitive 
control hypothesis was additionally tested by utilising a face task focusing on brain activation 
during processing of angry faces; as previously discussed, emotional dysregulation, is thought 
to result from a disruption in interactions between prefrontal emotion-controlling regions and 
subcortical (e.g. amygdala) emotion-generating regions. The dual hypothesis that my group of 
adolescents with elevated levels of PLE, would present differences in neural activation during a 
reward task and a face task, when compared to their counterparts without PLE, was examined. 
Those differences will be similar to those described in the literature discussed above, listing 
neural differences between schizophrenia patients and healthy controls, and neural 
differences between adolescents and young adults with and without prodromal psychotic 
symptoms.  
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Hypothesis (Face Task Study) 
 Reduced activation of the amygdala and associated network including prefrontal, 
parahippocampal, insular and caudate regions in high‐PLE subjects at age 14 and 19 
during a FT 108,51 [see also 3.2.1.]. 
Hypothesis (Reward Task Study) 
 Reduced activation of the prefrontal cortices, the temporal cortices, the cingulate cortices 
and the striatum in high‐PLE subjects at age 14 and 19 during a reward task 102,103 [see also 
3.3.1.].  
Hypothesis (Neuropsychological Study) 
 The presence of increased PLE in adolescence is associated with deficits in performance 
on risky and affective decision making neuropsychological tasks 104.  
4.2. Participants 
Neuroimaging and clinical data were obtained from the IMAGEN database, from eight sites in 
France, Ireland, Germany and the United Kingdom (https://imagen‐europe.com/). IMAGEN 
combines brain imaging, genetics, and psychiatry to increase our understanding of adolescent 
development and human behaviour such as sensitivity to reward and punishment, impulsivity 
and emotional response. Research teams from London, Nottingham, Dublin, Paris, Berlin, 
Hamburg, Mannheim and Dresden have been following 2,000 young people and their parents 
from the age of 14, with follow up assessments at age 16 and 19. Exclusion criteria 
encompassed significant pregnancy and birth complications, medical, neurological, psychiatric 
and neurodevelopmental conditions and MRI contraindications. All local ethics research 
committees approved the study. Written consent was obtained from the parents or guardians 
and verbal consent was obtained from the adolescents. 
Table 2: IMAGEN Exclusion Criteria 
Pregnancy and 
birth 
1. Use of alcohol by the mother during pregnancy (>210 ml alcohol/week) 
2. Diabetes of the mother during pregnancy (onset before pregnancy, treated 
by insulin) 
3. Premature birth (< 35 weeks) and/or detached placenta 
4. Hyperbilirubinemia requiring transfusion 
Medical History 1. Type 1 diabetes 
2. Systemic rheumatological disorders 
3. Malignant tumours requiring chemotherapy 





2. Bacterial Infection of CNS 
3. Brain tumour 
4. Head trauma with loss of consciousness >30 minutes 
5. Muscular/myotonic dystrophy 
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Developmental 
conditions 
1. Nutritional and metabolic diseases 
2. Major neuro‐developmental disorders 
3. Hearing deficit requiring hearing aid 
4. Vision problems (strabismus, visual deficit not correctible) 
Mental Health 1. Treatment for schizophrenia, bipolar disorder 
2. IQ < 70 
MRI 
Contraindications 
1. Metal implants 
2. Electronic implants  
3. Severe claustrophobia 
 
In my study, data from age 14 years as baseline (BL) and age 19 years as follow‐up (FU) 
timepoints were used. A total of 1,434 adolescents were initially selected, based on quality 
controls and completeness of their behavioural and neuroimaging datasets. The sample was 
later stratified following 2 distinct methods, as described in the following paragraphs.  
4.3. Measures 
4.3.1. Psychopathology Measure 
At FU assessment, the Community Assessment of Psychic Experience Questionnaire (CAPE) 
was used as a measure of Psychotic‐Like Experiences in my adolescent population. The most 
extended version of CAPE was used, encompassing 42 items, which can be grouped in three 
dimensions of symptoms: positive (comprising bizarre and social delusions), negative and 
depressive. Each item is scored based on frequency (how often is the item experienced) and 
severity (how distressing is the experience): 
 Frequency: [0] item is never present; [1] item is sometimes present; [2] item is often 
present; [3] item is nearly always present 
 Severity: [0] item was scored 0 in base of frequency; [1] item is present and not distressing, 
[2] item is present and a bit distressing; [3] item is present and quite distressing; [4] item is 
present and very distressing 
CAPE‐42 worksheet is presented in APPENDIX I; its clustering was already described in Table 1 
(2.2. The Community Assessment of Psychic Experience Questionnaire).  
4.3.2. Epidemiological Features 
The following parameters were also described in my overall sample (n=1,434): gender (% 
male); handedness (% right); age at BL and FU; age‐normalised IQ at BL; determined by 
administration of selected subscales of the Wechsler intelligence battery for children (WISC) 
223; estimates of depression as measured by the Adolescent Depression Rating Scale (ADRS) 224; 
levels of alcohol consumption, as measured by the Alcohol Use Disorders Identification Test 
(AUDIT) 225; levels of cannabis use, as measured by the cannabis scale of the Drug Abuse 
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Screening Test (DAST) 226. Verbal IQ was estimated via the vocabulary and similarities 
subscales; performance IQ was evaluated using the block‐design and matrix‐reasoning 
subscales. Correlations between selected CAPE scores and frequencies histograms of those 
scores are described in APPENDIX VI and APPENDIX VII.  
Table 3: Epidemiological Characteristics, Overall Sample 
Overall Sample (n=1,434) Min Max Mean SE SD Var 
GENDER (Male %) 
  
47.10% 
   
HANDEDNESS (R %) 
  
86.10% 
   
AGE BL (y) 12.73 15.92 14.42 0.01 0.40 0.16 
AGE FU2 (y) 16.82 22.01 19 0.02 0.76 0.57 
WISC VERBAL SCORE (BL) 57 155 112.21 0.41 14.92 222.63 
WISC PERFORMANCE SCORE (BL) 63 149 108.65 0.39 14.47 209.39 
ADRS TOTAL SCORE (FU) 4 20 18.64 0.06 2.17 4.69 
AUDIT TOTAL SCORE (FU) 0 27 5.63 0.11 4.22 17.81 
DAST CANNABIS TOTAL SCORE (FU) 0 11 0.89 0.05 1.81 3.29 
CAPE GRAND TOTAL SCORE (FU) 0 182 50.21 0.80 30.09 905.20 
CAPE POSITIVE Sx TOTAL SCORE (FU) 0 91 13.97 0.29 10.89 118.58 
CAPE BIZARRE Sx TOTAL SCORE (FU) 0 60 3.64 0.16 6.01 36.14 
CAPE SOCIAL DELUSIONS TOTAL SCORE (FU) 0 41 10.33 0.17 6.44 41.48 
CAPE NEGATIVE Sx TOTAL SCORE (FU) 0 74 20.96 0.38 14.22 202.27 
CAPE DEPRESSIVE Sx TOTAL SCORE (FU) 0 49 15.28 0.25 9.63 92.76 
CAPE ITEMS [5 + 7 + 33] SCORE (FU) 0 16 1.51 0.06 2.34 5.47 
Abbreviations 
WISC: Wechsler Intelligence Batter for Children 223; ADRS: Adolescent Depression Rating Scale 224; 
AUDIT: Alcohol Use Disorders Identification Test 225; DAST: Drug Abuse Screening Test 226; CAPE: 
Community Assessment of Psychic Experiences Questionnaire 73; SD: Standard Deviation; SE: 
Standard Error; Var: Variance; Sx: Symptoms 
 
4.3.3. CANTAB Measures 
Originally developed at the University of Cambridge, the Cambridge Neuropsychological Test 
Automated Battery (CANTAB) includes highly sensitive, precise and objective measures of 
cognitive function, correlated to neural networks 227, given the limitations of 
neuropsychological testing. CANTAB tests have demonstrated sensitivity to detecting changes 
in neuropsychological performance and include tests of working memory; learning and 
executive function; visual, verbal and episodic memory; attention, information processing and 
reaction time; social and emotion recognition, decision making and response control. In my 
study, the focus was placed on the following CANTAB tasks: 
Affective Go-NoGo Task (AGN): assessment of information processing biases for positive and 
negative stimuli; this task was chosen as a proxy for ‘hot’ cognition (cognitive functions mostly 
influenced by the individual’s emotional state), as related to the affective/inhibitory function 
of frontal and limbic areas of the brain. My rationale for employing this cognitive task is that it 
rules out a global deficit in cognitive inhibition, in the absence of explicit reward, 
complementary to my fMRI reward task. Details of AGN task are described in APPENDIX VIII. 
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Cambridge Guessing Task (CGT): assessment of decision‐making and risk‐taking behaviour 
outside a learning context; this task was chosen as a proxy for ‘cold’ cognition (cognitive 
functions mostly independent of the individual’s emotional state), as related to the executive 
functions of the frontal areas of the brain. Details of the CGT task are described in APPENDIX IX.  
Participants completed the AGN and CGT tasks both at BL and FU.  
4.4. Procedure  
4.4.1. Faces Task 
In the Face Task (FT) volunteers were asked to passively watch short black and white video 
clips (2‐5s) presenting faces with neutral and angry expressions as well as control non‐
biological motion stimuli (concentric circles). Subjects were shown faces that always started 
from a neutral expression, and then either turned angry or displayed a neutral movement 
without a particular emotional content (for example, twitching the nose). These stimuli were 
arranged in 18s blocks, each block including 4–7 video clips, depicting faces of the same 
emotion (either angry or neutral). Altogether there were five blocks of neutral faces and five 
blocks containing angry faces. In between two blocks of face clips, a 18s non‐biological control 
video clip was presented, that consisted of expanding and contracting black‐and‐white 
concentric circles of various contrasts, roughly matching the contrast and motion 
characteristics of video clips. Prior to fMRI scanning, participants were instructed that they 
would be presented wish short video clips showing faces with angry and neutral expressions as 
well as moving circles. They were asked to watch the video clips carefully and lie as still as 
possible during the task. The same instruction was given to them directly before the task 
started.  
Participants completed the FT both at BL and FU. Details of the FT are described in APPENDIX X. 
FT includes various contrasts between angry, neutral faces and control stimuli. In my study, I 
focused on the contrast between angry faces and control stimuli, as this shows maximal effects 
in the literature and has been described previously 228.  
4.4.2. Monetary Incentive Delay Task 
The adapted Monetary Incentive Delay (MID) Task is a widely‐used assessment of rewarded 
learning ostensibly presented as a reaction time task, testing both motor speed and visual‐
motor skills by using a monetary incentive. It measures how quickly a subject can react to a 
briefly presented visual target (the instructions are to press a button with the left or right 
index finger) that only appears for a short time on the left or right of the screen. If the subject 
can hit the target, they will score points. The subject can tell where the target will appear and 
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how many points they can win by the symbol they see on the screen before each trial. A 
triangle means no points, a circle with a line means 2 points and a circle with three lines means 
10 points. Responding too early or too late will result in a loss. The task lasts 11 minutes and is 
adaptive ‐ the maximum that can be won is 200 points. The subjects receive 1 M&M (or similar 
chocolates/sweets) for every 5 points to enhance motivation during the task. The MID shows 
subjects’ sequences of clues, target, and feedback phase. The cue indicates the amount of gain 
and the subjects are instructed to respond when the target shows, roughly 4sec after the clue 
(anticipation period), after which a 1.5sec feedback message tells the subject about the win or 
loss of a trial (feedback period).  
Participants completed the MID tasks both at BL and FU. Details of the MID task are described 
in APPENDIX XI. 
MID task includes various conditions: reward anticipation and receipt of feedback of positive 
(small or large win) or negative outcomes (no win). In my study, I focused on the key 
anticipation and feedback epochs; and the neuroimaging contrast between the large‐win and 
no‐win conditions, as these shows maximal effects in the literature and have been described 
previously 229,230.  
4.5. Stratification of the Sample 
From the literature 53, two groups in my initial cross sectional assessment were identified: one 
group with high rates of PLE and the other with low rates of PLE’s. I followed a two‐step 
procedure during this stratification process.  
4.5.1. CAPE Total Score, General Stratification 
In this approach, high PLE and low PLE group were identified, based on a summary of total 
scores (frequency and severity) of all 42 items of CAPE. As CAPE total scores did not follow a 
normal distribution, high and low scorers were selected within the upper and lower 10th 
percentile. This resulted in n=149 subjects in the high group (representing a psychosis 
proneness phenotype) and n=149 subjects in the low group (representing healthy controls). 
The high group CAPE total score ranged 91‐182, corresponding to an itemised score range of 
2.17‐4.33. As discussed earlier in chapter II, cut‐off levels in the area of 2.0 per CAPE item 
provide adequate positive predictive value for transition to psychosis, based on the relevant 
literature. The lower edge of my high PLE group range is extremely close to this cut‐off values; 
this provides an extra value of my high PLE group as representative of the psychosis proneness 
phenotype (see section 2.2.4.). The two groups were equivalent for handedness, age and IQ 
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scores, with higher percentages of male participants in the low group (56.4% vs 33.6%). The 
characteristics of both groups are described in detail in APPENDIX XII.  
Graph 1: CAPE Grand Total Scores Frequencies Histogram 
 
4.5.2. CAPE 3-Items Score, Specific Stratification 
In this approach, focus was placed on specific CAPE items which have a clinical significance and 
a better predictive value for future transition to psychosis. A study from Australia suggested 
that bizarre experiences and persecutory ideation were the subtypes of PLE more strongly 
associated with distress, depression and poor functioning, which are all risk factors for 
transition to psychosis 170. Besides, another study examining the predictive value of adolescent 
psychopathology, showed that hallucinations at age 13 were significantly associated with 
elevated psychoticism scores (PDI) at age 21 140. As discussed earlier, the question about 
auditory hallucinations (among a 7‐item screening questionnaire for PLE) provided the best 
predictive power for this item and for any PLE 78. Finally, two studies from Australia 151 and 
Chile 150, exploring the dimensionality of CAPE‐15, revealed a best fit for a hierarchical model, 
including persecutory ideation, bizarre experiences and perceptual abnormalities, as specific 
factors.   
Consequently, 3 representative CAPE items were considered, which could reflect the 
symptomatology described above. Items No 5 (messages from media, bizarre delusion); No 7 
(being persecuted, social delusion) and No 33 (auditory hallucinations, perceptual 
abnormalities) were chosen and a composite score was generated by adding their total scores 
(frequency and severity). As my composite scores, did not follow a normal distribution, I 
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variability of the scores within the high group. This resulted in n=366 subjects in the high group 
(representing a psychosis proneness phenotype) and n=330 subjects in the low group 
(representing healthy controls).  
The high group CAPE 3‐items score ranged 3‐16, corresponding to an itemised score range of 
1‐5.33. As discussed earlier in chapter II, cut‐off levels in the area of 2.0 per CAPE item provide 
adequate positive predictive value for transition to psychosis, based on the relevant literature. 
The lower edge of my high PLE group range is also close to this cut‐off values; this provides an 
extra value of my high PLE group as representative of the psychosis proneness phenotype (see 
section 2.2.4.). The two groups were equivalent for handedness, age and IQ scores, with higher 
percentages of male participants in the low group (55.5% vs 41.5%). The characteristics of both 
groups are described in detail in APPENDIX XIII.  
Graph 2: CAPE 3-Items Score Frequencies Histogram 
 
4.6. fMRI Acquisition 
Structural and fMRI data were acquired at eight IMAGEN assessment sites with 3‐T scanners 
from various manufacturers (Siemens, Philips, General Electric, and Bruker). The scanning 
variables were specifically chosen to be compatible with all scanners. The same scanning 
protocol was used at all sites. In brief, high‐resolution T1‐weighted three‐dimensional 
structural images were acquired for anatomical localization and co‐registration with the 
functional time series. fMRI blood‐oxygen‐level‐dependent (BOLD) images were acquired with 
a gradient‐echo, echo‐planar imaging (EPI) sequence. 191 volumes were acquired for each 
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consisted of 40 slices aligned to the anterior commissure‐posterior commissure line (2.4 mm 
slice thickness, 3.4 mm slice gap) acquired in a descending order. The echo time was optimized 
(TE=30 ms, TR=2200 ms) to provide reliable imaging of subcortical areas. Voxel size was set at 
3.4mm x 3.4mm x 2.4mm, matrix size at 642, and FOV at 218mm.  
fMRI was performed on 3T scanners from a range of manufacturers (Siemens, Munich, 
Germany; Philips, Best, The Netherlands; General Electrics, Chalfont St Giles, UK; Bruker, 
Ettlingen, Germany). A key challenge for the ability to pool data acquired on MR scanners of 
different manufacturers related to their variation in availability and implementation of 
particular image‐acquisition techniques. To address this problem, for each technique, a set of 
parameters compatible with all scanners, particularly those directly affecting image contrast or 
signal‐to‐ noise, was devised and held constant across sites. Where manufacturer‐specific 
choices had to be made (for example the design of head coil), the best manufacturer‐specific 
option was used at all sites with the same scanner type. Two quality control procedures were 
regularly implemented at each site: (a) The American College of Radiology phantom was 
scanned to provide information about geometric distortions and signal uniformity related to 
hardware differences in radiofrequency coils and gradient systems, image contrast and 
temporal stability, and a custom phantom was scanned for diffusion related parameters. (b) 
Several healthy volunteers were regularly scanned at each site to assess factors that cannot be 
measured using phantoms alone and at multiple sites to determine inter‐site variability in 
structural and functional measures (for example, tissue contrast in raw MRI signal, tissue 
relaxation properties). 
A full description of the scanning protocols, their cross‐site standardization and quality checks, 
and pre‐processing of resulting data are provided elsewhere 231; acquisition parameters are 
summarised in APPENDIX V. 
4.7. fMRI Analysis 
4.7.1. Pre-Processing 
The pre‐processing of the EPI data was done with SPM12 (Statistical Parametric Mapping; 
http://www.fil.ion.ucl.ac.uk/spm). Time series data were first corrected for slice‐timing, then 
corrected for movement (spatial realignment), non‐linearly warped on the MNI space (using a 
custom EPI template), and Gaussian‐smoothed at 5mm Full Width and Half Maximum 
(FWHM).  
4.7.2. First-Level Analysis 
Activation maps were computed with SPM12, and regressed using a general linear model 
(GLM) with Autoregressive (AR) noise modes (SPM default) against a design‐matrix built from 
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the information contained in the IMAGEN behavioural files. Estimated movement parameters 
were added to the design matrix in the form of 21 additional columns (3 translations, 3 
rotations, 3 translations with a shift x1 TR before, 3 translations shifted x1 TR later and 9 
additional columns corresponding to the long‐term effects of the movement). The regressors’ 
modelling the experimental conditions were convolved using SPM’s default Haemodynamic 
Response Function (HRF). The estimated model (“beta”) parameters maps were linearly‐
combined to yield contrast maps and significance maps, while the residual variance of the 
model fit was stored as an additional map.  
For the FT Study, one within‐subject contrast of interest was selected for investigation, both at 
BL and FU:  
 [Angry Faces] – [Control Stimuli].  
The selection was made with the intention of exploring inclusively processes relating to brain 
function in association with emotive/threatening face perception. This approach is 
advantageous as it permits independent characterisation of the cerebral milieu associated with 
these conditions, and its results are less dependent on pre‐conceived views of the critical 
distinctions between sub‐components of the faces task.  
For the MID Study, two within‐subject contrasts of interest were selected for investigation, 
both at BL and FU:  
 [Anticipation of large win] – [Anticipation of no win].  
 [Feedback of large win] – [Feedback of no win].  
The selection was made with the intention of exploring processes relating to brain function in 
association with anticipation and feedback reward processing in general. This approach is 
advantageous as it permits independent characterisation of the cerebral milieu associated with 
these conditions, and its results are less dependent on pre‐conceived views of the critical 
distinctions between sub‐components of the MDI task.  
4.7.3. Second-Level Analysis 
As Exploratory whole brain analysis proved insensitive, task‐related regions of interest were 
identified, for the above first‐level contrasts, at a corrected Family Wise Error (FEW) of p<0.05. 
A functional Regions of Interest (fROI) analysis approach was chosen by focusing on high and 
low CAPE scorers, as described in the stratification of the sample, either using the CAPE total 
score or the CAPE 3‐items score at age 19 years. A mask was applied to identify ROIs at BL and 
FU based on the four following conditions: 
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 ROIs showing increased activation in the high PLE group but not the low PLE group 
(‘high>low’ or [1 ‐1]) 
 ROIs showing increased activation in the low PLE group but not in the high PLE group 
(‘low>high’ or [‐1 1]) 
 ROIs showing increased activation both in the high PLE and low PLE groups (‘group average 
positive’ or [0.5 0.5]) 
 ROIs showing decreased activation both in the high PLE and low PLE groups (‘group 
average negative’ or [‐0.5 ‐0.5]) 
This approach provides an unbiased estimate of the activation, as the ‘group average 
positive/negative’ are orthogonal to ‘high>low’ or ‘low>high’ and is also supported by 
literature on functional localisers 232. ROIs were further filtered from supra‐threshold based on 
literature of psychosis and UHR for psychosis, and fewer ROIs were selected for further 
analysis. 
Brain activation levels were extracted for the selected ROIs (expressed as contrast parameter 
estimates) during the baseline and follow‐up states for both stratification approaches. A 
factorial design (mixed model 2‐way ANOVA with group as fixed and subject as random 
effects) was employed to investigate the interaction effect of group*time and the main effects 
of group (high vs low PLE scorers in both stratification approaches) and time (baseline vs 
follow‐up) on brain activation levels, for the ROIs identified previously. Further ad-hoc cross-
sectional and longitudinal analysis was applied to clarify the direction of factorial findings 
(independent and paired t‐tests respectively, at a corrected p=.05 level). Additional 
exploratory analysis was also reported, when statistically significant. Effect sizes were 
calculated and reported. 
4.8. CANTAB Measures Analysis 
The following measures, from the AGN and CGT tasks, were included in my analysis.  
 AGN Total Omissions Negative/Positive: total number of missed responses to targets in 
the blocks specified by the value of target type (negative, positive).  
 CGT Risk Adjustment: Participants are expected to gamble an increased amount of their 
points when the odds are in their favour. Specifically, higher bets should be evident when 
the majority of the boxes are that of the colour chosen. Risk adjustment measures the 
tendency to gamble higher proportions of points on trials where a larger proportion of the 
boxes are of the participant’s chosen colours.  
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A factorial design (mixed model 2‐way ANOVA with group as fixed and subject as random 
effects) was employed to investigate the interaction effect of group*time and the main effects 
of group (high vs low PLE scorers in both stratification approaches) and time (baseline vs 
follow‐up) on AGN and CGT scores. Further ad‐hoc cross‐sectional and longitudinal analysis 
was applied to clarify the direction of factorial findings (independent and paired t‐tests 
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5.1. Overview 
Objective 
To examine the neuroimaging profile of healthy adolescents with an increased presence of 
Psychotic‐Like Experiences (PLE), during a face cognitive task.  
Method 
1,434 adolescents were assessed at 2 timepoints using functional MRI during a Faces Task (FT) 
at age 14 and 19 years. The sample was stratified into two groups of high PLE and low PLE 
based on their scores on the CAPE‐42 questionnaire at age 19. A general and specific 
stratification was applied, the general stratification used the CAPE Total Score, while the 
specific stratification used a CAPE Score of 3 specific clinically significant items. The first level 
analysis focused on a pre‐defined contrast of [Angry Faces] – [Control Stimuli]. The second 
level analysis examined between‐group differences using an a priori defined region of interest 
approach (ROIs). I performed a factorial analysis to examine the main effects of group, time 
and their interaction on brain activation. Additionally, I performed an exploratory analysis, by 
employing both a cross‐sectional design to compare brain activation levels between the high 
PLE and low PLE groups at ages 14 and 19, and a longitudinal design to compare brain 
activation levels between the two timepoints.  
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5.2. Results of fMRI Analysis 
The following ROIs were initially identified through the literature of faces, emotion and social 
cognition processing in psychosis and UHR for psychosis 51,194 and filtered through the second‐
level analysis. The ROIs listed here [MNI coordinates] showed differences in brain activation 
between groups (high PLE vs low PLE) and timepoints (BL vs FU). The main effect of group, 
time and the interaction of group*time on brain activation levels was examined by employing 
a mixed model 2‐way ANOVA, and post‐hoc paired/independent T‐tests.  
General Stratification ROIs  
[42 8 -14] Right Insular Cortex, BA13 (BL) 
[-12 5 10] Left Caudate Body (FU) 
[6 65 31] Right Frontal Lobe, Superior Frontal Gyrus, BA10 (FU) 
[33 -46 -5] Right Limbic Cortex, Parahippocampal Gyrus, BA19 (FU) 
Specific Stratification ROIs  
[-6 -73 -26] Left Cerebellum, Posterior Lobe, Declive (BL) 
[-33 11 10] Left Insular Cortex, BA13 (BL) 
[-15 -40 -44] Left Cerebellum, Posterior Lobe, Tonsil (FU) 
[-33 17 -11] Left Insular Cortex, BA13 (FU) 
5.2.1. Retrospective Control for Multiple Testing 
As multiple ROIs resulted from my Analysis, I performed a retrospective correction of the 
statistical significance threshold of the whole brain analysis, at a contrast level. As eight ROIs 
were identified in the [angry – control] contrast, I used a Bonferoni correction, introducing a 
new level of statistical significance at 0.00625 (0.05 / 8). Acknowledging this approach is a 
rather conservative one, I chose to present all eight ROIs, noting however that [42 8 ‐14] and [‐
33 17 ‐11] did not survive the updated threshold of 0.00625, corrected for multiple testing.  
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5.2.2. General Stratification 
Figure 2: FT Study, ROIs selected for Analysis, General Stratification 
BASELINE 





[‐12 5 10]: Left Caudate 
Body  
(L>H) 
[6 65 31]: Right Superior 
Frontal Gyrus  
(L>H) 
[33 ‐46 ‐5]: Right 
Parahippocampal Gyrus 
(L>H) 
For more detailed illustrations see APPENDIX XXI: General Stratification 
Right Insular Cortex [42 8 -14]  
There was an interaction effect of group*time [F(1, 230)=7.4, p=0.007], which was driven by a 
differential change in brain activation from BL to FU, showing significant increase in the low 
PLE group (t=‐2.0, p=0.043), and non‐significant decrease in the high PLE group. Additional 
exploratory analysis exhibited higher brain activation of the high PLE group compared to the 
low PLE group at BL (t=5.2, p<0.0001). 
Left Caudate Body [-12 5 10] 
No effects of group*time, group nor time were reported. Additional exploratory analysis 
exhibited higher brain activation of the low PLE group compared to the high PLE group at FU 
(t=‐2.588, p=0.01). 
Right Superior Frontal Gyrus [6 65 31] 
There was a main effect of group [F(1, 230)=4.2, p=0.041], which was driven by higher brain 
activation of the low PLE group compared to the high PLE group at FU (t=‐2.3, p=0.023). There 
was a main effect of time [F(1, 230)=6.9, p=0.009], which was driven by an increase in brain 
activation from BL to FU, significant only for the low PLE group, (t=‐3.3, p=0.001). 
CHAPTER V: THE FACES TASK STUDY 76 
 
EVANGELOS PAPANASTASIOU  DOCTORAL THESIS 
Right Parahippocampal Gyrus [33 -46 -5] 
There was a main effect of group [F(1, 230)=4.9, p=0.028], which was driven by higher brain 
activation of the low PLE group compared to the high PLE group at FU (t=‐2.8, p=0.005). There 
was a main effect of time [F(1, 230)=12.1, p=0.001], which was driven by a decrease in brain 
activation from BL to FU, significant only the high PLE group (t=4.3, p<0.0001).  















For a table of fROIs brain analysis results see APPENDIX XIV: General Stratification 
For a table of cross‐sectional analysis results see APPENDIX XV: General Stratification 
For a table of longitudinal analysis results see APPENDIX XVI: General Stratification 
  





F Sig. r 
Insular ROI [42 8 -14] Brain Activation, General Stratification 
GROUP 3.921 1 3.921 19.522 <0.0001 0.280 
TIME 0.002 1 0.002 0.002 0.968* 0.003 
GROUP * TIME 8.229 1 8.229 7.458 0.007 0.177 
Error(GROUP) 46.196 230 0.201       
Error(TIME) 253.769 230 1.103       
Caudate ROI [-12 5 10] Brain Activation, General Stratification 
GROUP 0.185 1 0.185 3.036 0.083* 0.114 
TIME 0.393 1 0.393 1.711 0.192* 0.086 
GROUP * TIME 0.734 1 0.734 3.200 0.075* 0.117 
Error(GROUP) 13.987 230 0.061       
Error(TIME) 52.784 230 0.229    
Frontal ROI [6 65 31] Brain Activation, General Stratification 
GROUP 1.146 1 1.146 4.212 0.041 0.134 
TIME 4.827 1 4.827 6.978 0.009 0.172 
GROUP * TIME 2.195 1 2.195 3.174 0.076* 0.117 
Error(GROUP) 62.564 230 0.272       
Error(TIME) 159.102 230 0.692    
Limbic ROI [33 -46 -5] Brain Activation, General Stratification 
GROUP 0.455 1 0.455 4.899 0.028 0.144 
TIME 3.171 1 3.171 12.106 0.001 0.224 
GROUP * TIME 0.723 1 0.723 2.76 0.098* 0.109 
Error(GROUP) 21.358 230 0.093       
Error(TIME) 60.247 230 0.262    
Abbreviations 
df: degrees of Freedom; F: F‐ratio; (*): not statistically significant at a p=0.05 level; 
r: Pearson’s correlation coefficient; 
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Graph 3: FT Study, Longitudinal Analysis Graphs, General Stratification 
Brain Activation at BL and FU, ROI [6 65 31],  
Right Superior Frontal Gyrus 
Brain Activation at BL and FU, ROI [33 -46 -5],  
Right Parahippocampal Gyrus 
  
Longitudinal changes are statistically significant 
(p<.05) for the Low PLE Group only (thick line); 
encircled (red dotted line) are statistically 
significant cross‐sectional differences (p<.05); SE 
bars are displayed. 
Longitudinal changes are statistically significant 
(p<.05) for the High PLE Group only (thick line); 
encircled (red dotted line) are statistically 
significant cross‐sectional differences (p<.05); SE 
bars are displayed. 
Brain Activation at BL and FU, ROI [42 8 -14],  




Longitudinal changes are statistically significant 
(p<.05) for the Low PLE Group only (thick line); 
encircled (red dotted line) are statistically 
significant cross‐sectional differences (p<.05); SE 
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BL to FU 
changes 
FU state 
Right Insular Cortex 
[42 8 -14] 
Group*Time H>L 
H ↓ NS 
L ↑ 
 
Left Caudate Body 
[-12 5 10] 
   L>H 
Right Superior 
Frontal Gyrus 




H ↑ NS 
L ↑ 
L>H 
Right Limbic Cortex 





L ↓ NS 
L>H 
H: High PLE Group; L: Low PLE Group;  
↑: Increase in brain activation (statistically significant); 
↑ NS: Increase in brain activation (statistically non‐significant); 
↓: Decrease in brain activation (statistically significant); 
↓ NS: Decrease in brain activation (statistically non‐significant) 
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5.2.3. Specific Stratification 
Figure 3: FT Study, ROIs selected for Analysis, Specific Stratification 
BASELINE 
[‐6 ‐73 ‐26]: Left 
Cerebellar Declive  
(H>L) 





[‐15 ‐40 ‐44]: Left 
Cerebellar Tonsil  
(L>H) 
[‐33 17 ‐11]: Left Insular 
Cortex  
(L>H) 
For more detailed illustrations see APPENDIX XXII: Specific Stratification 
Left Cerebellar Declive [-6 -73 -26] 
There was a main effect of group [F(1, 549)=7.196, p=0.008], which was driven by higher brain 
activation of the high PLE group compared to the low PLE group at BL (t=2.828, p=0.005).  
Left Insular Cortex [-33 11 10] 
There was an interaction effect of group*time [F(1, 549)=11; p=0.001], which was driven by a 
differential change in brain activation from BL to FU, showing significant decrease in the low 
PLE group (t=3.38, p=0.001) and non‐significant increase in the high PLE group. Additional 
exploratory analysis exhibited higher brain activation of the low PLE group compared to the 
high PLE group at BL (t=‐2.278, p=0.023). 
Left Cerebellar Tonsil [-15 -40 -44] 
No effects of group*time, group nor time were reported. Additional exploratory analysis 
exhibited higher brain activation of the low PLE group compared to the high PLE group at FU 
(t=‐2.75, p=0.006). 
Left Insular Cortex [-33 17 -11] 
There was a main effect of group [F(1, 549)=5.228, p=0.023], which was driven by higher brain 
activation of the low PLE group compared to the high PLE group at FU (t=‐2.275, p=0.023). 
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There was a main effect of time [F(1, 549)=7.336, p=0.007], which was driven by a decrease in 
brain activation from BL to FU, significant only for the low PLE group (t=3.258, p=0.001). 
Table 6: FT Study, Factorial Analysis, Mixed Model 2-Way ANOVA, Specific Stratification 





F Sig. r 
Cerebellar ROI [-6 -73 -26] Brain Activation, Specific Stratification 
GROUP 0.591 1 0.591 7.196 0.008 0.114 
TIME 0.755 1 0.755 3.201 0.074* 0.076 
GROUP * TIME 0.595 1 0.595 2.525 0.113* 0.068 
Error(GROUP) 45.060 549 0.082       
Error(TIME) 129.414 549 0.236       
Insular ROI [-33 11 10] Brain Activation, Specific Stratification 
GROUP 0.012 1 0.012 0.133 0.715* 0.016 
TIME 1.092 1 1.092 3.679 0.056* 0.082 
GROUP * TIME 3.263 1 3.263 11 0.001 0.140 
Error(GROUP) 47.887 549 0.087       
Error(TIME) 162.872 549 0.297       
Cerebellar ROI [-15 -40 -44] Brain Activation, Specific Stratification 
GROUP 0.001 1 0.001 0.017 0.896* 0.006 
TIME 0.175 1 0.175 1.005 0.317* 0.043 
GROUP * TIME 0.015 1 0.015 0.087 0.768* 0.013 
Error(GROUP) 95.561 549 0.174       
Error(TIME) 95.561 549 0.174       
Insular ROI [-33 17 -11] Brain Activation, Specific Stratification 
GROUP 0.53 1 0.53 5.228 0.023 0.097 
TIME 2.217 1 2.217 7.336 0.007 0.115 
GROUP * TIME 1.003 1 1.003 3.32 0.069* 0.078 
Error(GROUP) 55.619 549 0.101       
Error(TIME) 165.894 549 0.302       
Abbreviations 
df: degrees of Freedom; F: F‐ratio; (*): not statistically significant at a p=0.05 level; 
r: Pearson’s correlation coefficient; 
 
For a table of fROIs brain analysis results see APPENDIX XIV: Specific Stratification 
For a table of cross‐sectional analysis results see APPENDIX XV: Specific Stratification 
For a table of longitudinal analysis results see APPENDIX XVI: Specific Stratification 
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Graph 4: FT Study, Longitudinal Analysis Graphs, Specific Stratification 
Brain Activation at BL and FU, ROI [-33 17 -11],  
Left Insular Cortex 
Brain Activation at BL and FU, ROI [-33 11 10],  
Left Insular Cortex 
  
Longitudinal changes are statistically significant 
(p<.05) for the High PLE Group only (thick line); 
encircled (red dotted line) are statistically 
significant cross‐sectional differences (p<.05); SE 
bars are displayed. 
Longitudinal changes are statistically significant 
(p<.05) for the Low PLE Group only (thick line); 
encircled (red dotted line) are statistically 
significant cross‐sectional differences (p<.05); SE 
bars are displayed. 
 
































































[-6 -73 -26] 
Group H>L   
Left Insular Cortex 
[-33 11 10] 
Group*Time L>H 




[-15 -40 -44] 
   L>H 
Left Insular Cortex 





L ↓ NS 
L>H 
H: High PLE Group; L: Low PLE Group;  
↑: Increase in brain activation (statistically significant); 
↑ NS: Increase in brain activation (statistically non‐significant); 
↓: Decrease in brain activation (statistically significant); 
↓ NS: Decrease in brain activation (statistically non‐significant); 
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5.3. Results of CANTAB Measures  
The main effect of group, time and the interaction of group*time on CANTAB measures was 
examined by employing a mixed model 2‐way ANOVA, and post‐hoc paired/independent T‐
tests.  
Table 8: CANTAB Measures Factorial Analysis, Mixed Model 2-Way ANOVA, General & 
Specific Stratification 





F Sig. r 
AGN Total Omissions Negative Scores, General Stratification 
GROUP 73.817 1 73.817 2.498 .116* 0.124 
TIME 3006.213 1 3006.213 50.236 <0.0001 0.490 
GROUP * TIME 144.599 1 144.599 2.416 .122* 0.122 
Error(GROUP) 4699.301 159 29.555    
Error(TIME) 9514.780 159 59.841    
AGN Total Omissions Positive Scores, General Stratification 
GROUP 77.094 1 77.094 2.919 .089* 0.134 
TIME 3423.720 1 3423.720 58.778 <0.0001 0.520 
GROUP * TIME 77.335 1 77.335 1.328 .251* 0.091 
Error(GROUP) 4199.102 159 26.409    
Error(TIME) 9261.485 159 58.248    
CGT Risk Adjustment Scores, Specific Stratification  
GROUP 2.360 1 2.360 3.143 .077* 0.076 
TIME 53.065 1 53.065 52.930 <0.0001 0.298 
GROUP * TIME 8.273 1 8.273 8.252 .004 0.122 
Error(GROUP) 406.935 542 .751    
Error(TIME) 543.379 542 1.003    
Abbreviations 
df: degrees of Freedom; F: F‐ratio; (*): not statistically significant at a p=0.05 level; r: 
Pearson’s correlation coefficient; 
 
For a table of cross‐sectional analysis results see APPENDIX XX: Cross‐Sectional Analysis 
For a table of longitudinal analysis result see APPENDIX XX: Longitudinal Analysis 
5.3.1. General Stratification 
There was a main effect of time on AGN Total Omissions for both positive [F(1, 159)=58.8, 
p<0.0001] and negative stimuli [F(1, 159)=50.2, p<0.0001], which was driven by a decrease 
from BL to FU, across the high PLE group (AGN positive: t=4.5, p<0.0001; AGN negative: t=3.7, 
p<0.001) and the low PLE group (AGN positive: t=6.3, p<0.0001; AGN negative: t=6.4, 
p<0.0001). Additional exploratory analysis revealed that the high PLE group scored lower 
compared to the low PLE group on AGN Total Omissions for both positive and negative stimuli 
at BL.   
5.3.2. Specific Stratification 
There was an interaction effect of group*time on CGT Risk Adjustment scores [F(1, 542)=8.252, 
p=0.004], which was driven by an increase from BL to FU, significant for both the high PLE 
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group (t=‐7.313, p<0.0001) and the low PLE group (t=‐3.058, p<0.0001); the high PLE group 
showed however a steeper increase between BL and FU, compared to the low PLE group.  
Graph 5: CANTAB Measures, Longitudinal Analysis Graphs, General & Specific Stratification 
AGN Total Omissions Positive Stimuli Mean 
Scores at BL and FU,  
General Stratification 
AGN Total Omissions Negative Stimuli Mean 
Scores at BL and FU,  
General Stratification 
  
CGT Risk Adjustment Mean Scores at BL and 




Longitudinal changes are statistically significant (p<.05) for the High PLE Group and the Low PLE 
Group (thick lines); encircled (red dotted line) are statistically significant cross‐sectional differences 
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5.4. Correlations 
In exploratory analysis, I investigated whether brain activation levels for my identified fROIs 
correlated with selected CAPE and CANTAB scores. The strength of these correlations proved 
weak, though numerous statistically significant results were generated. Most notably, baseline 
BOLD signals of the Right Insular ROI [42 8 ‐14] positively correlated with CAPE grand total 
scores (rho=0.292, p<0.0001) and CAPE 3‐items scores (rho=0.265, p<0.0001);  
See Appendix XXV  
Table 9: CANTAB Measures, Summary of Findings, General & Specific Stratification 
  












General Time L>H 
H ↓  





General Time L>H 
H ↓  








H: High PLE Group; L: Low PLE Group;  
↑: Increase in CANTAB score (statistically significant); 
↓: Decrease in CANTAB score (statistically significant) 
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5.5. Discussion 
5.5.1. Overview of fMRI Studies 
The primary finding, if one looks at ROIs based on the general PLE stratification, is that brain 
areas showed differences in brain activation at BL and FU, between the high PLE and low PLE 
groups. In summary, in the high PLE group, an early state of hyperactivation in right insular 
cortical areas [42 8 ‐14], was replaced by a later state of hypoactivation in right frontal [6 65 
31] limbic [33 ‐46 ‐5] and left striatal [‐12 5 10] areas, when the general stratification was 
applied.  
Secondary findings, if one looks at ROIs based on the specific stratification, are that similar 
brain areas showed differences in brain activation at both BL and FU, between the high PLE 
and low PLE groups. In summary, in the high PLE group, an early state of hyperactivation in a 
left cerebellar area [‐6 ‐73 ‐26] and hypoactivation in a left insular area [‐33 11 10], was 
replaced by a later state of hypoactivation in both a left cerebellar area [‐15 ‐40 ‐44] and a left 
insular area [‐33 17 ‐11], when the specific stratification was applied.  
My longitudinal studies revealed differences in brain activation between BL and FU in relatively 
fewer brain areas, compared to the ones identified in the cross‐sectional studies. In summary, 
in the high PLE group, there was a decrease in brain activation between BL and FU in a right 
limbic area and a left insular area.   
My results nevertheless provide a partial confirmation of my research hypothesis, as 
engagement of prefrontal, parahippocampal, insular and caudate areas (but not the amygdala) 
was reaffirmed. 
5.5.2. Interpretation of fMRI Results 
Adolescents with high levels of PLE were examined using fMRI during facial emotions task. 
Under a wider consideration, identified ROIs appear connected to a broader neural circuit 
responsible for integrating social perception, cognition and behaviour, as was described earlier 
180. Dysregulation of this circuit leads to deficits in social perception, cognition and behaviour. 
Misidentification of facial expressions represent a crucial deficit during this process, and as 
observed extensively in SCZ literature, it can give rise to impaired social interactions and the 
development of paranoia.  
From a different perspective, young people at UHR of psychosis exhibit HPA axis hyper‐
activation and higher levels of plasma cortisol, which were positively associated with levels of 
depression and anxiety 233; the stress-vulnerability model has been already proposed for the 
aetiology of SCZ 234. One could hypothesize that abnormal facial processing, can both invoke 
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and amplify stress reactions; amygdala and the prefrontal cortex are indeed components of 
both the ‘social’ and ‘stress’ systems of the brain.  
Considering my high PLE group results from a neuro‐developmental point of view one needs to 
distinguish between states (patterns of brain activation which are pertinent only to a 
particular timepoint) versus traits (patterns of brain activation which persist along various 
timepoints). 
In my cross‐sectional studies, I revealed different hypoactivation and hyperactivation states at 
different timepoints, with relatively more brain areas involved at FU compared to BL, when I 
consider a general stratification of my sample. These observations might represent a 
developmental process in the course of the prodromal psychosis phenotype, during which 
fewer areas show aberrant activation at BL (insular cortex, cerebellum), compared to FU 
(frontal, limbic, insular, caudate and cerebellum). My longitudinal studies confirmed that in the 
high PLE group, brain activation of a limbic area [33 ‐46 ‐5], showed a significant decrease 
between BL and FU; the same area was also hypoactive at FU in the high PLE group. This 
variation could potentially underpin an ‘aberrant’ developmental process, leading to under‐
recruitment of critical limbic areas during perception of angry faces, generating its full 
potential at a later age and, thus introducing a risk for the future emergence of psychosis. 
Similarly, in the high PLE group, brain activation of a frontal area [6 65 31] showed a non‐
significant increase between BL and FU; the same area remained hypoactive at FU in the high 
PLE group, compared to the low PLE group, which could also represent a stable deficit in 
frontal activation. The above changes followed similar directions in both groups; however, an 
insular area [42 8 ‐14] exhibited opposing trends in brain activation changes between BL and 
FU (non‐significant decrease in the high PLE group vs significant increase in the low PLE group). 
The significance of this finding is not clear; it is possible however that this area of maximum 
divergence can have a role in differentiating the two groups, during a facial‐emotional task.  
Hypoactivation of frontal areas might also represent a trait in the development of psychosis, 
as it appears in all phases of the continuum, from prodromal to schizophrenia. Frontal 
hypoactivation or ‘hypo-frontality’ has been extensively researched in schizophrenia, in 
relation to a variety of behaviours, including motivation, executive functions and psychotic 
symptomatology 235. Another position is that during working memory tasks, patients with 
schizophrenia can either recruit more extended prefrontal resources, or fail to sustain 
recruitment of adequate prefrontal areas, compared to controls, which eventually results in 
poorer outcomes 236. Besides, functional dysconnectivity of fronto-striatal circuitry can 
represent a risk phenotype for psychosis. First‐episode psychosis is associated with 
pronounced dysregulation of cortico‐striatal systems, characterized most prominently by 
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hypo‐connectivity of dorsal and hyper‐connectivity of ventral fronto‐striatal circuits 237. A 
meta‐analysis of neurofunctional correlates of vulnerability to psychosis revealed 
hypoactivation of DLPFC and VLPFC as the most common finding in UHR and FEP populations 
238. Even in healthy individuals, aberrant front‐striatal prediction error signal, during a causal 
learning task, correlate with the severity of their delusion‐like beliefs 239. In my cross‐sectional 
study, when the general stratification was applied, I noted hypoactivation of a frontal [6 65 31] 
and a striatal [‐12 5 10] area in the high PLE group at FU, a finding consistent with perturbed 
fronto‐striatal connectivity.  
Additionally, when I consider a specific stratification of my sample, hypoactivation of two 
insular areas might also represent a trait across my two timepoints; the same applies to the 
cerebellum, where hyperactivation at an early phase is followed by hypoactivation at a later 
phase. Evidence suggest that cerebellum plays a role in cognition in healthy humans, and that 
cerebellar abnormalities occur in schizophrenia 240. Andreasen and colleagues proposed a 
model that implicated connectivity among nodes located in prefrontal regions, the thalamic 
nuclei and the cerebellum 241. A disruption in this circuitry produces ‘cognitive dysmetria’, 
which manifests as difficulty in prioritising, processing, coordinating and responding to 
information. This ‘poor mental coordination’ is a fundamental cognitive deficit in schizophrenia 
and can account for its broad diversity of symptoms. Consequently, my finding of BL 
hyperactivation and FU hypoactivation in two cerebellar ROIs in the high PLE group might 
represent an early indication of a pathology that could later generate a more pronounced 
deficit.   
A notable observation is the lack of amygdala regions among my results. Aberrant activation 
of the amygdala during a face recognition is probably one of neuroimaging hallmarks of 
psychosis. A study employing a similar IMAGEN sample as ours revealed that subjects with PLE 
demonstrated, among other findings, increased hippocampus/amygdala activation during 
processing of neutral faces, compared to controls 108. It is of note however, that the authors of 
this study employed a smaller sample (n=27), assessed PLEs at age 14 only and used a less 
extended assessment tool focusing on perceptual abnormalities and delusional thoughts. 
Besides, it is important to note that I am assessing a non‐clinical group of subjects; thus, my 
findings might correspond to prodromal brain alterations in a trajectory toward psychosis and 
predate changes that are later seen more consistently across the psychosis continuum.   
The schizophrenia literature of neuroimaging studies involving face tasks, has revealed a 
multitude of ROIs in various Broadmann Areas (BAs), with differences in brain activation 
between patients with schizophrenia or first‐episode psychosis and healthy controls, as shown 
in summary in APPENDIX II 189,192‐194,196,197. The insular cortices and caudate were reported to 
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exhibit increased activation in controls, during perception of neutral faces 196; in my studies, I 
demonstrated increased activation in caudate in the low PLE group, but also increased 
activation in the right insular cortex in the high PLE group, during perception of angry faces. 
The right parahippocampal gyrus, was also observed to show increased activation in controls 
during perception of fearful faces 193; in my studies, I noticed increased activation in the right 
parahippocampal gyrus in the low PLE group during perception of angry faces. These 
observations provide evidence for the presence of a potential extended psychosis phenotype 
encompassing prodromal and clinical presentations. The plethora of regions described in the 
schizophrenia literature of face tasks, which were not included in my findings, is also 
anticipated: a broader selection of brain areas seen in chronic psychosis can represent an 
epiphenomenon of the illness (e.g. linked to the presence of psychotic symptomatology) or 
even caused by events unrelated to the pathological process (e.g. antipsychotic treatment).  
Following a different line of research, it is of note that BA10 (superior frontal cortex), BA13 
(insular cortex) and BA19 (parahippocampal gyrus) ‐ some of the BAs that encompassed the 
ROIs resulted in my study ‐ are widely represented in various structural neuroimaging 
comparisons between childhood, adolescence and adulthood 216 [see APPENDIX III]. This 
finding is in agreement with the neurodevelopmental model of psychosis. If I consider that 
psychosis is associated with a multitude of developmental pitfalls, which can be 
conceptualised as abnormal maturation of the developing brain neurocircuitry, it is highly 
expected that brain areas showing larger structural changes during this process, would also 
show aberrant patterns of activation, consistent with the extended psychosis phenotype.   
5.5.3. Studies of CANTAB Measures 
Findings from my CANTAB studies can shed some more light to the interpretation of my fMRI 
results. 
General Stratification: During the AGN, the low PLE group exhibited higher scores of 
omissions, compared to the high PLE group at BL, suggestive of a reduced inhibitory control, 
which is not accounted by my cross‐sectional neuroimaging finding of reduced insular 
activation. On the contrary, a decrease in AGN scores from BL to FU seen in both the high PLE 
and low PLE groups, which corresponds to an improvement in affective/inhibitory control, 
could be partially accounted by a decrease in limbic activation from BL to FU in the high PLE 
group, and by an increase in prefrontal activation from BL to FU in the low PLE group. This 
observation is supported by the knowledge that affective tasks are largely mediated by limbic 
areas of the brain, while inhibitory control is largely mediated by the prefrontal cortices. 
Hyperactivation in the limbic system can account for an inability to regulate emotions, and as 
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discussed earlier, emotion regulation difficulties can be at the core of vulnerability to psychosis 
51.  
Specific Stratification: During the CGT, the low PLE group showed a better risk adjustment at 
BL which is not accounted by any of my cross‐sectional neuroimaging findings at BL (reduced 
cerebellar activation and increased insular activation in the low PLE group). Similarly, an 
increase in CGT scores from BL to FU seen in both the high PLE and low PLE groups, is not 
accounted by a decrease in insular activation from BL to FU in the high PLE group.  
5.5.4. Limitations 
My study is not free of limitations. These are discussed below.  
 Characterisation of my high and low PLE groups. In both stratification strategies, I selected 
high and low scorers of CAPE42 questionnaire as an attempt to identify the two most 
polarised groups which would best represent the ‘prodromal psychotic’ and ‘healthy 
controls’ phenotypes. However, it turned out that my high PLE group did not indeed score 
too high in the selected scores. The high PLE general stratification group had a mean score 
of 111.64 (ranging 91‐182) compared with a theoretical maximum score of 294. Similarly, 
the high PLE specific stratification group had a mean score of 4.85 (ranging 3‐16) compared 
with a theoretical maximum of 21. Obviously, given these scores, one can suggest a low 
degree of ‘pre‐psychotic’ phenomenology in my high PLE groups, which introduces 
limitations to conducting comparisons with the low PLE groups, and discovering any 
differentiation at a brain activation level.  
 Evolution of PLE. My stratification was based on CAPE scores at age 19; as no similar scores 
were available at age 14, therefore I could not track the evolution of PLE between the two 
timepoints.  
 Natural history of PLE. In my studies, I have viewed the high‐PLE phenotype as a proxy for 
the ARMS for psychosis; however, as discussed earlier, PLE can have multiple clinical 
outcomes, thus leading to a variety of psychopathologies, other than psychosis, or even 
resolve completely.  
 Transition to psychosis. Lack of any longitudinal clinical data which could signal transition 
to psychosis introduces reasonable scepticism in the interpretation of my results, as to 
which extent my high PLE group is representative of an UHR for psychosis population. As 
discussed earlier, literature suggests that in the majority of cases, PLE resolve without any 
sequelae.  
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 Sample characteristics. Additional limitations might be sought in the higher representation 
of the male gender in my low PLE vs high PLE groups: 56.4% vs 33.6% (general 
stratification); 55.5% vs 41.5% (specific stratification). Male preponderance is however a 
common epidemiological trend in this clinical field 242.  Similarly, the IMAGEN design had 
applied very stringent exclusion criteria during the selection of participants, eliminating 
almost every possible medical and psychiatric co‐morbidity (see Table 2). This has 
consequently resulted in a population of ‘extremely healthy’ adolescents, which might not 
be entirely representative of the general populations, thus introducing an element of bias.  
 Appropriateness of the Face Task. Also, the relevance of the Face Task as a paradigm for 
the study of an important emotional aspect of quotidian social behaviour, might come 
with limitations, which can further reduce the clinical significance of my findings.  
5.5.5. Summary of Discussion 
Adolescents with high levels of PLE who underwent a faces task, demonstrate hyperactivation 
of insular cortical areas at BL, hypoactivation of prefrontal and limbic cortical areas and striatal 
subcortical areas at FU, and a decrease in limbic activation from BL to FU. The later might 
represent an aberrant developmental process, under‐recruiting critical limbic areas during 
perception of emotional faces. These findings reinforce the role of prefrontal and limbic 
cortices in the aetiology of psychosis, beyond the bounds of the illness phenotype or the use of 
antipsychotic medication. The ongoing follow up of this sample will permit the further testing 
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6.1. Overview 
Objective 
To examine the neuroimaging profile of healthy adolescents with an increased presence of 
Psychotic‐Like Experiences (PLE), during a reward cognitive task.  
Method 
1,434 adolescents were assessed at 2 timepoints using functional MRI during a Monetary 
Incentive Delay (MID) task at age 14 and 19 years. The sample was stratified into two groups of 
high PLE and low PLE based on their scores on the CAPE‐42 questionnaire at age 19. A general 
and specific stratification was applied, the general stratification used the CAPE Total Score, 
while the specific stratification used a CAPE Score of 3 specific clinically significant items. The 
first level analysis focused on two pre‐defined contrasts of [Anticipation of Large Win] – 
[Anticipation of No Win] and [Feedback of Large Win] – [Feedback of No Win]. The second 
level analysis examined between‐group differences using an a priori defined region of interest 
approach (ROIs) within the reward network. I performed a factorial analysis to examine the 
main effects of group, time and their interaction on brain activation. Additionally, I performed 
an exploratory analysis, by employing both a cross‐sectional design to compare brain 
activation levels between the high PLE and low PLE groups at ages 14 and 19, and a 
longitudinal design to compare brain activation levels between the two timepoints.  
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6.2. Results of fMRI Analysis 
The following ROIs were initially identified through the literature of reward processing in 
psychosis and UHR for psychosis 102,103 and subsequently filtered through the second‐level 
analysis. The ROIs listed here [MNI coordinates] showed differences in brain activation 
between groups (high PLE vs low PLE) and timepoints (BL vs FU). The main effect of group, 
time and the interaction of group*time on brain activation levels was examined by employing 
a mixed model 2‐way ANOVA, and post‐hoc paired/independent T‐tests.  
General Stratification ROIs 
[33 41 40] Right Frontal Lobe, Middle Frontal Gyrus, BA09 (BL, Feedback) 
[33 44 31] Right Frontal Lobe, Middle Frontal Gyrus, BA09 (BL, Feedback) 
[-36 47 31] Left Frontal Lobe, Middle Frontal Gyrus, BA10 (BL, Feedback) 
[-12 -28 40] Left Limbic Cortex, Cingulate Gyrus, BA31 (BL, Feedback) 
[9 8 1] Right Caudate Head (FU, Anticipation) 
Specific Stratification ROIs 
[57 -46 -14] Right Temporal Lobe, Inferior Temporal Gyrus, BA20/37 (BL, Feedback) 
[-30 -64 -32] Left Cerebellum, Uvula (BL, Feedback) 
[-24 68 -8] Left Frontal Lobe, Superior Frontal Gyrus, BA10 (FU, Anticipation) 
6.2.1. Retrospective Control for Multiple Testing 
As multiple ROIs resulted from my Analysis, I performed a retrospective correction of the 
statistical significance threshold of the whole brain analysis, at a contrast level. As six ROIs 
were identified in the feedback contrast, and two in the anticipation contrast, I applied this 
correction to both contrasts. I used a Bonferroni correction, introducing a new level of 
statistical significance at 0.008 (0.05 / 6) for the feedback contrast and a level of statistical 
significance at 0.025 (0.05 / 2) for the anticipation contrast. As this approach is considered to 
be overly conservative, I report data from all eight ROIs, noting however that [33 41 40] and 
[33 44 31] did not survive the updated threshold of 0.008, corrected for multiple testing.  
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6.2.2. General Stratification 
Figure 4: MID Study, ROIs selected for Analysis, General Stratification 
BASELINE 
[33 41 40] Right Middle 
Frontal Gyrus  
(L>H, Feedback) 
[33 44 31] Right Middle 
Frontal Gyrus  
(L>H, Feedback) 
[‐36 47 31] Left Middle 
Frontal Gyrus  
(L>H, Feedback) 






[9 8 1] Right Caudate Head 
(L>H, Anticipation) 
For more detailed illustrations see APPENDIX XXIII: General Stratification 
Right Middle Frontal Gyrus [33 41 40] 
There was an interaction effect of group*time [F(1, 93)=7.448, p=0.008], which was driven by a 
differential change in brain activation from BL to FU, showing significant increase in the high 
PLE group (t=‐3.18, p=0.003) and non‐significant decrease in the low PLE group. Additional 
exploratory analysis exhibited higher brain activation of the low PLE group compared to the 
high PLE group at BL during feedback (t=‐5.069, p<0.0001). 
Right Middle Frontal Gyrus [33 44 31] 
There was a main effect of time [F(1, 93)=5.009, p=0.028], which was driven by an increase in 
brain activation from BL to FU, significant only for the high PLE group (t=‐2.902, p=0.006). 
Additional exploratory analysis exhibited higher brain activation of the low PLE group 
compared to the high PLE group at BL during feedback (t=‐3.029, p=0.003). 
Left Middle Frontal Gyurs [-36 47 31] 
There was a main effect of time [F(1, 93)=5.559, p=0.02], which was driven by an increase in 
brain activation from BL to FU, significant only for the high PLE group (t=‐2.851, p=0.007). 
Additional exploratory analysis exhibited higher brain activation of the low PLE group 
compared to the high PLE group at BL during feedback (t=‐2.818, p=0.005). 
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Left Cingulate Gyrus [-12 -28 40]  
No effects of group*time, group nor time were reported. Additional exploratory analysis 
exhibited higher brain activation of the low PLE group compared to the high PLE group at BL 
during feedback (t=‐2.82, p=0.005). 
Right Caudate Head [9 8 1] 
No effects of group*time, group nor time were reported. Additional exploratory analysis 
exhibited higher brain activation of the low PLE group compared to the high PLE group at FU 
during anticipation (t=‐2.846, p=0.005).  
 Table 10: MID Study, Factorial Analysis, Mixed Model 2-Way ANOVA, General Stratification  





F Sig. r 
Caudate ROI [9 8 1] Brain Activation, General Stratification, Anticipation 
GROUP 1.100 1 1.100 2.791 0.099* 0.181 
TIME 1.684 1 1.684 1.635 0.205* 0.140 
GROUP * TIME 1.593 1 1.593 1.546 0.217* 0.136 
Error(GROUP) 32.311 82 0.394       
Error(TIME) 84.455 82 1.030       
Frontal ROI [33 41 40] Brain Activation, General Stratification, Feedback 
GROUP 4.108 1 4.108 3.598 0.061* 0.193 
TIME 7.632 1 7.632 1.527 0.220* 0.127 
GROUP * TIME 37.236 1 37.236 7.448 0.008 0.272 
Error(GROUP) 106.187 93 1.142       
Error(TIME) 464.966 93 5.000       
Frontal ROI [33 44 31] Brain Activation, General Stratification, Feedback 
GROUP 2.323 1 2.323 1.821 0.180* 0.139 
TIME 25.604 1 25.604 5.009 0.028 0.226 
GROUP * TIME 8.606 1 8.606 1.684 0.198* 0.133 
Error(GROUP) 118.659 93 1.276       
Error(TIME) 475.398 93 5.112       
Frontal ROI [-36 47 31] Brain Activation, General Stratification, Feedback 
GROUP 2.24 1 2.24 1.77 0.187* 0.137 
TIME 33.354 1 33.354 5.559 0.020 0.237 
GROUP * TIME 19.871 1 19.871 3.312 0.072* 0.185 
Error(GROUP) 117.68 93 1.265       
Error(TIME) 558.029 93 6       
Limbic ROI [-12 -28 40] Brain Activation, General Stratification, Feedback 
GROUP 0.839 1 0.839 0.801 0.373* 0.092 
TIME 5.911 1 5.911 1.906 0.171* 0.142 
GROUP * TIME 0.086 1 0.086 0.028 0.868* 0.017 
Error(GROUP) 97.359 93 1.047       
Error(TIME) 288.332 93 3.100       
Abbreviations 
df: degrees of Freedom; F: F‐ratio; (*): not statistically significant at a p=0.05 
level; r: Pearson’s correlation coefficient; 
 
For a table of fROIs brain analysis results see APPENDIX XVII: General Stratification 
For a table of cross‐sectional analysis results see APPENDIX XVIII: General Stratification 
For a table of longitudinal analysis results see APPENDIX XIX: General Stratification  
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Graph 6: MID Study, Longitudinal Analysis Graphs, General Stratification 
Brain Activation at BL and FU, ROI [-36 47 31],  
Left Middle Frontal Gyrus 
Brain Activation at BL and FU, ROI [33 44 31],  
Right Middle Frontal Gyrus 
  
Brain Activation at BL and FU, ROI [33 41 40], 




Longitudinal changes are statistically significant (p<.05) for the High PLE Group only (thick line);  
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L ↑ NS 
 
Left Middle Frontal 
Gyrus 





 L ↑ NS 
 
Left Limbic Cortex 







[9 8 1] 
   
L>H  
Anticipation 
H: High PLE Group; L: Low PLE Group;  
↑: Increase in brain activation (statistically significant);  
↑ NS: Increase in brain activation (statistically non‐significant); 
↓: Decrease in brain activation (statistically significant); 
↓ NS: Decrease in brain activation (statistically non‐significant) 
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6.2.3. Specific Stratification 
Figure 5: MID Study, ROIs selected for Analysis, Specific Stratification 
BASELINE 
[57 ‐46 ‐14] Right Inferior 
Temporal Gyrus  
(L>H, Feedback) 
[‐30 ‐64 ‐32] Left 





[‐24 68 ‐8] Left Superior 
Frontal Gyrus  
(L>H, Anticipation) 
For more detailed illustrations see APPENDIX XXIV: Specific Stratification 
Right Inferior Temporal Gyrus [57 -46 -14] 
No effects of group*time, group nor time were reported. Additional exploratory analysis 
exhibited higher brain activation of the low PLE group compared to the high PLE group at BL 
during feedback (t=‐3.126, p=0.002).  
Left Cerebellar Uvula [-30 -64 -32] 
There was an interaction effect of group*time [F(1, 218)=4.889, p=0.028], which was driven by 
differential change in brain activation from BL to FU, showing significant decrease in the low 
PLE group (t=2.249, p=0.027)., and non‐significant increase in the high PLE group. Additional 
exploratory analysis exhibited higher brain activation of the low PLE group compared to the 
high PLE group at BL during feedback (t=‐3.048, p=0.002).  
Left Superior Frontal Gyrus [-24 68 -8]  
No effects of group*time, group nor time were reported. Additional exploratory analysis 
exhibited higher brain activation of the low PLE group compared to the high PLE group at FU 
during anticipation (t=‐2.211, p=0.028). 
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Table 12: MID Study, Factorial Analysis, Mixed Model 2-Way ANOVA, Specific Stratification 





F Sig. r 
Frontal ROI [-24 68 -8] Brain Activation, Specific Stratification, Anticipation 
GROUP 0.326 1 0.326 0.747 0.388* 0.059 
TIME 6.548 1 6.548 3.271 0.072* 0.122 
GROUP * TIME 3.365 1 3.365 1.681 0.196* 0.088 
Error(GROUP) 93.830 215 0.436       
Error(TIME) 430.378 215 2.002       
Temporal ROI [57 -46 -14] Brain Activation, Specific Stratification, Feedback 
GROUP 3.155 1 3.155 3.091 0.080* 0.118 
TIME 9.444 1 9.444 2.760 0.098* 0.112 
GROUP * TIME 2.148 1 2.148 0.628 0.429* 0.054 
Error(GROUP) 222.561 218 1.021       
Error(TIME) 745.917 218 3.422       
Cerebellar ROI [-30 -64 -32] Brain Activation, Specific Stratification, Feedback 
GROUP 1.217 1 1.217 0.921 0.338* 0.065 
TIME 5.689 1 5.689 1.184 0.278* 0.074 
GROUP * TIME 23.486 1 23.486 4.889 0.028 0.148 
Error(GROUP) 288.073 218 1.321       
Error(TIME) 1047.221 218 4.804       
Abbreviations 
df: degrees of Freedom; F: F‐ratio; (*): not statistically significant at a p=0.05 
level; r: Pearson’s correlation coefficient; 
 
For a table of fROIs brain analysis results see APPENDIX XVII: Specific Stratification 
For a table of cross‐sectional analysis results see APPENDIX XVIII: Specific Stratification 
For a table of longitudinal analysis results see APPENDIX XIX: Specific Stratification 
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Graph 7: MID Study, Longitudinal Analysis Graph, Specific Stratification 
Brain Activation at BL and FU, ROI [-30 -64 -32], 
Left Cerebellar Uvula 
 
Longitudinal changes are statistically significant (p<.05) 
for the Low PLE Group only (thick line); encircled (red 
dotted line) are statistically significant cross‐sectional 
differences (p<.05); SE bars are displayed. 
 



























































[-24 68 -8] 
   
L>H 
Anticipation 
H: High PLE Group; L: Low PLE Group;  
↑: Increase in brain activation (statistically significant);  
↑ NS: Increase in brain activation (statistically non‐significant); 
↓: Decrease in brain activation (statistically significant); 
↓ NS: Decrease in brain activation (statistically non‐significant) 
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6.3. Results of CANTAB Measures  
Results of CANTAB measures are already presented in 5.3 Results of CANTAB Measures.  
6.4. Correlations 
In exploratory analysis, I investigated whether brain activation levels for my identified fROIs 
correlated with selected CAPE and CANTAB scores. The strength of these correlations proved 
weak, though numerous statistically significant results were generated. Most notably, baseline 
BOLD signals of the Right Middle Frontal Gyrus ROI [33 41 40] negatively correlated with CAPE 
grand total scores (rho=‐0.373, p<0.0001) and CAPE 3‐items scores (rho=‐0.296, p=0.004); also, 
follow‐up BOLD signals of the Right Caudate Head ROI [9 8 1] negatively correlated with CAPE 
grand total scores (rho=‐0.235, p=0.005) and CAPE 3‐items scores (rho=0.218, p=0.009).  
See APPENDIX XXV  
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6.5. Discussion 
6.5.1. Overview of fMRI Studies 
The primary finding, if one looks at ROIs based on the general PLE stratification, is that brain 
areas showed differences at BL and FU. In summary, in the high PLE group, an early state of 
hypoactivation in left [‐36 47 31] and right prefrontal [33 44 31] [33 41 40] and left limbic [‐12 ‐
28 40] cortical areas, was replaced by a later state of hypoactivation in right caudate [9 8 1], 
when the general stratification was applied. 
Secondary findings, if one looks at ROIs based on the specific stratification, are that again 
different brain areas showed differences at BL and FU. In summary, in the high PLE group, an 
early state of hypoactivation in right temporal cortical [57 ‐46 ‐14] and left cerebellar [‐30 ‐64 ‐
32] areas, was replaced by a later state of hypoactivation in a left prefrontal area [‐24 68 ‐8], 
when the specific stratification was applied.  
My longitudinal studies revealed differences in brain level activities between BL and FU in 
relatively fewer brain areas, compared to the ones identified in the cross‐sectional studies. In 
summary, in the high PLE group, there was an increase in brain activation between BL and FU 
in left and right prefrontal areas.  
My results nevertheless provide a confirmation of my research hypothesis as engagement of 
prefrontal, temporal, cingulate and striatal areas was reaffirmed.  
6.5.2. Interpretation of fMRI Results 
Adolescents with high levels of PLEs at age 19 years demonstrated a significant increase in 
prefrontal activation during a reward processing task between the ages of 14 and 19, 
compared to non‐significant changes seen in adolescents with low levels of PLE. The high PLE 
group also exhibited a decreased activation of the head of caudate relative to the low PLE 
group at age 19 years.  The decrease in the striatal activation is in agreement with my 
hypothesis and has been observed in the literature 42. However, the increase in frontal 
activation (between the ages of 14 and 19) is novel. Previous studies in early adolescent high 
risk populations have suggested a decreased frontal brain activation, compared to controls 102; 
this is in line with my findings of lower frontal activation (left and right middle frontal gyri) in 
my high PLE group, compared to the low PLE group at age 14. 
However, it needs to be borne in mind that I am assessing a non‐clinical group and one can 
speculate that I may be observing a compensatory mechanism in operation. Certainly, there is 
a contemporary view that suggests that abnormal perceptions may be a relatively common 
occurrence, and in most cases, they are appropriately contextualised, and an abnormal belief 
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or experience does not arise. In this case of adolescents with high levels of PLE, these are still 
largely being appropriately contextualised, as they have not developed to a clinical intensity. 
Indeed, the pattern of decreased striatal activation and increased prefrontal activation 
supports the suggestion that the evolution of clinically relevant psychotic symptoms requires 
not only a deficit in striatal reward processing but, also a failure of prefrontal executive 
processes 243,244. Thus, this prefrontal activation serves as a proxy of an efficient executive 
function and as a compensatory mechanism to ensure that any unusual experiences secondary 
to reward processing deficits do not become fixed and understood outside of the current 
context. It’s probable that the failure of the latter process leads to clinically relevant 
symptoms. The lack of any performance differences in executive functioning between the low 
and high PLE adolescent groups (at the age of 19) also lends additional support to this view. 
However, other possibilities are that this pattern of change in processing reward engages PFC 
and striatum in a different way to generate PLEs in these subjects; or even that these 
differences reflect the allocation of potential resources in a proactive healthy way. 
Considering my high PLE group results from a neuro‐developmental point of view, one needs 
to distinguish between states (patterns of brain activation which are observed only in a 
particular timepoint) versus traits (patterns of brain activation which persist along various 
timepoints).  
In my cross‐sectional studies, I revealed different hypoactivation states at different timepoints, 
with an observed narrowing of the brain areas involved at FU compared to BL. This might 
represent a developmental process in the course of the prodromal psychosis phenotype, 
during which the majority of the areas showing aberrant activation at an BL (frontal and 
limbic), might become subject to a ‘compensatory’ developmental process resulting from 
brain maturation. However, under an opposing ‘aberrant’ developmental process, other areas 
of hypoactivation (caudate) can emerge at a later phase of brain development and thus might 
represent a clinically significant marker of future emergence of psychosis. Striatal 
hypoactivation is linked to compromised motivational behaviour, and is indeed a finding 
shared by UHR for psychosis and schizophrenia populations 103. This is consistent with the 
observation that striatum as one of the key components of the cortico‐striatal‐thalamic 
circuitry plays a major role in reward‐driven behaviour 245.  
Hypoactivation of the frontal lobes (hypofrontality) and dysconnectivity of fronto-striatal 
circuitry were previously discussed in 5.5.2. Interpretation of fMRI Results. My longitudinal 
studies indeed confirmed that three frontal areas, showing hypoactivation in the high PLE 
group at BL, also manifested significant increase in activation from BL to FU. This change might 
represent the outcome of a ‘compensatory’ developmental process, either targeting brain 
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areas showing an activation deficit at an early phase or allowing cognitive control mechanisms 
to contextualise the PLE, in order to prevent an evolution to clinical symptoms. As discussed 
earlier, a reward‐associated dysregulation can be compensated by recruitment of additional 
prefrontal areas, in UHR for psychosis subjects 106. 
Ethological observations have traditionally distinguished between appetitive (anticipation or 
reward, motivational phase) and consummatory (outcome/feedback of reward, hedonic 
response) stages of reward processing; Basic research in healthy individuals has revealed that 
reward anticipation and outcomes may differentially recruit distinct regions that lie along the 
trajectory of ascending dopamine neurons; anticipation of reward vs non‐reward activated foci 
in the ventral striatum (including the nucleus accumbens), while reward vs non‐reward 
outcomes activated foci in the VMPFC 246,247. Additional research has revealed that monetary 
reward outcomes strongly activated the thalamus, while social reward outcomes were 
associated with pronounced bilateral amygdalae activation 248. Indeed, in my studies, three 
ROIs which resulted from the feedback contrast were located in middle fontal gyri; one ROI 
which resulted from the anticipation contrast was located in the dorsal striatum (caudate). A 
recent fMRI study from the IMAGEN sample 108 showed that during the MID task (anticipation 
large win ‐ no win), at age 14, the high psychosis proneness group, showed increased 
activation in the right anterior/middle cingulate gyrus and decreased activation in the left 
fusiform gyrus. It is of note however, that the authors of this study employed a smaller sample, 
assessed PLE at age 14 and used a less extended assessment tool for PLE focusing on 
perceptual abnormalities and delusional thoughts. Additionally, another study from the 
IMAGEN sample 249 identified a network containing a core striatal node and cortical nodes 
facilitating outcome prediction and response preparation at age 14; striatal areas were 
preferentially associated with hyperactivity symptoms; this highlights the importance of 
reward circuit elements in a variety of psychopathologies.   
The dopamine hypothesis of schizophrenia, specified subcortical hyper‐dopaminergia 
combined with prefrontal hypo‐dopaminergia as the cardinal features of neuro‐pathology of 
schizophrenia; this has been modified by inclusion of a presynaptic striatal dopamine 
dysregulation conceptualised as the final common pathway responsible for the mis‐appraisal 
of stimuli thus resulting in the emergence psychosis 199. The anhedonia hypothesis, postulates 
that dopamine plays a critical role in the subjective pleasure associated with positive rewards, 
and has been fundamental in the neurobiology of addiction and the understanding of incentive 
motivation 250. The two hypotheses converge in schizophrenia, where observed motivational 
impairments and reward‐processing abnormalities 198 were linked to multiple aberrant 
cortical‐striatal interactions 251. In my study, I showed that aberrant activation in this neural 
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circuit (frontal areas and caudate head) is present at ages 14 and 19 in subjects with a 
prodromal psychotic phenotype. This observation supports the presence of brain biomarkers 
across the whole spectrum of the extended psychosis phenotype. 
The schizophrenia literature of neuroimaging studies involving reward tasks, has revealed a 
multitude of ROIs in various BAs, with differences in brain activation between patients with 
schizophrenia or first‐episode psychosis and healthy controls, as shown in summary in 
APPENDIX II 202,205‐212. All ROIs described in the present study (probably at the exception of the 
cerebellar ones), fall within BAs identified in schizophrenia neuroimaging studies of reward 
tasks, as hosting ROIs with differential brain activation between psychotic and non‐psychotic 
subjects. These include BA09 (dorsolateral prefrontal cortex), BA10 (anterior prefrontal 
cortex), BA20 (inferior temporal gyrus), BA31 (dorsal posterior cingulate area) and Caudate 
Head. These observations provide evidence for the presence of an extended psychosis 
phenotype encompassing prodromal and clinical presentations. The plethora of BAs described 
in the schizophrenia literature of reward tasks, which were not included in my findings is also 
anticipated: a broader selection of brain areas seen in chronic psychosis can represent an 
epiphenomenon of the illness (e.g. linked to the presence of psychotic symptomatology) or 
even caused by events unrelated to the pathological process (e.g. antipsychotic treatment).  
The role of the cerebellum in schizophrenia was previously discussed in 5.5.2. Interpretation of 
fMRI Results. Consequently, my finding of BL hypoactivation in a left cerebellar ROI in the high 
PLE group might be an early indication of a pathology that could later generate a more 
pronounced deficit.   
Following a different line of research, it is of note that BA09 (dorsolateral prefrontal cortex), 
BA10 (anterior prefrontal cortex) and BA20 (inferior temporal gyrus) ‐ some of the BAs that 
encompassed the ROIs resulted in my study ‐ are widely represented in various structural 
neuroimaging comparisons between childhood, adolescence and adulthood 216, while BA31 
(posterior cingulate cortex) hosts one of the largest clusters showing changes between 
childhood and adolescence 218 [see APPENDIX III]. This finding is in agreement with the 
neurodevelopmental model of psychosis. If I consider that psychosis is associated with a 
multitude of developmental pitfalls, which can be conceptualised as abnormal maturation of 
the developing brain neurocircuitry, it is highly expected that brain areas showing larger 
structural changes during this process, would also show aberrant patterns of activation, 
consistent with the extended psychosis phenotype.  
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6.5.3. Studies of CANTAB Measures 
Findings from my CANTAB studies can shed some more light to the interpretation of my fMRI 
results. 
General Stratification: During the AGN, the low PLE group showed higher scores of omissions 
compared to the high PLE group at BL, suggestive of a reduced inhibitory control, despite the 
cross‐sectional neuroimaging finding of increased brain activation of frontal ROIs in the low 
PLE group compared to the high PLE group at BL. On the contrary, a decrease in AGN scores 
from BL to FU seen in both the high and low PLE groups, which corresponds to an 
improvement in affective/inhibitory control, can be partially accounted by the longitudinal 
neuroimaging finding of an increase in brain activation of prefrontal ROIs from BL to FU, 
significant only for the high PLE group. This lends support to the proposal that there were no 
significant differences in explicit cognitive control between the high and low PLE groups, 
compared to an implicit compensatory cognitive control mechanism, seen only in the high PLE 
group.  
Specific Stratification: During the CGT, the low PLE group showed a better risk adjustment at 
BL, which is not accounted by any of the cross‐sectional neuroimaging findings at BL (increased 
temporal and cerebellar activation in the low PLE group). The longitudinal CGT changes do not 
find any match, as only a cerebellar ROI resulting from the specific classification showed 
longitudinal changes (significant only for the low PLE group). 
6.5.4. Limitations 
My study is not free of limitations. These were discussed in detail in 5.5.4. Limitations. In 
addition, the relevance of the MID task as a paradigm for the study of quotidian reward‐
related behaviour, might come with limitations, which can further reduce the clinical 
significance of my findings.   
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6.5.5. Summary of Discussion 
Adolescents with high levels of PLE performing a reward processing task, demonstrate 
hypoactivation of prefrontal and limbic areas at BL, hypoactivation of the caudate at FU, and 
an increase in prefrontal activation from BL to FU. The later might represent a ‘compensatory’ 
developmental process, permitting cognitive control mechanisms to contextualise the PLE, 
sufficient to preclude an evolution to clinical intensity; an observation which is consistent with 
the aberrant salience model of psychosis. These findings reinforce the role of components of 
the brain reward circuit, such as the prefrontal cortex and the striatum in the aetiology of 
psychosis, beyond the bounds of the illness phenotype or the use of antipsychotic medication. 
The ongoing follow up of this sample will permit the further testing of this change as a useful 
brain biomarker for the psychosis or other psychiatric phenotypes.  
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FT Studies 
Adolescents presenting with elevated overall PLE scores at age 19 years exhibited an early 
state (BL) of hyperactivation in right insular cortical areas, during perception of angry faces; 
this was replaced by a later state (FU) of hypoactivation in right prefrontal and right limbic 
cortical areas and left striatal subcortical areas, during perception of angry faces. There was a 
decrease in activation of right limbic cortical areas, from BL to FU, in the high general PLE 
group.  
Adolescents presenting with elevated specific PLE scores at age 19 years exhibited an early 
state (BL) of hyperactivation in left cerebellar and hypoactivation in left insular cortical areas, 
during perception of angry faces; this was replaced by a later state (FU) of hypoactivation in 
left cerebellar and left insular cortical areas, during perception of angry faces. There was a 
decrease in activation of left insular cortical areas, from BL to FU, in the high specific PLE 
group. 
These results suggest evidence of aberrant changes during adolescent development with 
reduced limbic and insular activation over time; this might reflect an under‐recruitment of 
critical areas during perception of emotional faces. My findings reinforce the role of prefrontal 
and limbic cortices in the aetiology of psychosis, beyond the bounds of the illness phenotype 
and without the confounds of the impact of the illness or the use of antipsychotic medication.  
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Table 14: FT Studies, Summary of Findings, High PLE Group 
Brain ROI Stratification BL state 
BL to FU 
changes 
FU state Comment 
Right Insular 
Cortex 




↓ NS   
Left Caudate 
Body 
[-12 5 10] 






[6 65 31] 






[33 -46 -5] 











   
Left Insular 
Cortex 




↑ NS   
Left Cerebellum 
[-15 -40 -44] 






[-33 17 -11] 






Hyper-active: High PLE Group shows greater brain activation than Low PLE Group 
Hypo-active: Low PLE Group shows greater brain activation than High PLE Group 
↑: Increase in brain activation (statistically significant);  
↑ NS: Increase in brain activation (statistically non‐significant); 
↓: Decrease in brain activation (statistically significant); 
↓ NS: Decrease in brain activation (statistically non‐significant) 
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MID Studies 
Adolescents presenting with elevated overall PLE scores at age 19 years exhibited an early 
state (BL) of hypoactivation in left and right prefrontal and left limbic cortical areas, during 
reward feedback; this was replaced by a later state (FU) of hypoactivation in right striatal 
subcortical areas, during the reward anticipation. There was also an increase in activation of 
left and right prefrontal areas, from BL to FU, in the high general PLE group.  
Adolescents presenting with elevated specific PLE scores at age 19 years exhibited an early 
state (BL) of hypoactivation in right temporal cortical areas and left cerebellar areas, during 
reward feedback; this was replaced by a later state (FU) of hypoactivation in left prefrontal 
cortical areas, during reward anticipation. 
These results suggest evidence of compensatory changes during adolescent development with 
increased prefrontal activation over time; this might allow cognitive control mechanisms to 
contextualise the PLE, so to prevent transition to clinically significant symptoms; an 
observation which is consistent with the aberrant salience model of psychosis. My findings 
reinforce the role of components of the brain reward circuit, such as the prefrontal cortex and 
the striatum in the aetiology of psychosis, beyond the bounds of the illness phenotype and 
without the confounds of the impact of the illness or the use of antipsychotic medication. 
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BL to FU 
changes 
FU state Comment 
Right Middle 
Frontal Gyrus 































Left Limbic Cortex 





   
Right Caudate 
Head 
















   
Left Cerebellum 





↑ NS   
Left Superior 
Frontal Gyrus 







Hyper-active: High PLE Group shows greater brain activation than Low PLE Group 
Hypo-active: Low PLE Group shows greater brain activation than High PLE Group 
↑: Increase in brain activation (statistically significant);  
↑ NS: Increase in brain activation (statistically non‐significant); 
↓: Decrease in brain activation (statistically significant); 
↓ NS: Decrease in brain activation (statistically non‐significant) 
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CANTAB Studies 
Adolescents presenting with an elevated frequency of PLE at age 19 years exhibited an early 
state (BL) of enhanced inhibitory control and compromised risk‐taking behaviour, compared to 
the low PLE group. There was an improvement in both cognitive domains from BL to FU, noted 
in both the high and low PLE groups. These results suggest evidence of a compensatory change 
during adolescent development, which could be accounted by the observed increased 
prefrontal activation and decreased limbic activation.  
Table 16: CANTAB Studies, Summary of Findings, High PLE Group 
  
CANTAB score Stratification BL state 
BL to FU 
changes 
































of judgment in 
risk‐taking 
behaviour 
↑: Increase in CANTAB score (statistically significant); 
↓: Decrease in CANTAB score (statistically significant) 
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My Project in Summary 
I adopted the contemporary and widely accepted continuum model of psychosis, focussed on 
a healthy population with pre‐clinical manifestations of the extended psychosis phenotype. 
The underlying idea was that biomarkers of psychosis, can be sought across the whole 
spectrum of this disorder, and not exclusively in those with clinically significant psychotic 
symptoms. An obvious repercussion of this approach is that the boundaries between abnormal 
psychology and psychopathology become quite blurred. This is, however, consistent with the 
continuum model, and offers the advantage of assessing larger numbers of individuals along 
the neurodevelopmental trajectory of adolescence, free of confounds from (a) illness 
chronicity (b) social / occupational / educational influences, and (c) the effects of exposure to 
antipsychotic medication. Taking this view into account, my findings add to the knowledge 
characterizing the associations of the neurodevelopmental trajectory with psychosis. 
Psychotic‐Like experiences (PLE) were chosen as a representative of the sub‐clinical 
manifestations of the extended psychosis phenotype, in line with the continuum model of 
psychosis. There were no other proxy measures of PLE collected in this sample, and CAPE was 
added specifically for this purpose. As persistence of PLE has been predictive of increased rates 
of future transition to psychosis, this phenotype holds particular clinical significance. CAPE‐42 
was used as an appropriate tool to measure PLE, having exhibited adequate validity and 
reliability, added to its usability as a self‐administered questionnaire. I do not claim that 
presence of PLE, reflected in high CAPE scores can predict transition to psychosis; however, 
early adolescent PLE are a recognised risk factor for psychosis. 
As current research in psychosis has emphasized the importance of dysconnectivity between 
brain areas, I chose functional neuroimaging as my vehicle to investigate brain activity. I 
attempted to investigate the neural correlates of the prodromal psychosis phenotype by 
employing two well established cognitive tasks of face and reward processing along with 
functional neuroimaging.  
The two tasks are different in terms of focus: the face task targets brain activation during 
processing of angry faces; the reward task singles out brain activation during anticipation and 
feedback of possible monetary gain. However, as demonstrated in the psychosis literature, 
both tasks have the potential to unmask disrupted interactions between higher / prefrontal 
cortical area and lower / subcortical areas (the striatum during reward tasks; the amygdala and 
related limbic areas during face / emotional tasks).  
My results provide support of an aberrant salience model of psychosis. In order to 
contextualise emerging PLE and prevent transition to clinically significant symptoms, a 
CHAPTER VII: CONCLUSIONS 115 
 
EVANGELOS PAPANASTASIOU  DOCTORAL THESIS 
cognitive control mechanism recruits frontal cortical areas. In my reward study, this could be 
manifested as a compensatory increase in prefrontal activation between BL and FU during 
feedback, combined with a striatal hypoactivation at FU during anticipation. However, it is 
equally possible that cognitive control mechanisms fail to address an underlying aberrant 
salience process. In my face study, the latter might be demonstrated by a FU prefrontal 
hypoactivation state combined with an aberrant decrease in limbic activation between BL and 
FU, during perception of angry faces.  
The limitations of my studies have been already discussed previously; to a great extent these 
drawbacks were inherited because I drew my data from a larger project (IMAGEN) initially 
designed to study various aspects of adolescent brain development and behaviour such as 
sensitivity to rewards, impulsivity and emotional processing. A larger cohort of adolescents 
would enable us to eventually assembly larger high and low PLE groups and increase the 
power of my analyses; an earlier age at BL timepoint (e.g. at years 11 of age), combined with 
the use of CAPE questionnaire at both BL and FU would permit a longer and more accurate 
observation of the evolution of PLE; finally, and most importantly, the longitudinal follow up of 
the high PLE group and the inclusion of transition to psychosis data would validate a neural 
characterisation of the UHR for psychosis population. I hope however that given all current 
shortcomings, my studies contributed to the neuroimaging literature of the extended 
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Future Directions 
I advocate further research in line with the above contemporary models of psychosis to 
confirm the presence and extend the list of similar brain biomarkers across the whole 
spectrum of the psychosis phenotype. Focus on prodromal psychotic manifestations provides 
however the advantage of studying psychosis beyond the bounds of the illness phenotype or 
the use of antipsychotic medication. Besides, early detection of high‐risk individuals allows for 
the timely implementation of early interventions, which could steer a developmental 
trajectory away from the future psychotic outcome.  
Current assessment of the ARMS is based almost exclusively on clinical interviews; the nature 
of these methods might account for the large variability in calculating transition rates to 
psychosis. The simple paradigm of the high PLE endophenotype offers however the 
opportunity to conceptualise a brain ‘signature’, by combining CAPE scores with selected 
CANTAB scores and functional neuroimaging markers; this could form the basis for modelling 
the risk of deviation towards psychosis and apply this model at an individual level.  
There is an increasing interest in speaking of symptoms as dimensions rather than discrete 
psychopathological constructs or categorical diagnosis; the NIMH Research Domain Criteria 
(RDoC) conceptualises mental illness as disorders demarcated by symptoms, mapping onto 
cognitive systems and then to neural circuits. Evidence for these mechanism in these multiple 
levels of explanation can be quantified with the tools of cognitive science 252. This approach 
leads towards a ‘stratified’ or ‘personalised’ psychiatry and relies on multi‐dimensional 
representation of both definition of disorder and the clinical trajectories and outcomes 253.  
By combining a brief self‐administered questionnaire (such as CAPE), with other behavioural 
markers (such as selected CANTAB measures), functional neuroimaging, and potentially a 
genetic test, one could assembly a future screening toolkit with enhanced predictive value, for 
the reliable and swift detection of individuals at high risk for psychosis. I hope my research has 
contributed towards this direction.  
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APPENDIX I: CAPE-42 Worksheet 
If sometimes, often or nearly always in column A, go to column B. If never in column A, go 
straight to the next question in column.  
 
Column A Column B 
Do you have a specific 
feeling, thought or 
mental experience? 
How distressed are you 










































































1) Do you ever feel sad? 0 1 2 3 1 2 3 4 
2) Do you ever feel as if people seem to drop 
hints about you or say things with a double 
meaning? 
0 1 2 3 1 2 3 4 
3) Do you ever feel that you are not a very 
animated person? 
0 1 2 3 1 2 3 4 
4) Do you ever feel that you are not much of a 
talker when you are conversing with other 
people? 
0 1 2 3 1 2 3 4 
5) Do you ever feel as if things in magazines or 
on TV were written especially for you? 
0 1 2 3 1 2 3 4 
6) Do you ever feel as if some people are not 
what they seemed to be? 
0 1 2 3 1 2 3 4 
7) Do you ever feel as if you are being 
persecuted in some way? 
0 1 2 3 1 2 3 4 
8) Do you ever feel that you experience few or 
no emotions at important events? 
0 1 2 3 1 2 3 4 
9) Do you ever feel pessimistic about 
everything? 
0 1 2 3 1 2 3 4 
10) Do you ever feel as if there is a conspiracy 
against you? 
0 1 2 3 1 2 3 4 
11) Do you ever feel as if you are destined to be 
someone very important? 
0 1 2 3 1 2 3 4 
12) Do you ever feel as if there is no future for 
you? 
0 1 2 3 1 2 3 4 
13) Do you ever feel that you are a very special 
or unusual person? 
0 1 2 3 1 2 3 4 
14) Do you ever feel as if you do not want to 
live anymore? 
0 1 2 3 1 2 3 4 
15) Do you ever think that people can 
communicate telepathically? 
0 1 2 3 1 2 3 4 
16) Do you ever feel that you have no interest 
in being with other people? 
0 1 2 3 1 2 3 4 
17) Do you ever feel as if electrical devices such 
as computers can influence the way you think? 
0 1 2 3 1 2 3 4 
18) Do you ever feel you are lacking motivation 
to do things? 
0 1 2 3 1 2 3 4 
19) Do you ever cry about nothing? 0 1 2 3 1 2 3 4 
20) Do you believe in the power of witchcraft, 
voodoo or the occult? 
0 1 2 3 1 2 3 4 
APPENDICES 126 
 
EVANGELOS PAPANASTASIOU  DOCTORAL THESIS 
21) Do you ever feel that you are lacking in 
energy? 
0 1 2 3 1 2 3 4 
22) Do you ever feel that people are looking at 
you oddly? 
0 1 2 3 1 2 3 4 
23) Do you ever feel that your mind is empty? 0 1 2 3 1 2 3 4 
24) Do you ever feel as if the thoughts in your 
head are being taken away from you? 
0 1 2 3 1 2 3 4 
25) Do you ever feel that you are spending your 
days doing nothing? 
0 1 2 3 1 2 3 4 
26) Do you ever feel as if the thoughts in your 
head are not your own? 
0 1 2 3 1 2 3 4 
27) Do you ever feel that your feelings are 
lacking in intensity? 
0 1 2 3 1 2 3 4 
28) Have your thoughts ever been so vivid that 
you are worried other people would hear 
them? 
0 1 2 3 1 2 3 4 
29) Do you ever feel you are lacking in 
spontaneity? 
0 1 2 3 1 2 3 4 
30) Do you ever hear your own thoughts 
echoed back to you? 
0 1 2 3 1 2 3 4 
31) Do you ever feel as if you are under the 
control of some force or power other than 
yourself? 
0 1 2 3 1 2 3 4 
32) Do you ever feel that your emotions are 
blunted? 
0 1 2 3 1 2 3 4 
33) Do you ever hear voices when you are 
alone? 
0 1 2 3 1 2 3 4 
34) Do you hear voices talking to each other 
when you are alone? 
0 1 2 3 1 2 3 4 
35) Do you ever feel that you are neglecting 
your appearance or personal hygiene? 
0 1 2 3 1 2 3 4 
36) Do you ever feel that you never get things 
done? 
0 1 2 3 1 2 3 4 
37) Do you feel that you have only few hobbies 
or interests? 
0 1 2 3 1 2 3 4 
38) Do you ever feel guilty? 0 1 2 3 1 2 3 4 
39) Do you ever feel like a failure? 0 1 2 3 1 2 3 4 
40) Do you ever feel tense? 0 1 2 3 1 2 3 4 
41) Do you ever feel as if a double has taken 
the place of a family member, friend or 
acquaintance? 
0 1 2 3 1 2 3 4 
42) Do you ever see objects, people or animals 
that other people cannot see? 
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APPENDIX II: fMRI differences between SCZ patients and controls. 
BA Face task 189,192-194,196,197 Reward Task 202,205-212 
1   
2   
3   
4   
5   
6 Precentral Gyrus, Frontal Lobe  
7 Superior Parietal Lobule, Parietal Lobe  
8   
9 Precentral Gyrus, Frontal Lobe Medial Frontal Gyrus, Frontal Lobe 
10  Medial Frontal Gyrus, Frontal Lobe 
11  Medial Frontal Gyrus, Frontal Lobe 
12   
13 Insula, Sub‐lobar  
14   
15   
16   
17   
18 Cuneus, Occipital Lobe, Precuneus, Parietal Lobe  
19 Lingual Gyrus, Occipital Lobe Middle Occipital Gyrus, Occipital Lobe 
20  Inferior Temporal Gyrus, Temporal Lobe 
21 Superior Temporal Gyrus, Temporal Lobe Superior Temporal Gyrus, Temporal Lobe 
22 Superior/Middle Temporal Gyrus, Temporal Lobe Middle Temporal Gyrus, Temporal Lobe 
23   
24 Cingulate Gyrus, Limbic Lobe Cingulate Gyrus, Limbic Lobe 
25   
26   
27 Parahippocampal Gyrus, Limbic Lobe  
28 Parahippocampal Gyrus, Limbic Lobe  
29 Posterior Cingulate Gyrus, Limbic Lobe  
30  Posterior Cingulate Gyrus, Limbic Lobe 
31 Precuneus, Parietal Lobe Cingulate Gyrus, Limbic Lobe 
32 Cingulate Gyrus, Limbic Lobe Cingulate Gyrus, Limbic Lobe 
33   
34 Parahippocampal Gyrus/Uncus, Limbic Lobe Subcallosal Gyrus, Frontal Lobe 
35 Parahippocampal Gyrus, Limbic Lobe  
36 Parahippocampal Gyrus, Limbic Lobe  
37 Sub‐gyral, Temporal Lobe Middle Temporal Gyrus, Temporal Lobe 
38 Superior Temporal Gyrus, Temporal Lobe Superior Temporal Gyrus, Temporal Lobe 
39 Middle Temporal Gyrus, Temporal Lobe  
40 Inferior Parietal Lobule, Parietal Lobe Inferior Parietal Lobule, Parietal Lobe 
41  Superior Temporal Gyrus, Temporal Lobe 
42   
43   
44 Inferior Frontal Gyrus, Frontal Lobe  
45   
46   
47 Inferior Frontal Gyrus, Frontal Lobe Inferior Frontal Gyrus, Frontal Lobe 
48   
49   
50   
51   
52   
 
Amygdala 
Putamen/Globus Pallidus, Lentiform Nucleus 
Caudate Head/Body 
Putamen/Globus Pallidus, Lentiform Nucleus 
Caudate Head 
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DFC Difference 216 
Adolescence to 
Adulthood Negative 
DFC Difference 216 
Child>Adolescent 
Largest Clusters 218 
Adolescent>Adult 
Largest Clusters 217 
1  Postcentral G.     
2    Postcentral G.   
3       
4    Precentral G.   
5  Postcentral G.  Postcentral G. Postcentral G.  
6 Precentral G. Superior Frontal G. Superior Frontal G. Precentral G. Superior Frontal G. Superior Frontal G. 
7 Postcentral G. Superior Par. Lob.  Postcentral G. Superior Par. Lob.  
8 Middle Frontal G. Superior Frontal G. Middle Frontal G. Middle Frontal G.  Superior Frontal G. 
9 Superior Frontal G. Superior Frontal G. Superior Frontal G. Superior Frontal G.   
10  Superior Frontal G. Middle Frontal G.    
11 Inferior Frontal G. Superior Frontal G. Superior Frontal G.    
12       
13      Insula, Sub‐lobar 
14       
15       
16       
17       
18 Cuneus, Occipital L,   Cuneus, Limbic L.   
19 Cuneus, Precuneus Middle Temporal G. Fusiform G. Precuneus, Limbic L.   
20 Inferior Temp. G.  Inferior Temporal G.    
21   Middle Temporal G.    
22 Superior Temp. G.  Superior Temp. G. Superior Temp. G.  Superior Temp. G. 
23       
24       
25       
26       
27       
28       
29       
30       
31     Cingulate Gyrus  
32       
33       
34       
35       
36       
37     Fusiform Gyrus  
38  Superior Temporal G.     
39  Middle Temporal G.     
40  Inferior Parietal Lob. Inferior Parietal Lob. Inferior Parietal Lob.   
41       
42       
43       
44       
45    Inferior Frontal G.   
46 Inferior Frontal G.   Inferior Frontal G.   
47 Middle Frontal G.  Orbital G., Frontal L. Middle Frontal G.   
48       
49       
50       
51       
52       
      Globus Pallidus 
Abbreviations  
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APPENDIX IV: The Edinburgh High Risk Study, Gray Matter changes in Psychosis.  






(GMD ↓ in 2y) 
221,222 
UHR+TPS+SCZ > 
UHR+TPS (GMD ↓ 
in 2y) 221,222 
1      
2      
3      
4      
5      
6      
7      
8      
9  Medial Frontal G.    
10  Medial Frontal G.    
11 Medial Frontal G.     
12      
13 Super. Temporal G.     
14      
15      
16      
17      
18      
19      
20    Inferior Temporal G. Inferior Temporal G. 
21 Middle Temporal G.     
22  Middle Temporal G.  Super. Temporal G.  
23      
24      
25      
26      
27      
28 Uncus, Limbic Lobe    Uncus, Limbic Lobe 
29      
30      
31      
32 Anter. Cingulate G. Anter. Cingulate G. Anter. Cingulate G.   
33      
34 Subcallosal Gyrus Parahippocampal G. Parahippocampal G.   
35 Parahippocampal G. Parahippocampal G.    
36    Uncus, Limbic Lobe  
37      
38      
39  Middle Temporal G.    
40  Postcentral G.    
41 Super. Temporal G.     
42      
43 Postcentral G.     
44  Precentral G.    
45  Inferior Frontal G.    
46      
47  Inferior Frontal G.    
48      
49      
50      
51      




 Caudate Tail  
Abbreviations 
BA: Brodmann Area; CTR: Controls; FEP: First Episode Psychosis; GMD: Gray Matter Density; G.: Gyrus; SCZ: 
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APPENDIX V: IMAGEN fMRI Acquisition Parameters 
Sequence Parameter Value 
No. of Volumes 191 (MID), 202 (FT) 
TR (ms) 2200 
TE (ms) 30 
ETL 32 
NSA 1 
Excitation flip angle (degrees) 75 
2D/3D 2D 
Voxel Size (mm) 3.4 x 3.4 x 2.4 
Matrix size 642 
No. of slices/DDAs 40/3 
FOV frequency (mm) 218 
FOV phase (%) 100% 
Slice thickness (mm) 2.4 
Slice gap (mm) 3.4 
Slice orientation Oblique (ACPC) 
In‐plane phase encode direction Anterior‐Posterior 
Slice acquisition order Sequential 
Slice acquisition direction  Superior‐Inferior 
Abbreviations 
TR: Repetition Time; TE: Echo Time; ETL: Echo Train Length; NSA: Number of Signal Averages (average 
number for each phase encoding step); DDA: Discarded or Disabled Acquisitions, Dummy Cycles; FOV: 
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In bold: Spearman’s rho (correlation coefficient), non‐parametric 
p: 2‐tailed significance level 
 
CAPE 3‐items scores showed the weakest correlation with all other scores, including the CAPE 
grand total scores; these properties reinforced my choice of this composite measure in 
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APPENDIX VII: Frequencies Histograms of selected CAPE scores, Overall Sample 
CAPE Positive Symptoms Total Scores Frequencies Histogram 
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CAPE Social Delusions Total Scores Frequencies Histogram 
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APPENDIX VIII: CANTAB Affective Go-NoGo Task (AGN) 
Overview of AGN Task 
 
Administration time: Around 10 minutes, depending on level of impairment. The modified 
IMAGEN version lasts approximately 8 minutes. 
Task: The test consists of several blocks, each of which presents a series of words from two of 
three different Affective categories: positive (e.g. joyful), anxiety‐related (e.g. attack), 
depression‐related (e.g. useless) and neutral (e.g. element). The subject is given a target 
category, as is asked to press the pad when they see a word matching this category. 
Test modes: Six modes. Four using positive and negative stimuli only, two using positive, 
negative and neutral stimuli. The affective Go‐NoGo task was supplemented by anxiety‐related 
words in Mannheim and the total number of blocks were reduced to shorten the task. IMAGEN 
used this modified mode including positive, anxiety‐related and depression‐related and neutral 
stimuli. 
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AGN Outcome Measures 
AGN Mean correct latency (positive): Average reaction time for correctly identified positive 
stimuli. 
AGN Mean correct latency (negative): Average reaction time for correctly identified negative 
stimuli. 
AGN Mean correct latency (neutral): Average reaction time for correctly identified neutral 
stimuli. 
AGN Total commissions (positive): Number of responses to distractors for positive stimuli. 
AGN Total commissions (negative): Number of responses to distractors for negative stimuli. 
AGN Total commissions (neutral): Number of responses to distractors for neutral stimuli. 
AGN Total omissions (positive): Number of missed responses for positive stimuli. 
AGN Total omissions (negative): Number of missed responses for negative stimuli. 
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APPENDIX IX: CANTAB Cambridge Guessing Task (CGT) 
Overview of CGT Task 
 
Administration time: Up to 30 minutes.; The modified IMAGEN version lasts approximately 15‐
20 minutes. 
Task: On each trial, the subject is presented with a row of ten boxes across the top of the 
screen, some of which are red and some of which are blue. At the bottom of the screen are 
rectangles containing the words ‘Red’ and ‘Blue’. The subject must guess whether a yellow 
token is hidden in a red or a blue box. In the gambling stages, subjects start with a number of 
points, displayed on the screen, and can select a proportion of these points, displayed in either 
rising or falling order, in a second box on the screen, to gamble on the confidence they have in 
their decision. A stake box on the screen displays the current amount of the bet. The subject 
must try to accumulate as many points as possible. 
Test modes: Ascending first (where stakes are displayed in ascending order for two stages, 
then in descending order for two stages) and Descending first (where stakes are displayed in 
descending order for two stages, then in ascending order for two stages). IMAGEN used a 
modified version in which the time between stakes is reduced from 5s to 2s to make the task 
shorter and more interesting for adolescents.  
Outcome measures: Several measures cover risk taking, quality of decision making, 
deliberation time, risk adjustment, delay aversion and overall proportion bet. 
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CGT Outcome Measures 
CGT Delay aversion: Tendency to bet larger amounts when possible bet amounts are 
presented in descending order (calculated by subtracting risk taking measure from ascending 
trials from risk taking measure of descending trials). 
CGT Deliberation time: Mean latency from presentation of coloured boxes to subject’s choice 
of which colour to bet on. 
CGT Overall proportion bet: Average proportion of the current point total (using nominal 
percentage) that subject is willing to risk on each gamble test trial. 
CGT Quality of decision making: Proportion of test trials on which the subject bets on the 
more likely outcome of the two choices. 
CGT Risk adjustment: Tendency to bet higher proportion of points when the large majority of 
boxes are the colour chosen. 
CGT Risk taking: Mean proportion of the current points total that subject is willing to risk on 
trial for which they have chosen the more likely outcome.  
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APPENDIX X: The Faces Task 
Blocks of videos showing faces neutral and angry faces. Faces that turn from neutral to angry 
(a) or stay neutral (c) are interspersed with blocks of control stimuli (b) 228.  
 
Instructions in English 
In the following scanning session, we will ask you to perform different tasks and games which 
are so far unfamiliar to you. Therefore, we would like to explain these tasks and games first 
outside the scanner using this standard computer. Additionally, you have the opportunity to 
practice some of the tasks. Let’s start with a few simple tasks which target basic functions of 
the brain. 
In this task you will be presented with short video clips showing faces with neutral and angry 
expressions as well as moving circles. Please watch them carefully and remember to lie as still 
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APPENDIX XI: The Monetary Incentive Delay Task 
Outline of the stages of the MID Task.  
 
Instructions in English 
In the following scanning session, we will ask you to perform different tasks and games which 
are so far unfamiliar to you. Therefore, we would like to explain these tasks and games first 
outside the scanner using this standard computer. Additionally, you have the opportunity to 
practice some of the tasks. Let’s start with a few simple tasks which target basic functions of 
the brain. 
This task is a reaction time task ‐ it tests how quickly you can press the button to hit a target, 
which is a white square appearing only for a short time on the left or right of the screen. If you 
manage to press the button as soon as the white square appears, you will score points. If you 
respond too early (before the white square appears) or too late (after the white square has 
disappeared) you will not gain any points. You can tell where the white square will appear and 
how many points you will win by the symbol you see on the screen before the white square is 
shown. A triangular symbol means you will not win any points, a circle with a line means you 
will win 2 points and a circle with three lines means you will win 10 points. You should try to 
win as many points as you can! ‐ but only if you press the button while the square is presented 
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APPENDIX XII: Epidemiological Characteristics of CAPE General Stratification Samples 
 CAPE GRAND TOTAL UPPER 10% (n=149) CAPE GRAND TOTAL LOWER 10% (n=149) 
 Min Max Mean SE SD Var Min Max Mean SE SD Var 
GENDER (Male %) 
  
33.60% 
     
56.40% 
   
HANDEDNESS (R %) 
  
85.90% 
     
82.60% 
   
AGE BL (y) 13.36 15.61 14.47 0.03 0.39 0.15 12.73 15.32 14.43 0.03 0.38 0.15 
AGE FU2 (y) 17.82 21.44 19.02 0.06 0.76 0.58 16.82 21.47 18.98 0.06 0.74 0.55 
WISC VERBAL SCORE (BL) 59 155 111.15 1.32 15.66 245.14 71 146 106.72 1.28 15.24 232.36 
WISC PERFORMANCE SCORE (BL) 73 147 108.49 1.33 15.79 249.31 63 149 105.20 1.20 14.42 208.02 
ADRS TOTAL SCORE (FU) 10 20 15.89 0.24 2.96 8.74 16 20 19.70 0.06 0.72 0.52 
AUDIT TOTAL SCORE (FU) 0 26 7.5 0.44 5.34 28.52 0 21 5.26 0.32 3.87 14.97 
DAST CANNABIS TOTAL SCORE (FU) 0 11 1.59 0.21 2.52 6.37 0 4 0.54 0.08 1.02 1.03 
CAPE GRAND TOTAL SCORE (FU) 91 182 111.64 1.74 21.26 451.95 0 16 9.54 0.39 4.75 22.55 
CAPE POSITIVE SYMPTOMS TOTAL SCORE (FU) 4 91 33.09 1.27 15.48 239.68 0 14 3.23 0.24 2.98 8.86 
CAPE BIZARRE DELUSIONS TOTAL SCORE (FU) 0 60 13.17 0.97 11.83 139.85 0 7 0.37 0.09 1.09 1.18 
CAPE SOCIAL DELUSIONS TOTAL SCORE (FU) 4 41 19.91 0.54 6.57 43.11 0 11 2.87 0.21 2.61 6.81 
CAPE NEGATIVE SYMPTOMS TOTAL SCORE (FU) 11 74 46.37 0.93 11.37 129.19 0 10 2.22 0.21 2.61 6.80 
CAPE DEPRESSIVE SYMPTOMS TOTAL SCORE (FU) 13 49 32.18 0.61 7.49 56.11 0 12 4.09 0.21 2.54 6.46 
CAPE ITEMS [5 + 7 + 33] SCORE (FU) 0 16 4.73 0.28 3.46 12 0 4 0.15 0.05 0.60 0.36 
Abbreviations 
WISC: Wechsler Intelligence Batter for Children 223; ADRS: Adolescent Depression Rating Scale 224; AUDIT: Alcohol Use Disorders Identification Test 225; DAST: Drug Abuse 
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APPENDIX XIII: Epidemiological Characteristics of CAPE Specific Stratification Samples 
 CAPE SPECIFIC ITEMS TOTAL UPPER 25% (n=366) CAPE SPECIFIC ITEMS TOTAL LOWER 25% (n=330) 
 Min Max Mean SE SD Var Min Max Mean SE SD Var 
GENDER (Male %)   41.50%      55.50%    
HANDEDNESS (R %)   84.70%      83.90%    
AGE BL (y) 13.21 15.92 14.44 0.02 0.42 0.17 12.73 15.5 14.41 0.02 0.40 0.16 
AGE FU2 (y) 17.75 21.53 18.99 0.04 0.75 0.56 16.82 21.9 18.97 0.04 0.75 0.56 
WISC VERBAL SCORE (BL) 59 155 111.12 0.86 15.84 250.83 71 150 109.37 0.86 15.12 228.55 
WISC PERFORMANCE SCORE (BL) 69 147 108.29 0.82 15.22 231.53 63 149 106.40 0.88 15.39 236.76 
ADRS TOTAL SCORE (FU) 10 20 17.88 0.14 2.62 6.87 16 20 19.68 0.04 0.73 0.54 
AUDIT TOTAL SCORE (FU) 0 26 6.00 0.24 4.51 20.33 0 27 5.47 0.24 4.38 19.17 
DAST CANNABIS TOTAL SCORE (FU) 0 11 1.12 0.11 2.13 4.54 0 7 0.58 0.07 1.20 1.44 
CAPE GRAND TOTAL SCORE (FU) 15 182 76.21 1.67 31.97 1021.99 0 29 17.35 0.44 7.98 63.63 
CAPE POSITIVE SYMPTOMS TOTAL SCORE (FU) 6 91 25.14 0.70 13.30 176.95 0 16 4.90 0.20 3.59 12.91 
CAPE BIZARRE DELUSIONS TOTAL SCORE (FU) 0 60 8.39 0.48 9.26 85.71 0 9 0.58 0.07 1.33 1.77 
CAPE SOCIAL DELUSIONS TOTAL SCORE (FU) 0 41 16.75 0.33 6.40 40.93 0 13 4.32 0.18 3.21 10.32 
CAPE NEGATIVE SYMPTOMS TOTAL SCORE (FU) 0 74 29.59 0.78 14.82 219.72 0 21 6.19 0.26 4.77 22.75 
CAPE DEPRESSIVE SYMPTOMS TOTAL SCORE (FU) 0 47 21.48 0.53 10.06 101.10 0 18 6.26 0.20 3.57 12.72 
CAPE ITEMS [5 + 7 + 33] SCORE (FU) 3 16 4.86 0.11 2.15 4.63 0 0 0 0 0 0 
Abbreviations 
WISC: Wechsler Intelligence Batter for Children 223; ADRS: Adolescent Depression Rating Scale 224; AUDIT: Alcohol Use Disorders Identification Test 225; DAST: Drug Abuse 
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APPENDIX XIV: FT Study, fROI Brain Analysis, Tables of Results 
Appendix XIV: General Stratification 
FT Study, fROI Brain Analysis, CAPE General Stratification 
Time-
Point 












X Y Z 
BL Angry‐Control High>Low 42 8 ‐14 Right Insular Cortex, BA13 2 0.007* 0.016* 5.19 5.06 
FU Angry‐Control Group Average Positive ‐12 5 10 Left Caudate Body 7 <0.0001 0.001 5.73 5.56 
FU Angry‐Control Group Average Positive 6 65 31 Right Frontal Lobe, Superior Frontal Gyrus, BA10 99 <0.0001 <0.0001 7.82 7.39 
FU Angry‐Control Group Average Negative 33 ‐46 ‐5 Right Limbic Cortex, Parahippocampal Gyrus, BA19 12543 NaN <0.0001 16.77 Inf 
Abbreviations 
BL: Baseline; FU: Follow‐up; High Group: Scorers in upper 10% of CAPE Total Score, n=149; Low Group: Scorers in lower 10% CAPE Total Score, n=149; High>Low: showing 
increased activation in the High but not in the Low Group; Low>High: showing increased activation in the Low but not in the High Group; Group Average Positive: showing 
increased activation in both High and Low Groups; Group Average Negative: showing decreased activation in both High and Low Groups; BA: Brodmann Area; K: number of 
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Appendix XIV: Specific Stratification 
FT Study, fROI Brain Analysis, CAPE Specific Stratification 
Time-
Point 
Contrast Analysis MNI 
coordinates 











X Y Z 
BL Angry‐Control Group Average Positive ‐6 ‐73 ‐26 Left Cerebellum, Posterior Lobe, Declive 129 <0.0001 <0.0001 13.43 Inf 
BL Angry‐Control Group Average Negative ‐33 11 10 Left Insular Cortex, BA13 4 0.002 0.003 5.42 5.35 
FU Angry‐Control Group Average Positive ‐15 ‐40 ‐44 Left Cerebellum, Posterior Lobe, Tonsil 3 0.003 <0.0001 7.29 7.14 
FU Angry‐Control Group Average Negative ‐33 17 ‐11 Left Insular Cortex, BA13 3 0.003 0.009* 5.2 5.14 
Abbreviations 
BL: Baseline; FU: Follow‐up; High Group: Scorers in upper 25% of CAPE 3‐Items Score, n=366; Low Group: Scorers in lower 25% CAPE 3‐Items Score, n=330; High>Low: showing 
increased activation in the High but not in the Low Group; Low>High: showing increased activation in the Low but not in the High Group; Group Average Positive: showing 
increased activation in both High and Low Groups; Group Average Negative: showing decreased activation in both High and Low Groups; BA: Brodmann Area; K: number of 
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APPENDIX XV: FT Study, Exploratory Cross-Sectional fROI Analysis, Tables of Results 
Appendix XV: General Stratification 
FT Study, Exploratory Cross-Sectional Analysis, Independent T-tests, CAPE General Stratification 
Time-
Point 













t-test for Equality of Means 
X Y Z t-test df Sig.  r  
BL 42 8 ‐14 Right Insular Cortex, BA13 0.146 ‐0.269 H>L 5.188 264 <0.0001 0.304 
FU ‐12 5 10 Left Caudate Body 0.066 0.173 L>H ‐2.588 255 0.01 0.160 
FU 6 65 31 Right Frontal Lobe, Superior Frontal Gyrus, BA10 0.245 0.446 L>H ‐2.283 257 0.023 0.141 
FU 33 ‐46 ‐5 Right Limbic Cortex, Parahippocampal Gyrus, BA19 ‐0.458 ‐0.324 L>H ‐2.85 255 0.005 0.176 
Abbreviations 
BL: Baseline; FU: Follow‐up; BA: Brodmann Area; H>L: High Group showing more activation than Low Group; L>H: Low Group showing more activation than High Group; r: 
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Appendix XV: Specific Stratification 
FT Study, Exploratory Cross-Sectional Analysis, Independent T-tests, CAPE Specific Stratification 
Time-
Point 













t-test for Equality of Means 
X Y Z t-test df Sig.  r  
BL ‐6 ‐73 ‐26 Left Cerebellum, Posterior Lobe, Declive 0.24 0.156 H>L 2.828 619 0.005 0.113 
BL ‐33 11 10 Left Insular Cortex, BA13 ‐0.128 ‐0.052 L>H ‐2.278 618 0.023 0.091 
FU ‐15 ‐40 ‐44 Left Cerebellum, Posterior Lobe, Tonsil 0.083 0.184 L>H ‐2.75 603 0.006 0.111 
FU ‐33 17 ‐11 Left Insular Cortex, BA13 ‐0.122 ‐0.048 L>H ‐2.275 596 0.023 0.093 
Abbreviations 
BL: Baseline; FU: Follow‐up; BA: Brodmann Area; H>L: High Group showing more activation than Low Group; L>H: Low Group showing more activation than 
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APPENDIX XVI: FT Study, Exploratory Longitudinal fROI Analysis, Tables of Results 
Appendix XVI: General Stratification 
FT Study, Exploratory Longitudinal Analysis, Paired T-tests, CAPE General Stratification 
MNI 
Coordinates 













t-test for Equality of Means 
X Y Z t-test df Sig.  r  
33 ‐46 ‐5 Right Limbic Cortex, 
Parahippocampal Gyrus, BA19 
HIGH & LOW General ‐0.267 ‐0.384 BL>FU 3.481 231 0.001 0.223 
HIGH General ‐0.283 ‐0.456 BL>FU 4.307 116 <0.0001 0.371 
LOW General ‐0.250 ‐0.311 BL>FU 1.129 114 0.261* 0.105 
6 65 31 Right Frontal Lobe, Superior Frontal 
Gyrus, BA10 
HIGH & LOW General 0.224 0.367 FU>BL ‐2.614 231 0.01 0.169 
HIGH General 0.203 0.250 FU>BL ‐0.579 116 0.564* 0.054 
LOW General 0.246 0.487 FU>BL ‐3.311 114 0.001 0.296 
42 8 ‐14 Right Insular Cortex, BA13 HIGH & LOW General ‐0.065 ‐0.064 FU>BL ‐0.017 231 0.987* 0.001 
HIGH General 0.157 ‐0.028 BL>FU 1.828 116 0.07* 0.167 
LOW General ‐0.291 ‐0.1 FU>BL ‐2.05 114 0.043 0.188 
Abbreviations 
BA: Brodmann Area; BL>FU: Baseline activation greater than Follow‐up activation; FU>BL: Follow‐up activation greater than Baseline activation; r: Pearson’s correlation 
coefficient, (*): not statistically significant at a p=0.05 level; df: degrees of Freedom. 
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Appendix XVI: Specific Stratification 
FT Study, Exploratory Longitudinal Analysis, Paired T-tests, CAPE Specific Stratification 













t-test for Equality of Means 
X Y Z t-test df Sig.  r  
‐33 17 ‐11 Left Insular Cortex, BA13 HIGH & LOW Specific ‐0.017 ‐0.083 BL>FU 2.795 550 0.005 0.118 
HIGH Specific ‐0.026 ‐0.132 BL>FU 3.258 288 0.001 0.189 
LOW Specific ‐0.007 ‐0.028 BL>FU 0.618 261 0.537* 0.038 
‐33 11 10 Left Insular Cortex, BA13 HIGH & LOW Specific ‐0.082 ‐0.123 BL>FU 1.742 550 0.082* 0.074 
HIGH Specific ‐0.123 ‐0.091 FU>BL ‐1.086 288 0.278* 0.063 
LOW Specific ‐0.037 ‐0.159 BL>FU 3.383 261 0.001 0.205 
Abbreviations 
BA: Brodmann Area; BL>FU: Baseline activation greater than Follow‐up activation; FU>BL: Follow‐up activation greater than Baseline activation; r: Pearson’s correlation 
coefficient, (*): not statistically significant at a p=0.05 level; df: degrees of Freedom.  
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APPENDIX XVII: MID Study, fROI Brain Analysis, Tables of Results 
Appendix XVII: General Stratification 
MID Study, fROI Brain Analysis, CAPE General Stratification 
Time-
Point 
Contrast Analysis MNI 
coordinates 












X Y Z 
BL Feedback LW‐NW Low>High 33 41 40 Right Frontal Lobe, Middle Frontal Gyrus, BA09 1 0.015* 0.037* 5.04 4.88 
BL Feedback LW‐NW Group Average Negative 33 44 31 Right Frontal Lobe, Middle Frontal Gyrus, BA09 1 0.015* 0.05* 4.98 4.82 
BL Feedback LW‐NW Group Average Negative ‐36 47 31 Left Frontal Lobe, Middle Frontal Gyrus, BA09/10 66 <0.0001 <0.0001 7.25 6.8 
BL Feedback LW‐NW Group Average Negative ‐12 ‐28 40 Left Limbic Cortex, Cingulate Gyrus, BA31 28 <0.0001 <0.0001 7.37 6.9 
FU Anticipation LW‐NW Group Average Positive 9 8 1 Right Caudate Head 1073 <0.0001 <0.0001 11.67 Inf. 
Abbreviations 
BL: Baseline; FU: Follow‐up; LW: Large Win; NW: No Win; High Group: Scorers in upper 10% of CAPE Total Score, n=149; Low Group: Scorers in lower 10% CAPE Total Score, 
n=149; High>Low: showing increased activation in the High but not in the Low Group; Low>High: showing increased activation in the Low but not in the High Group; Group 
Average Positive: showing increased activation in both High and Low Groups; Group Average Negative: showing decreased activation in both High and Low Groups; BA: 
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Appendix XVII: Specific Stratification 
MID Study, fROI Brain Analysis, CAPE Specific Stratification 
Time-
Point 












X Y Z 
BL Feedback LW‐NW Group Average Positive 57 ‐46 ‐14 Right Temp. Lobe, Inferior Temp. Gyrus, BA20/37 145 <0.0001 <0.0001 9.62 Inf. 
BL Feedback LW‐NW Group Average Positive ‐30 ‐64 ‐32 Left Cerebellum, Uvula 11 <0.0001 <0.0001 5.79 5.68 
FU Anticipation LW‐NW Group Average Positive ‐24 68 ‐8 Left Frontal Lobe, Superior Frontal Gyrus, BA10 2 0.006 0.005 5.39 5.27 
Abbreviations 
BL: Baseline; FU: Follow‐up; LW: Large Win; NW: No Win; High Group: Scorers in upper 25% of CAPE 3‐Items Score, n=366; Low Group: Scorers in lower 25% CAPE 3‐Items 
Score, n=330; High>Low: showing increased activation in the High but not in the Low Group; Low>High: showing increased activation in the Low but not in the High Group; 
Group Average Positive: showing increased activation in both High and Low Groups; Group Average Negative: showing decreased activation in both High and Low Groups; BA: 
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APPENDIX XVIII: MID Study, Exploratory Cross-Sectional fROI Analysis, Tables of Results 
Appendix XVIII: General Stratification 
MID Study, Exploratory Cross-Sectional Analysis, Independent T-tests, CAPE General Stratification 
Time-
Point 













t-test for Equality of Means 
X Y Z t-test df Sig.  r  
BL 33 41 40 Right Frontal Lobe, Middle Frontal Gyrus, BA09 ‐0.986 0.134 L>H ‐5.069 188 <0.0001 0.346 
BL 33 44 31 Right Frontal Lobe, Middle Frontal Gyrus, BA09 ‐1.011 ‐0.249 L>H ‐3.029 188 0.003 0.215 
BL ‐36 47 31 Left Frontal Lobe, Middle Frontal Gyrus, BA09/10 ‐1.446 ‐0.637 L>H ‐2.818 187 0.005 0.202 
BL ‐12 ‐28 40 Left Limbic Cortex, Cingulate Gyrus, BA31 ‐0.966 ‐0.426 L>H ‐2.82 169 0.005 0.212 
FU 9 8 1 Right Caudate Head 0.578 0.959 L>H ‐2.846 141 0.005 0.233 
Abbreviations 
BL: Baseline; FU: Follow‐up; BA: Brodmann Area; H>L: High Group showing more activation than Low Group; L>H: Low Group showing more activation than High Group; r: 
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Appendix XVIII: Specific Stratification 
MID Study, Exploratory Cross-Sectional Analysis, Independent T-tests, CAPE Specific Stratification 
Time-
Point 













t-test for Equality of Means 
X Y Z t-test df Sig.  r  
BL 57 ‐46 ‐14 Right Temporal Lobe, Inferior Temporal Gyrus, BA20/37 0.468 0.917 L>H ‐3.126 445 0.002 0.147 
BL ‐30 ‐64 ‐32 Left Cerebellum, Uvula 0.214 0.686 L>H ‐3.048 433 0.002 0.149 
FU ‐24 68 ‐8 Left Frontal Lobe, Superior Frontal Gyrus, BA10 0.107 0.257 L>H ‐2.211 312 0.028 0.124 
Abbreviations 
BL: Baseline; FU: Follow‐up; BA: Brodmann Area; H>L: High Group showing more activation than Low Group; L>H: Low Group showing more activation than High Group; r: 
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APPENDIX XIX: MID Study, Exploratory Longitudinal fROI Analysis, Tables of Results 
Appendix XIX: General Stratification 
MID Study, Exploratory Longitudinal Analysis, Paired T-tests, CAPE General Stratification 
MNI 
Coordinates 













t-test for Equality of Means 
X Y Z t-test df Sig.  r  
‐36 47 31 Left Frontal Lobe, Middle Frontal Gyrus, 
BA09/10 
HIGH & LOW General ‐1.025 ‐0.482 FU>BL ‐2.135 94 0.035 0.215 
HIGH General ‐1.454 ‐0.397 FU>BL ‐2.851 41 0.007 0.407 
LOW General ‐0.684 ‐0.548 FU>BL ‐0.399 52 0.692* 0.055 
33 44 31 Right Frontal Lobe, Middle Frontal 
Gyrus, BA09 
HIGH & LOW General ‐0.711 ‐0.223 FU>BL ‐2.094 94 0.039 0.212 
HIGH General ‐1.055 ‐0.230 FU>BL ‐2.902 41 0.006 0.413 
LOW General ‐0.437 ‐0.218 FU>BL ‐0.629 52 0.532* 0.087 
33 41 40 Right Frontal Lobe, Middle Frontal 
Gyrus, BA09 
HIGH & LOW General ‐0.461 ‐0.248 FU>BL ‐0.896 94 0.373* 0.092 
HIGH General ‐1.046 ‐0.131 FU>BL ‐3.18 41 0.003 0.445 
LOW General 0.002 ‐0.342 BL>FU 1.009 52 0.318* 0.138 
Abbreviations 
BA: Brodmann Area; BL>FU: Baseline activation greater than Follow‐up activation; FU>BL: Follow‐up activation greater than Baseline activation; r: Pearson’s correlation 
coefficient: (*): not statistically significant at a p=0.05 level; df: degrees of Freedom.  
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Appendix XIX: Specific Stratification 
MID Study, Exploratory Longitudinal Analysis, Paired T-tests, CAPE Specific Stratification 













t-test for Equality of Means 
X Y Z t-test df Sig.  r  
‐30 ‐64 ‐32 Left Cerebellum, Uvula HIGH & LOW Specific 0.291 0.156 BL>FU 0.902 219 0.368* 0.061 
HIGH Specific 0.072 0.238 FU>BL ‐0.827 118 0.41* 0.076 
LOW Specific 0.549 0.059 BL>FU 2.249 100 0.027 0.219 
Abbreviations 
BA: Brodmann Area; BL>FU: Baseline activation greater than Follow‐up activation; FU>BL: Follow‐up activation greater than Baseline activation; r: Pearson’s correlation 
coefficient: (*): not statistically significant at a p=0.05 level; df: degrees of Freedom. 
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APPENDIX XX: CANTAB Exploratory Cross-Sectional & Longitudinal Analysis, Tables of Results 
Appendix XX: Cross-Sectional Analysis 
CANTAB Measures Exploratory Cross-Sectional Analysis, Independent T-tests, CAPE General and Specific Stratification  






t-test for Equality of Means 
t-test df Sig.  r  
AGN Total Omissions Negative General  BL 10.052 13.177 L>H ‐3.021 235 0.003 0.193 
AGN Total Omissions Positive General  BL 12.035 14.645 L>H ‐2.817 237 0.005 0.180 
CGT Risk Adjustment Specific  BL 1.453 1.706 L>H ‐3.043 576 0.002 0.126 
Abbreviations 
AGN Total Omissions Negative/Positive: Affective Go‐NoGo Task, total number of missed responses to targets in the blocks specified by the value of target type 
(negative, positive); CGT Risk Adjustment: Cambridge Gambling Task, tendency to get higher proportions of points when the large majority of boxed are the 
colour chosen; General Stratification: using CAPE Total Score (High Group: Scorers in upper 10% of CAPE Total Score, n=149; Low Group: Scorers in lower 10% 
CAPE Total Score, n=149); Specific Stratification: using CAPE 3‐Items Score (High Group: Scorers in upper 25% of CAPE 3‐Items Score, n=366; Low Group: Scorers 
in lower 25% CAPE 3‐Items Score, n=330); H>L: High Group showing greater scores than Low Group; L>H: Low Group showing greater scores than High Group; r: 
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Appendix XX: Longitudinal Analysis 
CANTAB Measures Exploratory Longitudinal Analysis, Paired T-tests, CAPE General and Specific Stratification  






t-test for Equality of Means 
t-test df Sig.  r  
AGN Total Omissions Negative ALL 11.899 6.647 BL>FU 18.932 781 <0.0001 0.561 
 HIGH General 10.065 6.688 BL>FU 3.745 76 <0.0001 0.395 
 LOW General 12.369 7.095 BL>FU 6.385 83 <0.0001 0.574 
AGN Total Omissions Positive ALL 13.787 8.551 BL>FU 19.853 781 <0.0001 0.579 
 HIGH General 12.195 8.273 BL>FU 4.529 76 <0.0001 0.461 
 LOW General 14.274 8.964 BL>FU 6.352 83 <0.0001 0.572 
CGT Risk Adjustment ALL 1.606 1.934 FU>BL ‐11.329 1131 <0.0001 0.319 
 HIGH Specific 1.447 1.883 FU>BL ‐7.313 282 <0.0001 0.399 
 LOW Specific 1.702 1.891 FU>BL ‐3.058 260 <0.0001 0.186 
Abbreviations 
AGN Total Omissions Negative/Positive: Affective Go‐NoGo Task, total number of missed responses to targets in the blocks specified by the value 
of target type (negative, positive); CGT Risk Adjustment: Cambridge Gambling Task, tendency to get higher proportions of points when the large 
majority of boxed are the colour chosen; BL>FU: Mean Scores greater at BL; FU>BL: Mean Scores greater at FU; r: Pearson’s correlation coefficient; 
BL: Baseline; FU: Follow‐up: ALL: Whole sample, n=1,434: High General: Scorers in upper 10% of CAPE Total Score, n=149; Low General: Scorers in 
lower 10% CAPE Total Score, n=149: High Specific: Scorers in upper 25% of CAPE 3‐Items Score, n=366; Low Specific: Scorers in lower 25% CAPE 3‐
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APPENDIX XXI: FT Study, fROIs Illustrations, CAPE General Stratification 
FT Study, CAPE General Stratification, ROIs selected for analysis, Coronal View 
BASELINE [42 8 ‐14]: Right Insular Cortex (H>L) 
FOLLOW-UP [‐12 5 10]: Left Caudate Body (L>H); [6 65 31]: Right Superior Frontal Gyrus (L>H); [33 ‐46 ‐5]: Right Parahippocampal Gyrus (L>H) 
 
Horizontal Axis: Left=Left, Right=Right 
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FT Study, CAPE General Stratification, ROIs selected for analysis, Sagittal View 
BASELINE [42 8 ‐14]: Right Insular Cortex (H>L) 
FOLLOW-UP [‐12 5 10]: Left Caudate Body (L>H); [6 65 31]: Right Superior Frontal Gyrus (L>H); [33 ‐46 ‐5]: Right Parahippocampal Gyrus (L>H) 
 
Horizontal Axis: Left=Posterior, Right=Anterior  
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FT Study, CAPE General Stratification, ROIs selected for analysis, Axial View 
BASELINE [42 8 ‐14]: Right Insular Cortex (H>L) 
FOLLOW-UP [‐12 5 10]: Left Caudate Body (L>H); [6 65 31]: Right Superior Frontal Gyrus (L>H); [33 ‐46 ‐5]: Right Parahippocampal Gyrus (L>H) 
 
Horizontal Axis: Left=Left, Right=Right  
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APPENDIX XXII: FT Study, fROIs Illustrations, CAPE Specific Stratification 
FT Study, CAPE Specific Stratification, ROIs selected for analysis, Coronal View 
BASELINE [‐6 ‐73 ‐26]: Left Cerebellar Declive (H>L); [‐33 11 10]: Left Insular Cortex (L>H) 
FOLLOW-UP [‐15 ‐40 ‐44]: Left Cerebellar Tonsil (L>H); [‐33 17 ‐11]: Left Insular Cortex (L>H) 
 
Horizontal Axis: Left=Left, Right=Right 
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FT Study, CAPE Specific Stratification, ROIs selected for analysis, Sagittal View 
BASELINE [‐6 ‐73 ‐26]: Left Cerebellar Declive (H>L); [‐33 11 10]: Left Insular Cortex (L>H) 
FOLLOW-UP [‐15 ‐40 ‐44]: Left Cerebellar Tonsil (L>H); [‐33 17 ‐11]: Left Insular Cortex (L>H) 
 
Horizontal Axis: Left=Posterior, Right=Anterior  
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FT Study, CAPE Specific Stratification, ROIs selected for analysis, Axial View 
BASELINE [‐6 ‐73 ‐26]: Left Cerebellar Declive (H>L); [‐33 11 10]: Left Insular Cortex (L>H) 
FOLLOW-UP [‐15 ‐40 ‐44]: Left Cerebellar Tonsil (L>H); [‐33 17 ‐11]: Left Insular Cortex (L>H) 
 
Horizontal Axis: Left=Left, Right=Right  
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APPENDIX XXIII: MID Study, fROIs Illustrations, CAPE General Stratification 
MID Study, CAPE General Stratification, ROIs selected for analysis, Coronal View 
BASELINE [33 41 40] Right Middle Frontal Gyrus (L>H, Feedback); [33 44 31] Right Middle Frontal Gyrus (L>H, Feedback);  
[‐36 47 31] Left Middle Frontal Gyrus (L>H, Feedback); [‐12 ‐28 40] Left Cingulate Gyrus (L>H, Feedback) 
FOLLOW-UP [9 8 1] Right Caudate Head (L>H, Anticipation) 
 
Horizontal Axis: Left=Left, Right=Right 
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MID Study, CAPE General Stratification, ROIs selected for analysis, Sagittal View 
BASELINE [33 41 40] Right Middle Frontal Gyrus (L>H, Feedback); [33 44 31] Right Middle Frontal Gyrus (L>H, Feedback);  
[‐36 47 31] Left Middle Frontal Gyrus (L>H, Feedback); [‐12 ‐28 40] Left Cingulate Gyrus (L>H, Feedback) 
FOLLOW-UP [9 8 1] Right Caudate Head (L>H, Anticipation) 
 
Horizontal Axis: Left=Posterior, Right=Anterior  
Vertical Axis: Up=Superior, Down=Inferior   
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MID Study, CAPE General Stratification, ROIs selected for analysis, Axial View 
BASELINE [33 41 40] Right Middle Frontal Gyrus (L>H, Feedback); [33 44 31] Right Middle Frontal Gyrus (L>H, Feedback);  
[‐36 47 31] Left Middle Frontal Gyrus (L>H, Feedback); [‐12 ‐28 40] Left Cingulate Gyrus (L>H, Feedback) 
FOLLOW-UP [9 8 1] Right Caudate Head (L>H, Anticipation) 
 
Horizontal Axis: Left=Left, Right=Right 
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APPENDIX XXIV: MID Study, fROIs Illustrations, CAPE Specific Stratification 
MID Study, CAPE Specific Stratification, ROIs selected for analysis, Coronal View 
BASELINE [57 ‐46 ‐14] Right Inferior Temporal Gyrus (L>H, Feedback); [‐30 ‐64 ‐32] Left Cerebellar Uvula (L>H, Feedback) 
FOLLOW-UP [‐24 68 ‐8] Left Superior Frontal Gyrus (L>H, Anticipation) 
 
Horizontal Axis: Left=Left, Right=Right 
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MID Study, CAPE Specific Stratification, ROIs selected for analysis, Sagittal View 
BASELINE [57 ‐46 ‐14] Right Inferior Temporal Gyrus (L>H, Feedback); [‐30 ‐64 ‐32] Left Cerebellar Uvula (L>H, Feedback) 
FOLLOW-UP [‐24 68 ‐8] Left Superior Frontal Gyrus (L>H, Anticipation) 
 
Horizontal Axis: Left=Posterior, Right=Anterior  
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MID Study, CAPE Specific Stratification, ROIs selected for analysis, Axial View 
BASELINE [57 ‐46 ‐14] Right Inferior Temporal Gyrus (L>H, Feedback); [‐30 ‐64 ‐32] Left Cerebellar Uvula (L>H, Feedback) 
FOLLOW-UP [‐24 68 ‐8] Left Superior Frontal Gyrus (L>H, Anticipation) 
 
Horizontal Axis: Left=Left, Right=Right 
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APPENDIX XXV: Correlations between fROIs BOLD signals, and selected CANTAB and CAPE scores 
Baseline Correlations between BOLD signals, and selected CANTAB and CAPE scores 
 












































































MID, Feedback, Specific 
[57 ‐46 ‐14]  
-0.142 
(p=0.036) 
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Follow-up Correlations between BOLD signals, and selected CANTAB and CAPE scores 
 
Task, Stratification fROI 




























 FT, General 
[42 8 ‐14] 
    0.163 
(p=0.030) 
















































MID, Anticipation, Specific [‐24 68 ‐8] 
-0.150 
(p=0.006) 
    
In bold: Spearman’s rho (correlation coefficient), non‐parametric; p: 2‐tailed significance level; only statistically significant correlations are displayed. 
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APPENDIX XXVI: Publication 
 
Papanastasiou E, Mouchlianitis E, Joyce DW, et al. Examination of the Neural Basis of 
Psychoticlike Experiences in Adolescence During Reward Processing. JAMA 
Psychiatry. Published online August 01, 2018. doi:10.1001/jamapsychiatry.2018.1973 254 
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